Identification	O
of	O
phosphorylation	B-protein
sites	I-protein
for	O
Bruton	B-protein
's	I-protein
tyrosine	I-protein
kinase	I-protein
within	O
the	O
transcriptional	B-protein
regulator	I-protein
BAP/TFII-I	I-protein
.	O

Bruton	B-protein
's	I-protein
tyrosine	I-protein
kinase	I-protein
(	O
Btk	B-protein
)	O
,	O
a	O
member	O
of	O
the	O
Tec	B-protein
family	I-protein
of	I-protein
cytosolic	I-protein
kinases	I-protein
,	O
is	O
essential	O
for	O
B	B-cell_type
cell	I-cell_type
development	O
and	O
function	O
.	O

BAP/TFII-I	B-protein
,	O
a	O
protein	O
implicated	O
in	O
transcriptional	O
regulation	O
,	O
is	O
associated	O
with	O
Btk	B-protein
in	O
B	B-cell_type
cells	I-cell_type
and	O
is	O
transiently	O
phosphorylated	O
on	O
tyrosine	O
following	O
B	B-cell_type
cell	I-cell_type
receptor	O
engagement	O
.	O

BAP/TFII-I	B-protein
is	O
a	O
substrate	O
for	O
Btk	B-protein
in	O
vitro	O
and	O
is	O
hyperphosphorylated	O
on	O
tyrosine	O
upon	O
coexpression	O
with	O
Btk	B-protein
in	O
mammalian	B-cell_type
cells	I-cell_type
.	O

In	O
an	O
effort	O
to	O
understand	O
the	O
physiologic	O
consequences	O
of	O
BAP/TFII-I	B-protein
tyrosine	O
phosphorylation	O
following	O
B	O
cell	O
receptor	O
stimulation	O
,	O
site-directed	O
mutagenesis	O
and	O
phosphopeptide	O
mapping	O
were	O
used	O
to	O
locate	O
the	O
predominant	O
sites	O
of	O
BAP/TFII-I	B-protein
phosphorylation	O
by	O
Btk	B-protein
in	O
vitro	O
.	O

These	O
residues	O
,	O
Tyr248	O
,	O
Tyr357	O
,	O
and	O
Tyr462	O
,	O
were	O
also	O
found	O
to	O
be	O
the	O
major	O
sites	O
for	O
Btk	B-protein
-dependent	O
phosphorylation	O
of	O
BAP/TFII-I	B-protein
in	O
vivo	O
.	O

Residues	O
Tyr357	O
and	O
Tyr462	O
are	O
contained	O
within	O
the	O
loop	B-protein
regions	I-protein
of	O
adjacent	O
helix-loop-helix-like	B-protein
repeats	I-protein
within	O
BAP/TFII-I	B-protein
.	O

Mutation	O
of	O
either	O
Tyr248	O
,	O
Tyr357	O
,	O
or	O
Tyr462	O
to	O
phenylalanine	O
reduced	O
transcription	O
from	O
a	O
c-fos	B-DNA
promoter	I-DNA
relative	O
to	O
wild-type	B-DNA
BAP/TFII-I	I-DNA
in	O
transfected	O
COS-7	B-cell_line
cells	I-cell_line
,	O
consistent	O
with	O
the	O
interpretation	O
that	O
phosphorylation	O
at	O
these	O
sites	O
contributes	O
to	O
transcriptional	O
activation	O
.	O

Phosphorylation	O
of	O
BAP/TFII-I	B-protein
by	O
Btk	B-protein
may	O
link	O
engagement	O
of	O
receptors	O
such	O
as	O
surface	O
immunoglobulin	B-protein
to	O
modulation	O
of	O
gene	O
expression	O
.	O

THE	NULL
JOURNAL	NULL
oF	NULL
BIOLOGICAL	NULL
CHEMISTRY	NULL
©	NULL
2001	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

276	NULL
,	NULL
No	NULL
.	NULL

30	NULL
,	NULL
Issue	NULL
of	NULL
July	NULL
27	NULL
,	NULL
pp	NULL
.	NULL

27806-27815	NULL
,	NULL
2001	NULL
Printed	NULL
in	NULL
U.S.A	NULL
.	NULL

Identification	NULL
of	NULL
Phosphorylation	NULL
Sites	NULL
for	NULL
Bruton	NULL
's	NULL
Tyrosine	NULL
Kinase	NULL
within	NULL
the	NULL
Transcriptional	NULL
Regulator	NULL
BAP/TFII-I*	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
April	NULL
25	NULL
,	NULL
2001	NULL
Published	NULL
,	NULL
JBC	NULL
Papers	NULL
in	NULL
Press	NULL
,	NULL
May	NULL
28	NULL
,	NULL
2001	NULL
,	NULL
DOI	NULL
10.1074/jbe.M103692200	NULL
Ann	NULL
Marie	NULL
Egloff	NULL
and	NULL
Stephen	NULL
Desideriof	NULL
From	NULL
the	NULL
Department	NULL
of	NULL
Molecular	NULL
Biology	NULL
and	NULL
Genetics	NULL
and	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
,	NULL
The	NULL
Johns	NULL
Hopkins	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Baltimore	NULL
,	NULL
Maryland	NULL
21205	NULL
Bruton	NULL
's	NULL
tyrosine	NULL
kinase	NULL
(	NULL
Btk	NULL
)	NULL
,	NULL
a	NULL
member	NULL
of	NULL
the	NULL
Tec	NULL
family	NULL
of	NULL
cytosolic	NULL
kinases	NULL
,	NULL
is	NULL
essential	NULL
for	NULL
B	NULL
cell	NULL
development	NULL
and	NULL
function	NULL
.	NULL

BAP/TFII-I	NULL
,	NULL
a	NULL
protein	NULL
implicated	NULL
in	NULL
transcriptional	NULL
regulation	NULL
,	NULL
is	NULL
associated	NULL
with	NULL
Btk	NULL
in	NULL
B	NULL
cells	NULL
and	NULL
is	NULL
transiently	NULL
phosphorylated	NULL
on	NULL
tyrosine	NULL
following	NULL
B	NULL
cell	NULL
receptor	NULL
engagement	NULL
.	NULL

BAP/TFII-I	NULL
is	NULL
a	NULL
substrate	NULL
for	NULL
Btk	NULL
in	NULL
vitro	NULL
and	NULL
is	NULL
hyperphosphorylated	NULL
on	NULL
tyrosine	NULL
upon	NULL
coexpression	NULL
with	NULL
Btk	NULL
in	NULL
mammalian	NULL
cells	NULL
.	NULL

In	NULL
an	NULL
effort	NULL
to	NULL
understand	NULL
the	NULL
physiologic	NULL
consequences	NULL
of	NULL
BAP/TFII-I	NULL
tyrosine	NULL
phosphorylation	NULL
following	NULL
B	NULL
cell	NULL
receptor	NULL
stimulation	NULL
,	NULL
site-directed	NULL
mutagenesis	NULL
and	NULL
phosphopeptide	NULL
mapping	NULL
were	NULL
used	NULL
to	NULL
locate	NULL
the	NULL
predominant	NULL
sites	NULL
of	NULL
BAP/	NULL
TFII-I	NULL
phosphorylation	NULL
by	NULL
Btk	NULL
in	NULL
vitro	NULL
.	NULL

These	NULL
residues	NULL
,	NULL
Tyr	NULL
``	NULL
,	NULL
Tyr®	NULL
``	NULL
``	NULL
,	NULL
and	NULL
Tyr**	NULL
``	NULL
,	NULL
were	NULL
also	NULL
found	NULL
to	NULL
be	NULL
the	NULL
major	NULL
sites	NULL
for	NULL
Btk-dependent	NULL
phosphorylation	NULL
of	NULL
BAP/TFII-I	NULL
in	NULL
vivo	NULL
.	NULL

Residues	NULL
Tyr®*	NULL
``	NULL
and	NULL
Tyr	NULL
are	NULL
contained	NULL
within	NULL
the	NULL
loop	NULL
regions	NULL
of	NULL
adjacent	NULL
helix-loop-helix-like	NULL
repeats	NULL
within	NULL
BAP/TFIl-L	NULL
Mutation	NULL
of	NULL
either	NULL
Tyr®*	NULL
``	NULL
,	NULL
Tyr®	NULL
``	NULL
,	NULL
or	NULL
Tyr	NULL
``	NULL
to	NULL
phenylalanine	NULL
reduced	NULL
transcription	NULL
from	NULL
a	NULL
c-fos	NULL
promoter	NULL
relative	NULL
to	NULL
wild-type	NULL
BAP/TFII-I	NULL
in	NULL
transfected	NULL
COS-7	NULL
cells	NULL
,	NULL
consistent	NULL
with	NULL
the	NULL
interpretation	NULL
that	NULL
phosphorylation	NULL
at	NULL
these	NULL
sites	NULL
contributes	NULL
to	NULL
transcriptional	NULL
activation	NULL
.	NULL

Phosphorylation	NULL
of	NULL
BAP/TFII-I	NULL
by	NULL
Btk	NULL
may	NULL
link	NULL
engagement	NULL
of	NULL
receptors	NULL
such	NULL
as	NULL
surface	NULL
immunoglobulin	NULL
to	NULL
modulation	NULL
of	NULL
gene	NULL
expression	NULL
.	NULL

Bruton	NULL
's	NULL
tyrosine	NULL
kinase	NULL
(	NULL
Btk	NULL
)	NULL
,	NULL
which	NULL
is	NULL
expressed	NULL
in	NULL
B	NULL
cells	NULL
and	NULL
cells	NULL
of	NULL
the	NULL
myeloid	NULL
lineage	NULL
,	NULL
was	NULL
initially	NULL
identified	NULL
as	NULL
the	NULL
target	NULL
of	NULL
mutations	NULL
responsible	NULL
for	NULL
X-linked	NULL
agammaglobulinemia	NULL
in	NULL
humans	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

Patients	NULL
with	NULL
X-linked	NULL
agammaglobulinemia	NULL
exhibit	NULL
an	NULL
intrinsic	NULL
defect	NULL
in	NULL
B	NULL
cell	NULL
development	NULL
;	NULL
peripheral	NULL
B	NULL
cells	NULL
are	NULL
rare	NULL
and	NULL
of	NULL
an	NULL
immature	NULL
phenotype	NULL
,	NULL
but	NULL
the	NULL
number	NULL
of	NULL
pre-B	NULL
cells	NULL
in	NULL
the	NULL
bone	NULL
marrow	NULL
is	NULL
not	NULL
significantly	NULL
reduced	NULL
,	NULL
consistent	NULL
with	NULL
impairment	NULL
of	NULL
the	NULL
pre-B	NULL
to	NULL
B	NULL
cell	NULL
transition	NULL
(	NULL
3	NULL
)	NULL
.	NULL

A	NULL
point	NULL
mutation	NULL
in	NULL
the	NULL
orthologous	NULL
tyrosine	NULL
kinase	NULL
is	NULL
responsible	NULL
for	NULL
an	NULL
X-linked	NULL
deficiency	NULL
of	NULL
B	NULL
cell	NULL
function	NULL
(	NULL
X-linked	NULL
immunodeficiency	NULL
,	NULL
or	NULL
xid	NULL
)	NULL
in	NULL
the	NULL
mouse	NULL
(	NULL
4	NULL
,	NULL
5	NULL
)	NULL
.	NULL

The	NULL
mouse	NULL
xid	NULL
phenotype	NULL
is	NULL
distinct	NULL
from	NULL
X-linked	NULL
agammaglobulinemia	NULL
(	NULL
6	NULL
)	NULL
.	NULL

Antibody	NULL
responses	NULL
to	NULL
some	NULL
T	NULL
cell-independent	NULL
antigens	NULL
are	NULL
ab-sent	NULL
,	NULL
but	NULL
responses	NULL
to	NULL
most	NULL
T	NULL
cell-dependent	NULL
antigens	NULL
are	NULL
intact	NULL
.	NULL

*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
the	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
and	NULL
NCI	NULL
,	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Grant	NULL
CA16519	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.9.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

J	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
:	NULL
Dept	NULL
.	NULL

of	NULL
Molecular	NULL
Biology	NULL
and	NULL
Genetics	NULL
,	NULL
The	NULL
Johns	NULL
Hopkins	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
725	NULL
N.	NULL
Wolfe	NULL
St.	NULL
,	NULL
Baltimore	NULL
,	NULL
MD	NULL
21205	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
410-955-4785	NULL
;	NULL
Fax	NULL
:	NULL
410-955-9124	NULL
.	NULL

*The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
Btk	NULL
,	NULL
Bruton	NULL
's	NULL
tyrosine	NULL
kinase	NULL
;	NULL
SH1	NULL
,	NULL
SH2	NULL
,	NULL
and	NULL
SH3	NULL
,	NULL
Sre	NULL
homology	NULL
1	NULL
,	NULL
2	NULL
,	NULL
and	NULL
8	NULL
,	NULL
respectively	NULL
;	NULL
HLH	NULL
,	NULL
helix-loop-helix	NULL
;	NULL
MBP	NULL
,	NULL
maltose-binding	NULL
protein	NULL
;	NULL
DMEM	NULL
,	NULL
Dulbecco	NULL
's	NULL
modified	NULL
Eagle	NULL
's	NULL
medium	NULL
;	NULL
PVDF	NULL
,	NULL
polyvinylidene	NULL
difluoride	NULL
;	NULL
TK	NULL
,	NULL
thymidine	NULL
kinase	NULL
.	NULL

27806	NULL
Peripheral	NULL
B	NULL
cells	NULL
are	NULL
slightly	NULL
reduced	NULL
and	NULL
skewed	NULL
toward	NULL
an	NULL
immature	NULL
phenotype	NULL
.	NULL

Survival	NULL
of	NULL
peripheral	NULL
B	NULL
cells	NULL
is	NULL
dimin-ished	NULL
,	NULL
and	NULL
the	NULL
peritoneal	NULL
B-1	NULL
B	NULL
cell	NULL
population	NULL
is	NULL
absent	NULL
.	NULL

Notably	NULL
,	NULL
xid	NULL
mice	NULL
do	NULL
not	NULL
exhibit	NULL
the	NULL
block	NULL
in	NULL
early	NULL
B	NULL
cell	NULL
development	NULL
observed	NULL
in	NULL
patients	NULL
with	NULL
X-linked	NULL
agammaglobulinemia	NULL
.	NULL

Btk	NULL
null	NULL
mice	NULL
exhibit	NULL
a	NULL
phenotype	NULL
resembling	NULL
xid	NULL
,	NULL
suggesting	NULL
that	NULL
B	NULL
cell	NULL
development	NULL
has	NULL
a	NULL
more	NULL
stringent	NULL
requirement	NULL
for	NULL
Btk	NULL
in	NULL
humans	NULL
than	NULL
in	NULL
mice	NULL
(	NULL
7-10	NULL
)	NULL
.	NULL

Btk	NULL
belongs	NULL
to	NULL
the	NULL
Tec	NULL
family	NULL
of	NULL
cytosolic	NULL
protein-tyrosine	NULL
kinases	NULL
,	NULL
which	NULL
includes	NULL
Btk	NULL
,	NULL
Itk	NULL
,	NULL
Tec	NULL
,	NULL
and	NULL
Bmx	NULL
.	NULL

This	NULL
group	NULL
of	NULL
kinases	NULL
is	NULL
related	NULL
to	NULL
the	NULL
Src	NULL
family	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
SH3	NULL
,	NULL
SH2	NULL
,	NULL
and	NULL
SHI	NULL
(	NULL
catalytic	NULL
)	NULL
domains	NULL
.	NULL

It	NULL
is	NULL
distinguished	NULL
from	NULL
the	NULL
Sre	NULL
family	NULL
by	NULL
1	NULL
)	NULL
the	NULL
presence	NULL
of	NULL
pleckstrin	NULL
homology	NULL
and	NULL
Tec	NULL
homology	NULL
domains	NULL
,	NULL
which	NULL
serve	NULL
as	NULL
binding	NULL
sites	NULL
for	NULL
phospho-lipids	NULL
and	NULL
SH3	NULL
domains	NULL
,	NULL
respectively	NULL
;	NULL
2	NULL
)	NULL
the	NULL
absence	NULL
of	NULL
an	NULL
N-terminal	NULL
myristoylation	NULL
site	NULL
;	NULL
and	NULL
3	NULL
)	NULL
the	NULL
lack	NULL
of	NULL
a	NULL
regulatory	NULL
tyrosine	NULL
residue	NULL
near	NULL
the	NULL
carboxyl	NULL
terminus	NULL
(	NULL
11-14	NULL
)	NULL
.	NULL

An	NULL
atypical	NULL
member	NULL
of	NULL
the	NULL
Tec	NULL
family	NULL
,	NULL
Rlk/I'xk	NULL
,	NULL
lacks	NULL
a	NULL
pleckstrin	NULL
homology	NULL
domain	NULL
but	NULL
has	NULL
54-62	NULL
%	NULL
amino	NULL
acid	NULL
identity	NULL
to	NULL
Btk	NULL
in	NULL
the	NULL
remainder	NULL
of	NULL
its	NULL
sequence	NULL
(	NULL
15	NULL
,	NULL
16	NULL
)	NULL
.	NULL

Btk	NULL
has	NULL
been	NULL
implicated	NULL
as	NULL
important	NULL
in	NULL
signaling	NULL
from	NULL
the	NULL
B	NULL
cell	NULL
receptor	NULL
for	NULL
antigen	NULL
,	NULL
the	NULL
interleukin-5	NULL
and	NULL
-6	NULL
receptors	NULL
,	NULL
and	NULL
CD38	NULL
on	NULL
B	NULL
cells	NULL
(	NULL
17-19	NULL
)	NULL
;	NULL
the	NULL
FeeRI	NULL
receptor	NULL
on	NULL
mast	NULL
cells	NULL
(	NULL
20	NULL
)	NULL
;	NULL
the	NULL
FeyRI	NULL
on	NULL
macrophages	NULL
;	NULL
and	NULL
the	NULL
thrombin	NULL
receptor	NULL
on	NULL
platelets	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Upon	NULL
engagement	NULL
of	NULL
the	NULL
B	NULL
cell	NULL
receptor	NULL
,	NULL
Btk	NULL
is	NULL
phosphorylated	NULL
by	NULL
the	NULL
tyrosine	NULL
kinase	NULL
Lyn	NULL
at	NULL
residue	NULL
Tyr®	NULL
``	NULL
'	NULL
.	NULL

This	NULL
permits	NULL
Btk	NULL
to	NULL
undergo	NULL
autophosphorylation	NULL
at	NULL
residue	NULL
Tyr®	NULL
``	NULL
``	NULL
,	NULL
after	NULL
which	NULL
kinase	NULL
activity	NULL
is	NULL
increased	NULL
(	NULL
22	NULL
)	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
Btk	NULL
can	NULL
also	NULL
be	NULL
modulated	NULL
by	NULL
association	NULL
with	NULL
G	NULL
,	NULL
«	NULL
proteins	NULL
(	NULL
23	NULL
)	NULL
,	NULL
GBy	NULL
proteins	NULL
(	NULL
24	NULL
)	NULL
,	NULL
or	NULL
phosphatidylinositol	NULL
phosphates	NULL
(	NULL
25	NULL
)	NULL
.	NULL

A	NULL
fraction	NULL
of	NULL
Btk	NULL
coimmunoprecipitates	NULL
with	NULL
a	NULL
protein	NULL
of	NULL
~135	NULL
kDa	NULL
termed	NULL
BAP	NULL
(	NULL
for	NULL
Btk-associated	NULL
Brotein	NULL
)	NULL
;	NULL
based	NULL
on	NULL
this	NULL
association	NULL
,	NULL
BAP	NULL
was	NULL
purified	NULL
,	NULL
and	NULL
its	NULL
cDNA	NULL
was	NULL
molecu-larly	NULL
cloned	NULL
(	NULL
26	NULL
)	NULL
.	NULL

BAP	NULL
is	NULL
identical	NULL
to	NULL
the	NULL
putative	NULL
transcription	NULL
factor	NULL
TFII-I	NULL
(	NULL
27	NULL
)	NULL
,	NULL
which	NULL
was	NULL
identified	NULL
by	NULL
its	NULL
ability	NULL
to	NULL
stimulate	NULL
transcription	NULL
from	NULL
initiator	NULL
elements	NULL
(	NULL
27	NULL
)	NULL
and	NULL
its	NULL
synergy	NULL
with	NULL
Phox	NULL
I	NULL
and	NULL
serum	NULL
response	NULL
factor	NULL
in	NULL
enhancing	NULL
transcription	NULL
from	NULL
the	NULL
c-fos	NULL
promoter	NULL
(	NULL
28	NULL
)	NULL
.	NULL

A	NULL
distinctive	NULL
feature	NULL
of	NULL
BAP/TFII-I	NULL
is	NULL
the	NULL
occurrence	NULL
of	NULL
six	NULL
helix-loop-helix	NULL
(	NULL
HLH	NULL
)	NULL
-like	NULL
repeats	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
typical	NULL
HLH	NULL
motifs	NULL
,	NULL
however	NULL
,	NULL
which	NULL
contain	NULL
loop	NULL
regions	NULL
of	NULL
between	NULL
6	NULL
and	NULL
20	NULL
amino	NULL
acids	NULL
(	NULL
29	NULL
)	NULL
,	NULL
the	NULL
HLH-like	NULL
repeats	NULL
of	NULL
BAP/TFII-I	NULL
contain	NULL
extended	NULL
loop	NULL
regions	NULL
of	NULL
~70	NULL
amino	NULL
acids	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Four	NULL
isoforms	NULL
of	NULL
BAP/TFII-I	NULL
,	NULL
generated	NULL
by	NULL
alternative	NULL
splicing	NULL
of	NULL
primary	NULL
RNA	NULL
transcripts	NULL
,	NULL
are	NULL
differentially	NULL
expressed	NULL
in	NULL
various	NULL
tissues	NULL
.	NULL

Amino	NULL
acid	NULL
sequence	NULL
differences	NULL
among	NULL
these	NULL
four	NULL
isoforms	NULL
are	NULL
confined	NULL
to	NULL
the	NULL
interval	NULL
between	NULL
the	NULL
first	NULL
and	NULL
second	NULL
HLH-like	NULL
domains	NULL
(	NULL
80	NULL
)	NULL
.	NULL

Two	NULL
sequence	NULL
motifs	NULL
resem-	NULL
°	NULL
H.	NULL
Taylor	NULL
,	NULL
and	NULL
S.	NULL
Desiderio	NULL
,	NULL
unpublished	NULL
results	NULL
.	NULL

This	NULL
paper	NULL
is	NULL
available	NULL
on	NULL
line	NULL
at	NULL
http	NULL
:	NULL
//www.jbc.org	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
Btk	NULL
Phosphorylation	NULL
Sites	NULL
in	NULL
BAP/TFILI-I	NULL
bling	NULL
the	NULL
Sre	NULL
kinase	NULL
autophosphorylation	NULL
consensus	NULL
sequence	NULL
(	NULL
EDXDY	NULL
)	NULL
are	NULL
present	NULL
within	NULL
this	NULL
interval	NULL
and	NULL
are	NULL
preserved	NULL
in	NULL
all	NULL
four	NULL
BAP/TFII-I	NULL
isoforms	NULL
.	NULL

BAP/TFII-I	NULL
is	NULL
transiently	NULL
phosphorylated	NULL
on	NULL
tyrosine	NULL
following	NULL
B	NULL
cell	NULL
receptor	NULL
engagement	NULL
,	NULL
with	NULL
kinetics	NULL
that	NULL
closely	NULL
follow	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Btk	NULL
(	NULL
26	NULL
)	NULL
.	NULL

Increased	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
BAP/TFII-I	NULL
is	NULL
also	NULL
observed	NULL
upon	NULL
cotransfection	NULL
with	NULL
Btk	NULL
into	NULL
fibroblastoid	NULL
cells	NULL
.	NULL

This	NULL
response	NULL
is	NULL
dependent	NULL
upon	NULL
Btk	NULL
kinase	NULL
activity	NULL
,	NULL
since	NULL
cotransfection	NULL
with	NULL
the	NULL
kinase-inactive	NULL
mutant	NULL
Btk	NULL
(	NULL
K430E	NULL
)	NULL
fails	NULL
to	NULL
enhance	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
BAP/TFII-I	NULL
(	NULL
26	NULL
)	NULL
.	NULL

These	NULL
observations	NULL
and	NULL
the	NULL
physical	NULL
association	NULL
of	NULL
Btk	NULL
with	NULL
BAP/TFII-I	NULL
in	NULL
B	NULL
lymphoid	NULL
cells	NULL
(	NULL
26	NULL
)	NULL
suggested	NULL
that	NULL
BAP/TFII-I	NULL
is	NULL
a	NULL
physiologic	NULL
substrate	NULL
for	NULL
phosphorylation	NULL
by	NULL
Btk	NULL
following	NULL
B	NULL
cell	NULL
receptor	NULL
stimulation	NULL
.	NULL

Several	NULL
lines	NULL
of	NULL
evidence	NULL
suggest	NULL
that	NULL
phosphorylation	NULL
modulates	NULL
the	NULL
ability	NULL
of	NULL
BAP/TFII-I	NULL
to	NULL
stimulate	NULL
transcription	NULL
.	NULL

First	NULL
,	NULL
dephosphorylation	NULL
impairs	NULL
the	NULL
ability	NULL
of	NULL
BAP/TFII-I	NULL
to	NULL
stimulate	NULL
transcription	NULL
from	NULL
a	NULL
VB	NULL
promoter	NULL
in	NULL
vitro	NULL
,	NULL
while	NULL
sparing	NULL
its	NULL
ability	NULL
to	NULL
bind	NULL
the	NULL
VB	NULL
initiator	NULL
element	NULL
(	NULL
81	NULL
)	NULL
.	NULL

Second	NULL
,	NULL
stimulation	NULL
of	NULL
VB	NULL
transcription	NULL
by	NULL
BAP/TFII-I	NULL
in	NULL
transfected	NULL
cells	NULL
is	NULL
enhanced	NULL
by	NULL
wild-type	NULL
Btk	NULL
but	NULL
not	NULL
by	NULL
a	NULL
kinase-inactive	NULL
mutant	NULL
(	NULL
32	NULL
)	NULL
.	NULL

Third	NULL
,	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
BAP/TFII-I	NULL
in	NULL
transfected	NULL
cells	NULL
is	NULL
impaired	NULL
by	NULL
mutation	NULL
of	NULL
a	NULL
site	NULL
conforming	NULL
to	NULL
the	NULL
Sre	NULL
autophosphorylation	NULL
consensus	NULL
(	NULL
31	NULL
)	NULL
.	NULL

Fourth	NULL
,	NULL
epidermal	NULL
growth	NULL
factor	NULL
,	NULL
which	NULL
enhances	NULL
c-fos	NULL
promoter	NULL
activity	NULL
,	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
BAP/TFII-I	NULL
(	NULL
83	NULL
)	NULL
.	NULL

While	NULL
these	NULL
observations	NULL
are	NULL
consistent	NULL
with	NULL
the	NULL
interpretation	NULL
that	NULL
Btk	NULL
activates	NULL
BAP/TFII-I	NULL
by	NULL
tyrosine	NULL
phosphorylation	NULL
,	NULL
definitive	NULL
evidence	NULL
is	NULL
lacking	NULL
.	NULL

As	NULL
an	NULL
essential	NULL
step	NULL
in	NULL
defining	NULL
a	NULL
regulatory	NULL
relationship	NULL
between	NULL
Btk	NULL
and	NULL
BAP/TFII-I	NULL
,	NULL
we	NULL
have	NULL
mapped	NULL
the	NULL
major	NULL
Btk	NULL
phosphorylation	NULL
sites	NULL
in	NULL
BAP/TFII-I	NULL
.	NULL

Bacterially	NULL
expressed	NULL
,	NULL
purified	NULL
Btk	NULL
phosphorylates	NULL
BAP/TFII-I	NULL
at	NULL
three	NULL
predominant	NULL
sites	NULL
:	NULL
Tyr®**	NULL
,	NULL
Tyr®	NULL
``	NULL
``	NULL
,	NULL
and	NULL
Tyr*©	NULL
``	NULL
.	NULL

The	NULL
first	NULL
site	NULL
lies	NULL
in	NULL
the	NULL
inter-repeat	NULL
region	NULL
between	NULL
the	NULL
first	NULL
and	NULL
second	NULL
HLH-like	NULL
domains	NULL
;	NULL
the	NULL
two	NULL
other	NULL
sites	NULL
are	NULL
at	NULL
analogous	NULL
positions	NULL
in	NULL
putative	NULL
loop	NULL
regions	NULL
of	NULL
the	NULL
second	NULL
and	NULL
third	NULL
HLH-like	NULL
domains	NULL
.	NULL

When	NULL
Btk	NULL
is	NULL
coexpressed	NULL
with	NULL
BAP/TFII-I	NULL
in	NULL
mammalian	NULL
cells	NULL
,	NULL
BAP/TFII-I	NULL
is	NULL
specifically	NULL
hyperphosphorylated	NULL
at	NULL
the	NULL
same	NULL
three	NULL
sites	NULL
.	NULL

Btk-specific	NULL
hyperphosphorylation	NULL
of	NULL
a	NULL
BAP/TFII-I	NULL
fragment	NULL
in	NULL
vivo	NULL
was	NULL
eliminated	NULL
by	NULL
mutation	NULL
of	NULL
these	NULL
sites	NULL
to	NULL
phenylalanine	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
BAP/TFII-I	NULL
to	NULL
stimulate	NULL
expression	NULL
of	NULL
a	NULL
c-fos	NULL
reporter	NULL
,	NULL
in	NULL
COS-7	NULL
cells	NULL
was	NULL
impaired	NULL
by	NULL
mutation	NULL
of	NULL
Tyr	NULL
``	NULL
,	NULL
Tyr®	NULL
``	NULL
``	NULL
,	NULL
or	NULL
Tyr*®	NULL
to	NULL
phenylalanine	NULL
,	NULL
consistent	NULL
with	NULL
the	NULL
interpretation	NULL
that	NULL
phosphorylation	NULL
of	NULL
these	NULL
sites	NULL
plays	NULL
a	NULL
role	NULL
in	NULL
transcriptional	NULL
activation	NULL
.	NULL

Phosphorylation	NULL
of	NULL
BAP/TFII-I	NULL
by	NULL
Btk	NULL
,	NULL
and	NULL
perhaps	NULL
other	NULL
Tec-related	NULL
kinases	NULL
,	NULL
may	NULL
link	NULL
engagement	NULL
of	NULL
receptors	NULL
such	NULL
as	NULL
surface	NULL
immunoglobulin	NULL
to	NULL
modulation	NULL
of	NULL
gene	NULL
expression	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Plasmids	NULL
and	NULL
Cell	NULL
Lines-Plasmid	NULL
pBAPmyc	NULL
,	NULL
encoding	NULL
the	NULL
shortest	NULL
isoform	NULL
of	NULL
BAP/TFII-I	NULL
(	NULL
BAP/TFII-I	NULL
A	NULL
)	NULL
,	NULL
fused	NULL
at	NULL
the	NULL
carboxyl	NULL
terminus	NULL
to	NULL
a	NULL
Pro-Gily	NULL
linker	NULL
and	NULL
the	NULL
c-Myc	NULL
epitope	NULL
EQKLISEEDL	NULL
,	NULL
was	NULL
constructed	NULL
from	NULL
a	NULL
BAP	NULL
cDNA	NULL
clone	NULL
(	NULL
26	NULL
)	NULL
by	NULL
polymerase	NULL
chain	NULL
reaction	NULL
.	NULL

The	NULL
plasmid	NULL
pBAPmyc	NULL
(	NULL
BN	NULL
)	NULL
was	NULL
generated	NULL
from	NULL
pBAPmyc	NULL
by	NULL
introduction	NULL
of	NULL
Sail	NULL
,	NULL
Xbal	NULL
,	NULL
and	NULL
in-frame	NULL
BamHI	NULL
sites	NULL
5	NULL
'	NULL
of	NULL
the	NULL
BAP/TFII-I	NULL
coding	NULL
sequence	NULL
.	NULL

The	NULL
following	NULL
BAP/TFII-I	NULL
carboxy-	NULL
and	NULL
amino-truncations	NULL
were	NULL
constructed	NULL
from	NULL
pBAPmyc	NULL
(	NULL
BN	NULL
)	NULL
using	NULL
polymerase	NULL
chain	NULL
reaction	NULL
:	NULL
pBAP-N-1R	NULL
(	NULL
residues	NULL
1-189	NULL
)	NULL
,	NULL
pBAP-N-NR2	NULL
(	NULL
residues	NULL
1-303	NULL
)	NULL
,	NULL
pBAP-N-2R	NULL
(	NULL
residues	NULL
1-898	NULL
)	NULL
,	NULL
pBAP-N-8R	NULL
(	NULL
residues	NULL
1-508	NULL
)	NULL
,	NULL
pBAP-4R-CT	NULL
(	NULL
residues	NULL
514-957	NULL
)	NULL
,	NULL
and	NULL
pBAP-5R-CT	NULL
(	NULL
residues	NULL
675-957	NULL
)	NULL
.	NULL

All	NULL
constructs	NULL
share	NULL
an	NULL
identical	NULL
initiation	NULL
sequence	NULL
(	NULL
34	NULL
)	NULL
and	NULL
a	NULL
carboxyl-terminal	NULL
c-Myc	NULL
epitope	NULL
.	NULL

Tyrosine	NULL
to	NULL
phenylalanine	NULL
point	NULL
mutations	NULL
were	NULL
introduced	NULL
using	NULL
divergent	NULL
polymerase	NULL
chain	NULL
reaction	NULL
(	NULL
85	NULL
)	NULL
.	NULL

The	NULL
identities	NULL
of	NULL
mutant	NULL
constructs	NULL
were	NULL
verified	NULL
by	NULL
nucleotide	NULL
sequence	NULL
analysis	NULL
.	NULL

For	NULL
expression	NULL
of	NULL
c-Myc-tagged	NULL
BAP/TFII-I	NULL
and	NULL
BAP	NULL
truncation	NULL
proteins	NULL
in	NULL
Escherichia	NULL
coli	NULL
under	NULL
inducible	NULL
control	NULL
of	NULL
the	NULL
araBAD	NULL
promoter	NULL
,	NULL
the	NULL
BamHI/EcoRV	NULL
fragments	NULL
of	NULL
pBAPmyc	NULL
(	NULL
BN	NULL
)	NULL
and	NULL
its	NULL
derivatives	NULL
,	NULL
encoding	NULL
full-length	NULL
BAP/TFII-I	NULL
or	NULL
BAP/TFII-I	NULL
truncation	NULL
pro	NULL
27807	NULL
teins	NULL
,	NULL
were	NULL
inserted	NULL
between	NULL
the	NULL
Bg/II	NULL
and	NULL
Poul	NULL
!	NULL

sites	NULL
of	NULL
pBADHisB	NULL
(	NULL
Invitrogen	NULL
)	NULL
.	NULL

For	NULL
eukaryotic	NULL
expression	NULL
studies	NULL
,	NULL
the	NULL
SaZl/NofI	NULL
fragments	NULL
of	NULL
pBAPmyc	NULL
(	NULL
BN	NULL
)	NULL
and	NULL
its	NULL
derivatives	NULL
,	NULL
encoding	NULL
full-length	NULL
or	NULL
truncated	NULL
BAP/TFII-I	NULL
proteins	NULL
,	NULL
were	NULL
inserted	NULL
between	NULL
the	NULL
XhoI	NULL
and	NULL
NotI	NULL
sites	NULL
of	NULL
pCIS2	NULL
(	NULL
86	NULL
)	NULL
.	NULL

Btk	NULL
pCIS2	NULL
and	NULL
Btk	NULL
mutant	NULL
K4830EK	NULL
pCIS2	NULL
have	NULL
been	NULL
described	NULL
(	NULL
87	NULL
)	NULL
.	NULL

Plasmids	NULL
for	NULL
bacterial	NULL
expression	NULL
of	NULL
Btk	NULL
(	NULL
pMal-C2Btk	NULL
)	NULL
or	NULL
Btk	NULL
(	NULL
KA80E	NULL
)	NULL
(	NULL
pMal-C2Bke	NULL
)	NULL
,	NULL
fused	NULL
at	NULL
the	NULL
amino	NULL
terminus	NULL
to	NULL
maltose-binding	NULL
protein	NULL
(	NULL
MBP	NULL
)	NULL
,	NULL
were	NULL
constructed	NULL
by	NULL
inserting	NULL
the	NULL
2-kilobase	NULL
pair	NULL
BamHI	NULL
fragments	NULL
of	NULL
pCIS2Btk	NULL
and	NULL
pCIS2Btk	NULL
(	NULL
K430E	NULL
)	NULL
into	NULL
the	NULL
BamHI	NULL
site	NULL
of	NULL
pMal-C2	NULL
(	NULL
New	NULL
England	NULL
Biolabs	NULL
)	NULL
.	NULL

A	NULL
reporter	NULL
construct	NULL
containing	NULL
the	NULL
murine	NULL
c-fos	NULL
wild-type	NULL
promoter	NULL
(	NULL
33	NULL
)	NULL
was	NULL
a	NULL
kind	NULL
gift	NULL
of	NULL
D.	NULL
Kim	NULL
and	NULL
B.	NULL
Cochran	NULL
.	NULL

The	NULL
HindlI	NULL
fragment	NULL
containing	NULL
the	NULL
c-fos	NULL
promoter	NULL
was	NULL
cloned	NULL
into	NULL
the	NULL
HindII	NULL
site	NULL
upstream	NULL
of	NULL
the	NULL
firefly	NULL
luciferase	NULL
gene	NULL
within	NULL
the	NULL
Promega	NULL
PGL3	NULL
basic	NULL
vector	NULL
,	NULL
and	NULL
orientation	NULL
was	NULL
confirmed	NULL
by	NULL
sequence	NULL
analysis	NULL
.	NULL

The	NULL
herpes	NULL
simplex	NULL
thymidine	NULL
kinase	NULL
Renilla	NULL
vector	NULL
(	NULL
pRL-TK	NULL
)	NULL
was	NULL
purchased	NULL
from	NULL
Promega	NULL
.	NULL

The	NULL
human	NULL
embryonic	NULL
kidney	NULL
fibroblast	NULL
cell	NULL
line	NULL
298	NULL
and	NULL
the	NULL
simian	NULL
fibroblast	NULL
cell	NULL
line	NULL
COS-7	NULL
were	NULL
maintained	NULL
in	NULL
Dulbecco	NULL
's	NULL
modified	NULL
Eagle	NULL
's	NULL
medium	NULL
(	NULL
DMEM	NULL
)	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
,	NULL
50	NULL
ug/ml	NULL
streptomycin	NULL
,	NULL
and	NULL
50	NULL
units/ml	NULL
penicillin	NULL
.	NULL

Purification	NULL
of	NULL
Recombinant	NULL
Btk	NULL
and	NULL
Btk	NULL
(	NULL
K430E	NULL
)	NULL
-E.	NULL
coli	NULL
BL21	NULL
,	NULL
transformed	NULL
with	NULL
either	NULL
pMal-C2Btk	NULL
or	NULL
pMal-C2Bke	NULL
,	NULL
was	NULL
cultured	NULL
overnight	NULL
at	NULL
37°	NULL
C	NULL
in	NULL
50	NULL
ml	NULL
of	NULL
rich	NULL
medium	NULL
containing	NULL
2	NULL
g/liter	NULL
glucose	NULL
and	NULL
50	NULL
ug/ml	NULL
carbenicillin	NULL
.	NULL

The	NULL
overnight	NULL
cultures	NULL
were	NULL
diluted	NULL
1:20	NULL
in	NULL
the	NULL
same	NULL
medium	NULL
and	NULL
grown	NULL
at	NULL
37	NULL
°C	NULL
until	NULL
Ag	NULL
,	NULL
,	NULL
was	NULL
0.5	NULL
.	NULL

Expression	NULL
was	NULL
then	NULL
induced	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
isopropyl-l-thio-B-D-galac-topyranoside	NULL
to	NULL
0.3	NULL
mM	NULL
,	NULL
and	NULL
incubation	NULL
was	NULL
continued	NULL
for	NULL
3	NULL
h	NULL
at	NULL
37	NULL
°C	NULL
.	NULL

Cells	NULL
were	NULL
collected	NULL
by	NULL
centrifugation	NULL
and	NULL
resuspended	NULL
in	NULL
25	NULL
ml	NULL
of	NULL
buffer	NULL
F	NULL
(	NULL
50	NULL
mm	NULL
HEPES	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
,	NULL
10	NULL
mm	NULL
MgCl	NULL
,	NULL
,	NULL
20	NULL
ug/ml	NULL
aprotinin	NULL
,	NULL
20	NULL
pg/ml	NULL
leupeptin	NULL
,	NULL
2	NULL
ug/ml	NULL
chymostatin	NULL
,	NULL
2	NULL
ug/ml	NULL
pepstatin	NULL
,	NULL
and	NULL
2	NULL
pg/ml	NULL
antipain	NULL
)	NULL
per	NULL
500-ml	NULL
culture	NULL
.	NULL

Lysozyme	NULL
and	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
were	NULL
added	NULL
to	NULL
1	NULL
mg/ml	NULL
and	NULL
1	NULL
mM	NULL
,	NULL
respectively	NULL
.	NULL

After	NULL
incubation	NULL
for	NULL
30	NULL
min	NULL
on	NULL
ice	NULL
,	NULL
bacterial	NULL
suspensions	NULL
were	NULL
frozen	NULL
in	NULL
liquid	NULL
nitrogen	NULL
and	NULL
stored	NULL
at	NULL
-80	NULL
°C	NULL
.	NULL

MBP-Btk	NULL
and	NULL
MBP-Btk	NULL
(	NULL
K430E	NULL
)	NULL
fusion	NULL
proteins	NULL
were	NULL
purified	NULL
by	NULL
amylose	NULL
affinity	NULL
chromatography	NULL
(	NULL
New	NULL
England	NULL
Biolabs	NULL
)	NULL
.	NULL

Frozen	NULL
bacterial	NULL
suspensions	NULL
were	NULL
thawed	NULL
in	NULL
a	NULL
30°C	NULL
water	NULL
bath	NULL
with	NULL
gentle	NULL
agitation	NULL
and	NULL
then	NULL
placed	NULL
on	NULL
ice	NULL
.	NULL

Ice-cold	NULL
EDTA	NULL
was	NULL
added	NULL
for	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
2	NULL
mM	NULL
,	NULL
and	NULL
EGTA	NULL
was	NULL
added	NULL
for	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
10	NULL
mM	NULL
.	NULL

After	NULL
mixing	NULL
by	NULL
inversion	NULL
,	NULL
the	NULL
lysate	NULL
was	NULL
sonicated	NULL
for	NULL
three	NULL
cycles	NULL
of	NULL
10	NULL
pulses	NULL
each	NULL
with	NULL
a	NULL
Branson	NULL
microtip	NULL
sonifier	NULL
(	NULL
power	NULL
output	NULL
5	NULL
,	NULL
duty	NULL
cycle	NULL
50	NULL
%	NULL
)	NULL
.	NULL

An	NULL
equal	NULL
volume	NULL
(	NULL
25	NULL
ml	NULL
)	NULL
of	NULL
lysate	NULL
dilution	NULL
buffer	NULL
(	NULL
800	NULL
mM	NULL
NaCl	NULL
,	NULL
100	NULL
my	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
7.4	NULL
)	NULL
,	NULL
10	NULL
mM	NULL
EGTA	NULL
,	NULL
2	NULL
mM	NULL
EDTA	NULL
,	NULL
0.2	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
2	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
20	NULL
ug/ml	NULL
aprotinin	NULL
,	NULL
20	NULL
ug/ml	NULL
leupeptin	NULL
,	NULL
2	NULL
ug/ml	NULL
chymostatin	NULL
,	NULL
2	NULL
ug/ml	NULL
pepstatin	NULL
,	NULL
and	NULL
2	NULL
ug/ml	NULL
antipain	NULL
)	NULL
was	NULL
added	NULL
to	NULL
25	NULL
ml	NULL
of	NULL
bacterial	NULL
suspension	NULL
.	NULL

Suspensions	NULL
were	NULL
mixed	NULL
by	NULL
inversion	NULL
,	NULL
incubated	NULL
on	NULL
ice	NULL
for	NULL
20	NULL
min	NULL
,	NULL
and	NULL
then	NULL
clarified	NULL
by	NULL
centrifugation	NULL
at	NULL
30,000	NULL
x	NULL
g	NULL
for	NULL
20	NULL
min	NULL
at	NULL
4	NULL
°C	NULL
.	NULL

The	NULL
supernatant	NULL
was	NULL
loaded	NULL
twice	NULL
over	NULL
a	NULL
2-ml	NULL
amylose	NULL
resin	NULL
,	NULL
pre-equilibrated	NULL
with	NULL
wash	NULL
buffer	NULL
1	NULL
(	NULL
150	NULL
mm	NULL
NaCl	NULL
,	NULL
50	NULL
mm	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
7.4	NULL
)	NULL
,	NULL
10	NULL
mM	NULL
EGTA	NULL
,	NULL
2	NULL
mm	NULL
EDTA	NULL
,	NULL
0.1	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
20	NULL
pg/ml	NULL
aprotinin	NULL
,	NULL
20	NULL
pg/ml	NULL
leupeptin	NULL
,	NULL
2	NULL
ug/ml	NULL
chymostatin	NULL
,	NULL
2	NULL
ug/ml	NULL
pepstatin	NULL
,	NULL
and	NULL
2	NULL
ug/ml	NULL
antipain	NULL
)	NULL
.	NULL

The	NULL
column	NULL
was	NULL
washed	NULL
sequentially	NULL
with	NULL
10	NULL
ml	NULL
of	NULL
wash	NULL
buffer	NULL
1	NULL
,	NULL
10	NULL
ml	NULL
of	NULL
wash	NULL
buffer	NULL
1	NULL
supplemented	NULL
to	NULL
1	NULL
M	NULL
NaCl	NULL
,	NULL
and	NULL
10	NULL
ml	NULL
of	NULL
wash	NULL
buffer	NULL
2	NULL
(	NULL
100	NULL
mm	NULL
NaCl	NULL
,	NULL
50	NULL
mm	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
7.4	NULL
)	NULL
,	NULL
0.1	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
)	NULL
.	NULL

Bound	NULL
protein	NULL
was	NULL
eluted	NULL
with	NULL
3	NULL
ml	NULL
of	NULL
elution	NULL
buffer	NULL
(	NULL
100	NULL
mM	NULL
NaCl	NULL
,	NULL
50	NULL
mm	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
7.4	NULL
)	NULL
,	NULL
10	NULL
mM	NULL
maltose	NULL
,	NULL
0.1	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
and	NULL
10	NULL
%	NULL
glycerol	NULL
)	NULL
.	NULL

Eluates	NULL
were	NULL
dialyzed	NULL
against	NULL
elution	NULL
buffer	NULL
lacking	NULL
maltose	NULL
,	NULL
frozen	NULL
in	NULL
liquid	NULL
nitrogen	NULL
,	NULL
and	NULL
stored	NULL
at	NULL
-80	NULL
°C	NULL
.	NULL

Expression	NULL
and	NULL
Purification	NULL
of	NULL
Polyhistidine-tagged	NULL
BAP/TFIL-I	NULL
Fragments-Wild-type	NULL
and	NULL
mutant	NULL
BAP/TFII-I	NULL
fragments	NULL
,	NULL
tagged	NULL
at	NULL
the	NULL
amino	NULL
terminus	NULL
with	NULL
polyhistidine	NULL
,	NULL
were	NULL
expressed	NULL
from	NULL
the	NULL
BAP	NULL
pBAD	NULL
HIS	NULL
constructs	NULL
in	NULL
E.	NULL
coli	NULL
(	NULL
TOP10	NULL
;	NULL
Invitrogen	NULL
)	NULL
.	NULL

Bacterial	NULL
cultures	NULL
were	NULL
grown	NULL
overnight	NULL
at	NULL
37	NULL
°C	NULL
in	NULL
2	NULL
%	NULL
YT	NULL
containing	NULL
50	NULL
ug/ml	NULL
carbeni-cillin	NULL
,	NULL
diluted	NULL
1:10	NULL
in	NULL
the	NULL
same	NULL
medium	NULL
,	NULL
and	NULL
incubated	NULL
for	NULL
1	NULL
h	NULL
at	NULL
37	NULL
°C	NULL
.	NULL

Expression	NULL
was	NULL
induced	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
arabinose	NULL
to	NULL
0.002	NULL
%	NULL
(	NULL
w/v	NULL
)	NULL
and	NULL
further	NULL
incubation	NULL
for	NULL
4	NULL
h	NULL
at	NULL
87	NULL
°C	NULL
.	NULL

Cells	NULL
were	NULL
collected	NULL
by	NULL
centrifugation	NULL
and	NULL
resuspended	NULL
in	NULL
buffer	NULL
F	NULL
(	NULL
25	NULL
ml	NULL
per	NULL
500-ml	NULL
culture	NULL
)	NULL
.	NULL

After	NULL
the	NULL
addition	NULL
of	NULL
lysozyme	NULL
to	NULL
1	NULL
mg/ml	NULL
and	NULL
phenyImethylsulfonyl	NULL
fluoride	NULL
to	NULL
1	NULL
mM	NULL
,	NULL
bacterial	NULL
suspensions	NULL
were	NULL
incubated	NULL
on	NULL
ice	NULL
for	NULL
30	NULL
min	NULL
,	NULL
frozen	NULL
in	NULL
liquid	NULL
nitrogen	NULL
,	NULL
and	NULL
stored	NULL
at	NULL
-80	NULL
°C	NULL
.	NULL

Bacterial	NULL
suspensions	NULL
were	NULL
thawed	NULL
with	NULL
gentle	NULL
agitation	NULL
in	NULL
a	NULL
30	NULL
°C	NULL
water	NULL
bath	NULL
and	NULL
placed	NULL
on	NULL
ice	NULL
immediately	NULL
upon	NULL
thawing	NULL
.	NULL

Samples	NULL
were	NULL
sonicated	NULL
for	NULL
three	NULL
cycles	NULL
of	NULL
10	NULL
pulses	NULL
each	NULL
with	NULL
a	NULL
Branson	NULL
microtip	NULL
sonifier	NULL
(	NULL
power	NULL
output	NULL
5	NULL
,	NULL
duty	NULL
cycle	NULL
50	NULL
%	NULL
)	NULL
.	NULL

One	NULL
volume	NULL
of	NULL
2	NULL
%	NULL
imidazole	NULL
wash	NULL
buffer	NULL
(	NULL
500	NULL
mM	NULL
NaCl	NULL
,	NULL
100	NULL
mm	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
7.4	NULL
)	NULL
and	NULL
40	NULL
mM	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
27808	NULL
imidazole	NULL
)	NULL
containing	NULL
0.4	NULL
%	NULL
Tween	NULL
20	NULL
was	NULL
added	NULL
,	NULL
and	NULL
samples	NULL
were	NULL
incubated	NULL
on	NULL
ice	NULL
for	NULL
20	NULL
min	NULL
.	NULL

Lysis	NULL
was	NULL
completed	NULL
by	NULL
sonication	NULL
for	NULL
two	NULL
cycles	NULL
of	NULL
10	NULL
pulses	NULL
each	NULL
(	NULL
output	NULL
5	NULL
,	NULL
duty	NULL
cycle	NULL
50	NULL
%	NULL
)	NULL
.	NULL

Lysates	NULL
were	NULL
clarified	NULL
by	NULL
centrifugation	NULL
at	NULL
80,000	NULL
X	NULL
g	NULL
for	NULL
30	NULL
min	NULL
at	NULL
4	NULL
°C	NULL
,	NULL
diluted	NULL
2-fold	NULL
with	NULL
imidazole	NULL
wash	NULL
buffer	NULL
(	NULL
250	NULL
mM	NULL
NaCl	NULL
,	NULL
50	NULL
my	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
74	NULL
)	NULL
,	NULL
20	NULL
mM	NULL
imidazole	NULL
)	NULL
and	NULL
loaded	NULL
twice	NULL
onto	NULL
Ni**-nitrilotriacetic	NULL
acid	NULL
(	NULL
Invitrogen	NULL
)	NULL
.	NULL

Columns	NULL
were	NULL
washed	NULL
with	NULL
50	NULL
bed	NULL
volumes	NULL
of	NULL
imidazole	NULL
wash	NULL
buffer	NULL
,	NULL
followed	NULL
by	NULL
2	NULL
volumes	NULL
of	NULL
imidazole	NULL
pre-elution	NULL
buffer	NULL
(	NULL
250	NULL
mM	NULL
NaCl	NULL
,	NULL
50	NULL
mM	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
7.4	NULL
)	NULL
,	NULL
25	NULL
mM	NULL
imidazole	NULL
,	NULL
15	NULL
%	NULL
glycerol	NULL
)	NULL
.	NULL

Samples	NULL
were	NULL
eluted	NULL
with	NULL
1	NULL
bed	NULL
volume	NULL
of	NULL
imidazole	NULL
elution	NULL
buffer	NULL
(	NULL
300	NULL
mM	NULL
NaCl	NULL
,	NULL
250	NULL
mM	NULL
imidazole	NULL
,	NULL
50	NULL
mM	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
7.4	NULL
)	NULL
,	NULL
and	NULL
10	NULL
%	NULL
glycerol	NULL
)	NULL
;	NULL
dialyzed	NULL
against	NULL
a	NULL
buffer	NULL
containing	NULL
50	NULL
mM	NULL
NaCl	NULL
,	NULL
50	NULL
mM	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
7.4	NULL
)	NULL
,	NULL
1	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
,	NULL
0.1	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
and	NULL
10	NULL
%	NULL
glycerol	NULL
;	NULL
frozen	NULL
in	NULL
liquid	NULL
nitrogen	NULL
;	NULL
and	NULL
stored	NULL
at	NULL
-80	NULL
°C	NULL
.	NULL

In	NULL
Vitro	NULL
Phosphorylation-Purified	NULL
BAP/TFII-I	NULL
substrate	NULL
was	NULL
combined	NULL
with	NULL
20	NULL
ul	NULL
of	NULL
2X	NULL
kinase	NULL
buffer	NULL
(	NULL
40	NULL
mM	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
7.2	NULL
)	NULL
,	NULL
4	NULL
mM	NULL
MnCl	NULL
,	NULL
,	NULL
2	NULL
mM	NULL
Na	NULL
,	NULL
MoO	NULL
,	NULL
)	NULL
,	NULL
6	NULL
pl	NULL
of	NULL
distilled	NULL
H	NULL
,	NULL
O	NULL
,	NULL
and	NULL
10	NULL
uCi	NULL
of	NULL
[	NULL
y-	NULL
``	NULL
``	NULL
P	NULL
]	NULL
ATP	NULL
(	NULL
6000	NULL
Ci/mmol	NULL
;	NULL
PerkinElmer	NULL
Life	NULL
Sciences	NULL
)	NULL
.	NULL

Purified	NULL
MBP-Btk	NULL
or	NULL
MBP-Btk	NULL
(	NULL
KA30E	NULL
)	NULL
(	NULL
2	NULL
ug	NULL
in	NULL
5	NULL
pl	NULL
)	NULL
was	NULL
added	NULL
to	NULL
a	NULL
total	NULL
volume	NULL
of	NULL
40	NULL
pl	NULL
,	NULL
and	NULL
samples	NULL
were	NULL
incubated	NULL
at	NULL
37	NULL
°C	NULL
for	NULL
30	NULL
min	NULL
.	NULL

Reactions	NULL
were	NULL
terminated	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
SDS-polyacrylamide	NULL
gel	NULL
loading	NULL
buffer	NULL
.	NULL

Products	NULL
were	NULL
fractionated	NULL
by	NULL
gel	NULL
electrophoresis	NULL
and	NULL
transferred	NULL
to	NULL
PVDF	NULL
(	NULL
Millipore	NULL
Corp.	NULL
)	NULL
for	NULL
tryptic	NULL
phosphopeptide	NULL
mapping	NULL
.	NULL

Metabolic	NULL
Labeling-Transient	NULL
transfections	NULL
were	NULL
performed	NULL
by	NULL
the	NULL
calcium	NULL
phosphate	NULL
method	NULL
(	NULL
88	NULL
)	NULL
.	NULL

293	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
5	NULL
ug	NULL
of	NULL
wild-type	NULL
or	NULL
mutant	NULL
BAP/TFII-I	NULL
expression	NULL
constructs	NULL
in	NULL
pCIS2	NULL
,	NULL
5	NULL
ug	NULL
of	NULL
pCIS2Btk	NULL
or	NULL
pCIS2Btk	NULL
(	NULL
K430E	NULL
)	NULL
,	NULL
and	NULL
1	NULL
ug	NULL
of	NULL
pRSVT	NULL
.	NULL

At	NULL
40	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
labeled	NULL
for	NULL
4	NULL
h	NULL
at	NULL
87°C	NULL
with	NULL
250	NULL
pCi/ml	NULL
[	NULL
*Plorthophosphate	NULL
in	NULL
phosphate-free	NULL
DMEM	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
dialyzed	NULL
fetal	NULL
bovine	NULL
serum	NULL
,	NULL
50	NULL
ug/ml	NULL
streptomycin	NULL
,	NULL
and	NULL
50	NULL
units/ml	NULL
penicillin	NULL
.	NULL

Cells	NULL
were	NULL
treated	NULL
for	NULL
10	NULL
min	NULL
at	NULL
37	NULL
°C	NULL
with	NULL
1	NULL
mM	NULL
sodium	NULL
pervanadate	NULL
,	NULL
washed	NULL
once	NULL
with	NULL
5	NULL
ml	NULL
of	NULL
cold	NULL
PBS	NULL
containing	NULL
1	NULL
mM	NULL
Na	NULL
,	NULL
VO	NULL
,	NULL
and	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
collected	NULL
by	NULL
centrifugation	NULL
,	NULL
frozen	NULL
on	NULL
dry	NULL
ice	NULL
,	NULL
and	NULL
stored	NULL
at	NULL
-80	NULL
°C	NULL
.	NULL

Immunoprecipitation	NULL
of	NULL
Epitope-tagged	NULL
BAP/TFII-I-Cells	NULL
were	NULL
lysed	NULL
in	NULL
radioimmune	NULL
precipitation	NULL
buffer	NULL
(	NULL
150	NULL
mM	NULL
NaCl	NULL
,	NULL
50	NULL
mM	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
8.0	NULL
)	NULL
,	NULL
1	NULL
mM	NULL
Na	NULL
,	NULL
VO	NULL
,	NULL
,	NULL
1	NULL
mM	NULL
Na	NULL
,	NULL
MoO0	NULL
,	NULL
,	NULL
1	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
,	NULL
1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
1	NULL
%	NULL
sodium	NULL
deoxycholate	NULL
,	NULL
0.5	NULL
%	NULL
SDS	NULL
,	NULL
10	NULL
ug/ml	NULL
aprotinin	NULL
,	NULL
10	NULL
ug/ml	NULL
leupeptin	NULL
,	NULL
2.5	NULL
ug/ml	NULL
pepstatin	NULL
,	NULL
2.5	NULL
ug/ml	NULL
antipain	NULL
,	NULL
and	NULL
1	NULL
ug/ml	NULL
chymostatin	NULL
)	NULL
for	NULL
30	NULL
min	NULL
on	NULL
ice	NULL
.	NULL

Lysates	NULL
were	NULL
clarified	NULL
by	NULL
centrifugation	NULL
at	NULL
15,000	NULL
%	NULL
g	NULL
for	NULL
30	NULL
min	NULL
at	NULL
4	NULL
°C	NULL
.	NULL

Epitope-tagged	NULL
BAP/TFII-I	NULL
was	NULL
immunoprecipitated	NULL
by	NULL
incubation	NULL
with	NULL
anti-c-Myc	NULL
monoclonal	NULL
antibody	NULL
9E10	NULL
for	NULL
1	NULL
h	NULL
on	NULL
ice	NULL
.	NULL

Following	NULL
the	NULL
addition	NULL
of	NULL
25	NULL
ul	NULL
of	NULL
protein	NULL
A/G-Sepharose	NULL
beads	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
,	NULL
Inc.	NULL
,	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
suspensions	NULL
were	NULL
rocked	NULL
for	NULL
1	NULL
h	NULL
at	NULL
4	NULL
°C	NULL
.	NULL

Beads	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
for	NULL
10	NULL
min	NULL
each	NULL
in	NULL
radicimmune	NULL
precipitation	NULL
buffer	NULL
;	NULL
immunoprecipitated	NULL
proteins	NULL
were	NULL
solubilized	NULL
in	NULL
SDS-loading	NULL
buffer	NULL
and	NULL
resolved	NULL
by	NULL
polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
.	NULL

Protein	NULL
was	NULL
transferred	NULL
to	NULL
PVDF	NULL
(	NULL
Millipore	NULL
)	NULL
for	NULL
tryptic	NULL
phosphopeptide	NULL
mapping	NULL
.	NULL

Analysis	NULL
of	NULL
Tryptic	NULL
Phosphopeptides-Tryptic	NULL
phosphopeptides	NULL
were	NULL
prepared	NULL
according	NULL
to	NULL
methods	NULL
previously	NULL
described	NULL
(	NULL
89	NULL
)	NULL
and	NULL
analyzed	NULL
by	NULL
alkaline	NULL
gel	NULL
electrophoresis	NULL
(	NULL
40	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
PVDF	NULL
membrane	NULL
slices	NULL
containing	NULL
phosphoproteins	NULL
were	NULL
excised	NULL
,	NULL
washed	NULL
with	NULL
water	NULL
,	NULL
and	NULL
then	NULL
soaked	NULL
in	NULL
0.5	NULL
%	NULL
polyvinylpyrolidone	NULL
(	NULL
Sigma	NULL
)	NULL
for	NULL
30	NULL
min	NULL
at	NULL
37	NULL
°C	NULL
.	NULL

Membranes	NULL
were	NULL
then	NULL
washed	NULL
five	NULL
times	NULL
with	NULL
water	NULL
and	NULL
once	NULL
with	NULL
freshly	NULL
prepared	NULL
0.05	NULL
1	NULL
NH	NULL
,	NULL
HCO	NULL
,	NULL
.	NULL

Immobilized	NULL
proteins	NULL
were	NULL
digested	NULL
with	NULL
1	NULL
ml	NULL
of	NULL
0.3	NULL
mg/ml	NULL
trypsin	NULL
(	NULL
L-l-tosylamido-2-phenylethyl	NULL
chloromethyl	NULL
ketone-treated	NULL
,	NULL
Sigma	NULL
)	NULL
in	NULL
0.05	NULL
1	NULL
NH	NULL
,	NULL
HCO	NULL
,	NULL
overnight	NULL
at	NULL
87	NULL
°C	NULL
.	NULL

Super-natants	NULL
were	NULL
dried	NULL
under	NULL
vacuum	NULL
and	NULL
washed	NULL
three	NULL
times	NULL
in	NULL
water	NULL
.	NULL

Dried	NULL
pellets	NULL
were	NULL
dissolved	NULL
in	NULL
10	NULL
ul	NULL
of	NULL
sample	NULL
buffer	NULL
(	NULL
0.125	NULL
M	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
6.8	NULL
)	NULL
,	NULL
6	NULL
M	NULL
urea	NULL
)	NULL
and	NULL
fractionated	NULL
on	NULL
a	NULL
40	NULL
%	NULL
alkaline	NULL
gel	NULL
as	NULL
described	NULL
(	NULL
40	NULL
)	NULL
.	NULL

Phosphopeptides	NULL
were	NULL
detected	NULL
by	NULL
a	NULL
PhosphorImager	NULL
(	NULL
Molecular	NULL
Dynamics	NULL
,	NULL
Inc.	NULL
,	NULL
Sunnyvale	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Analysis	NULL
of	NULL
c-Fos	NULL
Transcriptional	NULL
Activity-The	NULL
ability	NULL
of	NULL
BAP/TFII-I	NULL
to	NULL
stimulate	NULL
transcription	NULL
from	NULL
the	NULL
c-fos	NULL
promoter	NULL
was	NULL
assessed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
83	NULL
)	NULL
with	NULL
modifications	NULL
.	NULL

COS-7	NULL
cells	NULL
,	NULL
grown	NULL
to	NULL
80-90	NULL
%	NULL
confluence	NULL
,	NULL
were	NULL
trypsinized	NULL
,	NULL
resuspended	NULL
in	NULL
DMEM	NULL
containing	NULL
10	NULL
%	NULL
FBS	NULL
and	NULL
0.1	NULL
mM	NULL
nonessential	NULL
amino	NULL
acids	NULL
(	NULL
NEAA	NULL
)	NULL
,	NULL
and	NULL
seeded	NULL
in	NULL
24-well	NULL
plates	NULL
at	NULL
6	NULL
X	NULL
10°	NULL
cells/well	NULL
.	NULL

Cells	NULL
were	NULL
transfected	NULL
16-20	NULL
h	NULL
later	NULL
using	NULL
LipofectAMINE	NULL
2000	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
)	NULL
.	NULL

Each	NULL
well	NULL
was	NULL
transfected	NULL
with	NULL
0.1	NULL
ug	NULL
of	NULL
c-fos	NULL
in	NULL
PGL3	NULL
,	NULL
0.1	NULL
ug	NULL
of	NULL
pRL-TK	NULL
,	NULL
and	NULL
0.6	NULL
ug	NULL
of	NULL
either	NULL
pCIS2	NULL
or	NULL
wild-type	NULL
or	NULL
mutant	NULL
BAPmyc	NULL
in	NULL
pCIS2	NULL
.	NULL

For	NULL
each	NULL
well	NULL
,	NULL
1	NULL
pl	NULL
of	NULL
LipofectAMINE	NULL
2000	NULL
was	NULL
diluted	NULL
in	NULL
50	NULL
ul	NULL
of	NULL
OPTI-MEM	NULL
(	NULL
Life	NULL
Technologies	NULL
)	NULL
,	NULL
incubated	NULL
for	NULL
5	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
and	NULL
then	NULL
combined	NULL
with	NULL
DNA	NULL
diluted	NULL
in	NULL
50	NULL
pl	NULL
of	NULL
OPTI-MEM	NULL
.	NULL

Complexes	NULL
were	NULL
allowed	NULL
to	NULL
form	NULL
for	NULL
30	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
and	NULL
then	NULL
added	NULL
to	NULL
each	NULL
well	NULL
,	NULL
which	NULL
contained	NULL
250	NULL
ml	NULL
of	NULL
fresh	NULL
DMEM	NULL
containing	NULL
0.1	NULL
mM	NULL
NEAA	NULL
.	NULL

Btk	NULL
Phosphorylation	NULL
Sites	NULL
in	NULL
BAP/TFILI-I	NULL
A	NULL
LI	NULL
ILI	NULL
M	NULL
lil	NULL
Ul	NULL
.	NULL

I1	NULL
l	NULL
BAP	NULL
_	NULL
|NRi	NULL
iR	NULL
NR2	NULL
2R	NULL
sr	NULL
ar	NULL
__	NULL
5r	NULL
_	NULL
eR	NULL
|	NULL
[	NULL
AGpSETpovorkaptekpLa	NULL
)	NULL
-	NULL
[	NULL
Petanvpserseppevevne	NULL
]	NULL
I	NULL
H	NULL
Louie	NULL
o	NULL
oo	NULL
mano	NULL
5	NULL
Bi	NULL
a+	NULL
£s	NULL
ses	NULL
___	NULL
ss	NULL
?	NULL

BAP	NULL
NR11R	NULL
NR2	NULL
2R	NULL
3R	NULL
4R	NULL
5R	NULL
_	NULL
6R	NULL
19	NULL
68	NULL
503	NULL
606	NULL
ro	NULL
902	NULL
~	NULL
FL	NULL
k	NULL
N-3R	NULL
¥	NULL
N-2R	NULL
1	NULL
N-NR2	NULL
|	NULL
N1R	NULL
|	NULL
4R-CT	NULL
5R_CT	NULL
57s	NULL
fiﬁ-	NULL
‘	NULL
L	NULL
ar	NULL
1	NULL
Fic	NULL
.	NULL

1	NULL
.	NULL

Organization	NULL
of	NULL
BAP/TFII-I	NULL
and	NULL
truncation	NULL
mutants	NULL
used	NULL
in	NULL
this	NULL
study	NULL
.	NULL

A	NULL
,	NULL
large	NULL
rectangle	NULL
,	NULL
BAP/TFII-I	NULL
;	NULL
shaded	NULL
boxes	NULL
,	NULL
HLH-like	NULL
domains	NULL
1R	NULL
through	NULL
6R	NULL
.	NULL

The	NULL
first	NULL
(	NULL
NRL	NULL
)	NULL
and	NULL
second	NULL
(	NULL
NRZ	NULL
)	NULL
nonrepeat	NULL
regions	NULL
are	NULL
labeled	NULL
.	NULL

Tyrosine	NULL
residues	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
Sre	NULL
autophosphorylation	NULL
consensus	NULL
sequence	NULL
EDXDY	NULL
are	NULL
indicated	NULL
by	NULL
filled	NULL
arrows	NULL
.	NULL

The	NULL
remaining	NULL
tyrosine	NULL
residues	NULL
are	NULL
indicated	NULL
by	NULL
open	NULL
arrows	NULL
.	NULL

Amino	NULL
acid	NULL
residues	NULL
encoded	NULL
by	NULL
alternative	NULL
exons	NULL
are	NULL
indicated	NULL
in	NULL
the	NULL
rectangles	NULL
labeled	NULL
I	NULL
and	NULL
II	NULL
.	NULL

B	NULL
,	NULL
BAP/TFII-I	NULL
truncation	NULL
mutants	NULL
.	NULL

Large	NULL
rectangle	NULL
,	NULL
BAP/TFII-I	NULL
A.	NULL
HLH-like	NULL
domains	NULL
and	NULL
nonrepeat	NULL
regions	NULL
are	NULL
indicated	NULL
as	NULL
in	NULL
A.	NULL
Amino	NULL
acid	NULL
residues	NULL
at	NULL
the	NULL
ends	NULL
of	NULL
HLH-like	NULL
domains	NULL
and	NULL
at	NULL
the	NULL
termini	NULL
are	NULL
numbered	NULL
.	NULL

Heavy	NULL
lines	NULL
,	NULL
BAP/TFII-I	NULL
A	NULL
sequences	NULL
retained	NULL
in	NULL
epitope-tagged	NULL
fusion	NULL
constructs	NULL
.	NULL

Numbers	NULL
correspond	NULL
to	NULL
amino	NULL
acid	NULL
residues	NULL
of	NULL
BAP/TFII-I	NULL
A	NULL
.	NULL

The	NULL
c-Myc	NULL
epitope	NULL
is	NULL
indicated	NULL
by	NULL
a	NULL
small	NULL
rectangle	NULL
.	NULL

Mutant	NULL
proteins	NULL
are	NULL
designated	NULL
at	NULL
the	NULL
left	NULL
.	NULL

FL	NULL
,	NULL
full-length	NULL
.	NULL

After	NULL
5	NULL
h	NULL
at	NULL
37°C	NULL
,	NULL
medium	NULL
was	NULL
replaced	NULL
with	NULL
DMEM	NULL
supplemented	NULL
with	NULL
0.5	NULL
%	NULL
FBS	NULL
,	NULL
50	NULL
ug/ml	NULL
streptomycin	NULL
,	NULL
and	NULL
50	NULL
units/ml	NULL
penicillin	NULL
.	NULL

At	NULL
36-40	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
10	NULL
%	NULL
FBS	NULL
for	NULL
5	NULL
h.	NULL
Cells	NULL
were	NULL
then	NULL
lysed	NULL
in	NULL
100	NULL
ml	NULL
of	NULL
passive	NULL
lysis	NULL
buffer	NULL
and	NULL
assayed	NULL
for	NULL
firefly	NULL
and	NULL
Renilla	NULL
luciferase	NULL
activity	NULL
using	NULL
the	NULL
Promega	NULL
dual	NULL
luciferase	NULL
kit	NULL
,	NULL
and	NULL
c-fos	NULL
reporter	NULL
activity	NULL
was	NULL
assessed	NULL
as	NULL
the	NULL
ratio	NULL
of	NULL
firefly	NULL
to	NULL
Renilla	NULL
activities	NULL
.	NULL

The	NULL
effects	NULL
of	NULL
Btk	NULL
and	NULL
BAP/TFII-I	NULL
on	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
c-fos	NULL
promoter	NULL
were	NULL
assessed	NULL
as	NULL
above	NULL
,	NULL
except	NULL
that	NULL
transfections	NULL
contained	NULL
0.4	NULL
ug	NULL
of	NULL
pCIS2	NULL
vector	NULL
or	NULL
pCIS2-BAP/TFII-I	NULL
and	NULL
0.3	NULL
ug	NULL
of	NULL
pCIS2Btk	NULL
or	NULL
pCIS2Btk	NULL
(	NULL
KA30E	NULL
)	NULL
.	NULL

RESULTS	NULL
Expression	NULL
and	NULL
Purification	NULL
of	NULL
BAP/	NULL
TFII-I	NULL
and	NULL
BAP/	NULL
TFII-I	NULL
Fragments-The	NULL
overall	NULL
strategy	NULL
used	NULL
in	NULL
these	NULL
phosphorylation	NULL
site	NULL
mapping	NULL
studies	NULL
was	NULL
1	NULL
)	NULL
to	NULL
determine	NULL
which	NULL
portions	NULL
of	NULL
BAP/TFII-I	NULL
are	NULL
phosphorylated	NULL
by	NULL
Btk	NULL
in	NULL
vitro	NULL
;	NULL
2	NULL
)	NULL
to	NULL
define	NULL
the	NULL
specific	NULL
tyrosine	NULL
residues	NULL
phosphorylated	NULL
by	NULL
Btk	NULL
in	NULL
vitro	NULL
by	NULL
a	NULL
combination	NULL
of	NULL
phosphopeptide	NULL
mapping	NULL
and	NULL
site-directed	NULL
mu-tagenesis	NULL
;	NULL
and	NULL
3	NULL
)	NULL
to	NULL
verify	NULL
that	NULL
the	NULL
same	NULL
tyrosine	NULL
residues	NULL
are	NULL
hyperphosphorylated	NULL
in	NULL
vivo	NULL
upon	NULL
coexpression	NULL
of	NULL
BAP/TFII-I	NULL
with	NULL
active	NULL
Btk	NULL
.	NULL

The	NULL
shortest	NULL
BAP/TFII-I	NULL
isoform	NULL
,	NULL
BAP/TFII-I	NULL
A	NULL
,	NULL
contains	NULL
all	NULL
24	NULL
tyrosine	NULL
residues	NULL
present	NULL
in	NULL
the	NULL
larger	NULL
isoforms	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
.	NULL
``	NULL

This	NULL
isoform	NULL
and	NULL
its	NULL
derivative	NULL
polypeptide	NULL
fragments	NULL
were	NULL
therefore	NULL
used	NULL
for	NULL
in	NULL
vitro	NULL
phosphorylation	NULL
site	NULL
mapping	NULL
.	NULL

The	NULL
following	NULL
BAP/TFII-I	NULL
protein	NULL
fragments	NULL
,	NULL
fused	NULL
at	NULL
the	NULL
amino	NULL
terminus	NULL
to	NULL
polyhistidine	NULL
and	NULL
the	NULL
carboxyl	NULL
terminus	NULL
to	NULL
a	NULL
c-Myc	NULL
epitope	NULL
,	NULL
were	NULL
expressed	NULL
in	NULL
bacterial	NULL
cells	NULL
and	NULL
purified	NULL
by	NULL
Ni**	NULL
nitrilotriacetic	NULL
acid	NULL
affinity	NULL
chromatography	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
;	NULL
BAP	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
Btk	NULL
Phosphorylation	NULL
Sites	NULL
in	NULL
BAP/TFILI-I	NULL
27809	NULL
A	NULL
B	NULL
MBP	NULL
Bik	NULL
MBP	NULL
Bke	NULL
MBP	NULL
Bik	NULL
MBP	NULL
Bke	NULL
[	NULL
MBP	NULL
atk	NULL
Bke	NULL
Prom	NULL
!	NULL

<	NULL
€-MBP	NULL
Btk	NULL
MBP	NULL
Btk	NULL
-g.	NULL
N-2R	NULL
-g	NULL
|	NULL
i	NULL
*	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
32p	NULL
silver	NULL
stain	NULL
C	NULL
Mn	NULL
:	NULL
Mg	NULL
100:1	NULL
Mn	NULL
10007	NULL
MBP	NULL
Btk	NULL
__|__	NULL
MBP	NULL
Bke	NULL
MBP	NULL
Btk	NULL
_|_	NULL
MBP	NULL
Bke	NULL
-B-	NULL
Bik	NULL
Mn	NULL
:	NULL
Mg	NULL
100:1	NULL
|	NULL
-e-	NULL
Bke	NULL
Mn	NULL
:	NULL
Mg	NULL
100:1	NULL
[	NULL
{	NULL
Me2	NULL
:	NULL
]	NULL
mm	NULL
[	NULL
io	NULL
]	NULL
s	NULL
|2	NULL
]	NULL
+	NULL
[	NULL
.2	NULL
]	NULL
i0	NULL
[	NULL
s	NULL
[	NULL
2	NULL
]	NULL
i	NULL
]	NULL
2	NULL
]	NULL
i0|s	NULL
[	NULL
2	NULL
]	NULL
1|2	NULL
]	NULL
i0|5	NULL
]	NULL
2	NULL
]	NULL
1	NULL
-m-	NULL
Bik	NULL
Mn	NULL
MBP	NULL
Bik	NULL
-q	NULL
»	NULL
=®	NULL
®	NULL
#	NULL
w	NULL
#	NULL
®	NULL
3	NULL
8	NULL
a00	NULL
|M	NULL
[	NULL
out	NULL
a	NULL
ams	NULL
<	NULL
=	NULL
amas	NULL
am	NULL
aus	NULL
~	NULL
As	NULL
ds	NULL
s	NULL
as	NULL
<	NULL
>	NULL
an	NULL
ats	NULL
d	NULL
it	NULL
(	NULL
+	NULL
r	NULL
200	NULL
N-	NULL
22	NULL
-s	NULL
»	NULL
|	NULL
With	NULL
wo	NULL
w	NULL
t	NULL
wa	NULL
e	NULL
t=o	NULL
--	NULL
-o	NULL
--	NULL
--	NULL
-	NULL
6	NULL
B	NULL
d	NULL
6	NULL
i	NULL
$	NULL
O	NULL
[	NULL
Me	NULL
2+	NULL
]	NULL
mM	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
111213141516	NULL
17	NULL
18	NULL
19	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

Phosphorylation	NULL
of	NULL
a	NULL
BAP/TFII-I-derived	NULL
protein	NULL
fragment	NULL
in	NULL
vitro	NULL
by	NULL
bacterially	NULL
expressed	NULL
MBP-Btk	NULL
.	NULL

A	NULL
,	NULL
autophosphoryla-	NULL
tion	NULL
of	NULL
recombinant	NULL
MBP-Btk	NULL
in	NULL
vitro	NULL
.	NULL

Btk	NULL
,	NULL
fused	NULL
at	NULL
the	NULL
amino	NULL
terminus	NULL
to	NULL
maltose-binding	NULL
protein	NULL
(	NULL
MBP-Btk	NULL
)	NULL
,	NULL
was	NULL
expressed	NULL
in	NULL
E.	NULL
colt	NULL
and	NULL
purified	NULL
by	NULL
amylose	NULL
affinity	NULL
chromatography	NULL
.	NULL

A	NULL
similar	NULL
fusion	NULL
containing	NULL
catalytically	NULL
inactive	NULL
Btk	NULL
(	NULL
K430E	NULL
)	NULL
(	NULL
MBP-Btk	NULL
(	NULL
KA80E	NULL
)	NULL
)	NULL
was	NULL
expressed	NULL
and	NULL
purified	NULL
in	NULL
parallel	NULL
.	NULL

Fusion	NULL
proteins	NULL
were	NULL
assayed	NULL
for	NULL
autokinase	NULL
activity	NULL
in	NULL
vitro	NULL
.	NULL

2	NULL
ul	NULL
(	NULL
Zanes	NULL
1	NULL
and	NULL
4	NULL
)	NULL
,	NULL
5	NULL
ul	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
5	NULL
)	NULL
,	NULL
or	NULL
10	NULL
ul	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
6	NULL
)	NULL
of	NULL
MBP-Btk	NULL
(	NULL
lanes	NULL
1-3	NULL
)	NULL
or	NULL
MBP-Btk	NULL
(	NULL
KA4830E	NULL
)	NULL
(	NULL
Zanes	NULL
4-6	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
10	NULL
uCi	NULL
of	NULL
[	NULL
y-	NULL
``	NULL
``	NULL
P	NULL
]	NULL
JATP	NULL
for	NULL
80	NULL
min	NULL
at	NULL
37	NULL
°C	NULL
in	NULL
a	NULL
buffer	NULL
containing	NULL
20	NULL
mM	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
7.2	NULL
)	NULL
,	NULL
2	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
and	NULL
10	NULL
mM	NULL
MnCl	NULL
,	NULL
.	NULL

Products	NULL
were	NULL
fractionated	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
detected	NULL
by	NULL
PhosphorImager	NULL
(	NULL
/eft	NULL
pane	NULL
?	NULL
)	NULL

or	NULL
silver	NULL
stain	NULL
(	NULL
right	NULL
panel	NULL
)	NULL
.	NULL

The	NULL
arrows	NULL
indicate	NULL
the	NULL
position	NULL
of	NULL
MBP-Btk	NULL
and	NULL
MBP-Btk	NULL
(	NULL
K4830E	NULL
)	NULL
.	NULL

The	NULL
product	NULL
of	NULL
a	NULL
contaminating	NULL
bacterial	NULL
protein	NULL
kinase	NULL
is	NULL
marked	NULL
by	NULL
an	NULL
asterisk	NULL
.	NULL

B	NULL
,	NULL
phosphorylation	NULL
of	NULL
the	NULL
BAP/TFII-I	NULL
N-2R	NULL
fragment	NULL
by	NULL
Btk	NULL
in	NULL
vitro	NULL
.	NULL

MBP-Btk	NULL
(	NULL
10	NULL
ul	NULL
,	NULL
lanes	NULL
1-3	NULL
)	NULL
,	NULL
MBP-Bke	NULL
(	NULL
10	NULL
ul	NULL
,	NULL
lanes	NULL
5-7	NULL
)	NULL
,	NULL
or	NULL
kinase	NULL
dialysis	NULL
buffer	NULL
(	NULL
10	NULL
ul	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
was	NULL
combined	NULL
with	NULL
10	NULL
ul	NULL
(	NULL
Zanes	NULL
1	NULL
,	NULL
4	NULL
,	NULL
and	NULL
5	NULL
)	NULL
or	NULL
2	NULL
ul	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
6	NULL
)	NULL
BAP/TFII-I	NULL
N-2R	NULL
.	NULL

BAP/TFII-I	NULL
N-2R	NULL
was	NULL
omitted	NULL
from	NULL
reactions	NULL
analyzed	NULL
in	NULL
lanes	NULL
3	NULL
and	NULL
7	NULL
.	NULL

Reaction	NULL
conditions	NULL
were	NULL
identical	NULL
to	NULL
those	NULL
in	NULL
A	NULL
.	NULL

Following	NULL
fractionation	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
protein	NULL
was	NULL
transferred	NULL
to	NULL
PVDF	NULL
and	NULL
treated	NULL
with	NULL
1	NULL
N	NULL
KOH	NULL
for	NULL
2	NULL
h	NULL
at	NULL
55	NULL
°C	NULL
.	NULL

Radiolabeled	NULL
protein	NULL
was	NULL
detected	NULL
by	NULL
PhosphorImager	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
MBP-Btk	NULL
and	NULL
BAP/TFII-I	NULL
N-2R	NULL
are	NULL
indicated	NULL
by	NULL
arrows	NULL
.	NULL

A	NULL
contaminating	NULL
phosphoprotein	NULL
is	NULL
indicated	NULL
by	NULL
an	NULL
asterisk	NULL
.	NULL

C	NULL
,	NULL
metal	NULL
dependence	NULL
of	NULL
MBP-Btk	NULL
activity	NULL
.	NULL

MBP-Btk	NULL
(	NULL
10	NULL
ul	NULL
,	NULL
lanes	NULL
1-5	NULL
and	NULL
17-15	NULL
)	NULL
or	NULL
MBP-Bke	NULL
(	NULL
10	NULL
pl	NULL
,	NULL
lanes	NULL
6-10	NULL
and	NULL
16-19	NULL
)	NULL
was	NULL
incubated	NULL
with	NULL
4	NULL
ul	NULL
of	NULL
BAP	NULL
N-2R	NULL
in	NULL
20	NULL
mM	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
7.2	NULL
)	NULL
,	NULL
1	NULL
mM	NULL
Na	NULL
,	NULL
MoO	NULL
,	NULL
,	NULL
10	NULL
uCi	NULL
of	NULL
[	NULL
y-*°P	NULL
]	NULL
JATP	NULL
,	NULL
and	NULL
the	NULL
indicated	NULL
concentrations	NULL
of	NULL
100:1	NULL
manganese/magnesium	NULL
(	NULL
lanes	NULL
1-10	NULL
)	NULL
or	NULL
manganese	NULL
alone	NULL
(	NULL
lanes	NULL
11-19	NULL
)	NULL
.	NULL

Protein	NULL
was	NULL
fractionated	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
transferred	NULL
to	NULL
PVDF	NULL
,	NULL
and	NULL
stained	NULL
with	NULL
Ponceau	NULL
S.	NULL
Radiolabeled	NULL
protein	NULL
was	NULL
detected	NULL
by	NULL
PhosphorImager	NULL
panel	NULL
)	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
radiolabel	NULL
incorporated	NULL
into	NULL
BAP/TFII-I	NULL
N-2R	NULL
,	NULL
as	NULL
quantitated	NULL
by	NULL
scintillation	NULL
counting	NULL
,	NULL
is	NULL
plotted	NULL
as	NULL
a	NULL
function	NULL
of	NULL
[	NULL
Me**	NULL
]	NULL
(	NULL
right	NULL
panel	NULL
)	NULL
.	NULL

N-3R	NULL
(	NULL
residues	NULL
1-503	NULL
)	NULL
,	NULL
BAP	NULL
N-2R	NULL
(	NULL
residues	NULL
1-398	NULL
)	NULL
,	NULL
BAP	NULL
N-NR2	NULL
(	NULL
residues	NULL
1-303	NULL
)	NULL
,	NULL
BAP	NULL
N-1R	NULL
(	NULL
residues	NULL
1-189	NULL
)	NULL
,	NULL
BAP	NULL
4R-CT	NULL
(	NULL
residues	NULL
514-957	NULL
)	NULL
,	NULL
and	NULL
BAP	NULL
5R-CT	NULL
(	NULL
residues	NULL
675-957	NULL
)	NULL
.	NULL

Wild-type	NULL
BAP/TFII-I	NULL
,	NULL
tagged	NULL
with	NULL
polyhistidine	NULL
and	NULL
a	NULL
c-Myc	NULL
epitope	NULL
,	NULL
was	NULL
expressed	NULL
and	NULL
purified	NULL
in	NULL
parallel	NULL
.	NULL

Expression	NULL
and	NULL
Purification	NULL
of	NULL
Btk-To	NULL
define	NULL
the	NULL
sites	NULL
at	NULL
which	NULL
Btk	NULL
phosphorylates	NULL
BAP/TFII-I	NULL
in	NULL
vitro	NULL
,	NULL
it	NULL
was	NULL
essential	NULL
to	NULL
obtain	NULL
active	NULL
Btk	NULL
in	NULL
a	NULL
form	NULL
free	NULL
of	NULL
contaminating	NULL
tyrosine	NULL
kinases	NULL
.	NULL

Btk	NULL
immunoprecipitated	NULL
from	NULL
mammalian	NULL
cells	NULL
was	NULL
unsatisfactory	NULL
for	NULL
this	NULL
purpose	NULL
,	NULL
since	NULL
pilot	NULL
experiments	NULL
with	NULL
a	NULL
kinase-inactive	NULL
mutant	NULL
Btk	NULL
revealed	NULL
the	NULL
presence	NULL
of	NULL
additional	NULL
tyrosine	NULL
kinase	NULL
activities	NULL
in	NULL
such	NULL
preparations	NULL
.	NULL

Recovery	NULL
of	NULL
catalytically	NULL
active	NULL
Btk	NULL
,	NULL
expressed	NULL
in	NULL
E.	NULL
coli	NULL
,	NULL
has	NULL
been	NULL
demonstrated	NULL
(	NULL
23	NULL
)	NULL
.	NULL

We	NULL
therefore	NULL
employed	NULL
recombinant	NULL
Btk	NULL
,	NULL
obtained	NULL
from	NULL
bacterial	NULL
cells	NULL
,	NULL
since	NULL
prokaryotes	NULL
are	NULL
devoid	NULL
of	NULL
tyrosine	NULL
kinases	NULL
.	NULL

Btk	NULL
,	NULL
fused	NULL
at	NULL
the	NULL
amino	NULL
terminus	NULL
to	NULL
MBP	NULL
,	NULL
was	NULL
expressed	NULL
in	NULL
E.	NULL
coli	NULL
BL21	NULL
and	NULL
purified	NULL
by	NULL
amylose	NULL
affinity	NULL
chromatography	NULL
.	NULL

Btk	NULL
(	NULL
KA430E	NULL
)	NULL
,	NULL
a	NULL
kinase-inactive	NULL
mutant	NULL
,	NULL
was	NULL
prepared	NULL
in	NULL
parallel	NULL
for	NULL
use	NULL
as	NULL
a	NULL
control	NULL
.	NULL

Btk	NULL
activity	NULL
was	NULL
initially	NULL
assessed	NULL
by	NULL
autophosphorylation	NULL
and	NULL
by	NULL
phosphorylation	NULL
of	NULL
the	NULL
BAP	NULL
truncation	NULL
substrate	NULL
BAP	NULL
N-2R	NULL
.	NULL

Increasing	NULL
amounts	NULL
of	NULL
the	NULL
MBP-Btk	NULL
and	NULL
MBP-Btk	NULL
(	NULL
K430E	NULL
)	NULL
preparations	NULL
were	NULL
incubated	NULL
with	NULL
[	NULL
y-°°P	NULL
]	NULL
ATP	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

Following	NULL
polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
,	NULL
protein	NULL
was	NULL
detected	NULL
by	NULL
PhosphorImager	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
,	NULL
left	NULL
)	NULL
and	NULL
by	NULL
silver	NULL
staining	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
,	NULL
right	NULL
)	NULL
.	NULL

A	NULL
prominent	NULL
phosphorylated	NULL
species	NULL
was	NULL
observed	NULL
at	NULL
the	NULL
position	NULL
of	NULL
MBP	NULL
Btk	NULL
in	NULL
reactions	NULL
containing	NULL
wild-type	NULL
protein	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
,	NULL
lanes	NULL
1-3	NULL
and	NULL
7-9	NULL
)	NULL
;	NULL
in	NULL
reactions	NULL
containing	NULL
similar	NULL
amounts	NULL
of	NULL
the	NULL
kinase-inactive	NULL
mutant	NULL
,	NULL
the	NULL
corresponding	NULL
fusion	NULL
protein	NULL
was	NULL
phosphorylated	NULL
at	NULL
levels	NULL
at	NULL
least	NULL
3.6-fold	NULL
lower	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
,	NULL
lanes	NULL
4-6	NULL
and	NULL
10-12	NULL
)	NULL
.	NULL

A	NULL
prominent	NULL
75-kDa	NULL
phosphorylated	NULL
species	NULL
was	NULL
observed	NULL
in	NULL
all	NULL
reactions	NULL
.	NULL

This	NULL
protein	NULL
is	NULL
of	NULL
bacterial	NULL
origin	NULL
,	NULL
since	NULL
it	NULL
is	NULL
also	NULL
present	NULL
in	NULL
Ni	NULL
nitrilotriacetic	NULL
acid	NULL
affinity	NULL
preparations	NULL
of	NULL
BAP/TFII-I	NULL
fragments	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

Phosphorylation	NULL
of	NULL
this	NULL
protein	NULL
and	NULL
the	NULL
trace	NULL
phosphorylation	NULL
of	NULL
MBP-Btk	NULL
(	NULL
K430E	NULL
)	NULL
are	NULL
likely	NULL
carried	NULL
out	NULL
by	NULL
a	NULL
contaminating	NULL
,	NULL
bacterial	NULL
serine/threonine	NULL
kinase	NULL
.	NULL

To	NULL
assess	NULL
phosphorylation	NULL
activity	NULL
in	NULL
frans	NULL
,	NULL
equivalent	NULL
amounts	NULL
of	NULL
MBP-Btk	NULL
and	NULL
MBP-Btk	NULL
(	NULL
K430E	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
decreasing	NULL
amounts	NULL
of	NULL
the	NULL
BAP	NULL
N-2R	NULL
fragment	NULL
and	NULL
[	NULL
y-°°P	NULL
]	NULL
JATP	NULL
.	NULL

BAP	NULL
N-2R	NULL
was	NULL
phosphorylated	NULL
in	NULL
reactions	NULL
containing	NULL
MBP-Btk	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
but	NULL
not	NULL
in	NULL
reactions	NULL
containing	NULL
MBP-Btk	NULL
(	NULL
KA430E	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
or	NULL
in	NULL
a	NULL
reaction	NULL
from	NULL
which	NULL
enzyme	NULL
was	NULL
omitted	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
autokinase	NULL
activity	NULL
,	NULL
a	NULL
phosphorylated	NULL
species	NULL
corresponding	NULL
in	NULL
size	NULL
to	NULL
the	NULL
input	NULL
MBP	NULL
fusion	NULL
protein	NULL
was	NULL
present	NULL
in	NULL
reactions	NULL
containing	NULL
wild-type	NULL
MBP-Btk	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
lanes	NULL
1-3	NULL
)	NULL
but	NULL
not	NULL
in	NULL
reactions	NULL
containing	NULL
the	NULL
kinase	NULL
inactive	NULL
mutant	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
lanes	NULL
5-7	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicated	NULL
that	NULL
the	NULL
MBP-Btk	NULL
preparation	NULL
obtained	NULL
from	NULL
bacterial	NULL
cells	NULL
possesses	NULL
autokinase	NULL
activity	NULL
as	NULL
well	NULL
as	NULL
activity	NULL
toward	NULL
a	NULL
BAP/TFII-I	NULL
fragment	NULL
.	NULL

Before	NULL
proceeding	NULL
to	NULL
phosphorylation	NULL
site	NULL
mapping	NULL
studies	NULL
,	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
27810	NULL
the	NULL
divalent	NULL
cation	NULL
dependence	NULL
of	NULL
MBP-Btk	NULL
in	NULL
vitro	NULL
was	NULL
opti-mized	NULL
.	NULL

Autophosphorylation	NULL
and	NULL
phosphorylation	NULL
of	NULL
the	NULL
BAP	NULL
N-2R	NULL
fragment	NULL
were	NULL
assessed	NULL
at	NULL
various	NULL
concentrations	NULL
of	NULL
Mg**	NULL
or	NULL
Mn**	NULL
,	NULL
alone	NULL
or	NULL
in	NULL
combination	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
C	NULL
)	NULL
.	NULL

Reaction	NULL
products	NULL
were	NULL
resolved	NULL
by	NULL
polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
,	NULL
transferred	NULL
to	NULL
PVDF	NULL
membrane	NULL
,	NULL
and	NULL
visualized	NULL
by	NULL
Phospho-rlmager	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
,	NULL
leff	NULL
panel	NULL
)	NULL
.	NULL

As	NULL
observed	NULL
above	NULL
,	NULL
MBP-Btk	NULL
exhibited	NULL
autokinase	NULL
activity	NULL
as	NULL
well	NULL
as	NULL
activity	NULL
against	NULL
BAP	NULL
N-2R	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
,	NULL
lanes	NULL
1-5	NULL
and	NULL
11-15	NULL
)	NULL
,	NULL
while	NULL
MBP-Btk	NULL
(	NULL
KA430E	NULL
)	NULL
exhibited	NULL
neither	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
,	NULL
lanes	NULL
6-10	NULL
and	NULL
15-19	NULL
)	NULL
.	NULL

Membrane	NULL
slices	NULL
containing	NULL
BAP	NULL
N-2R	NULL
,	NULL
visualized	NULL
by	NULL
staining	NULL
with	NULL
Ponceau	NULL
S	NULL
,	NULL
were	NULL
excised	NULL
,	NULL
and	NULL
°°P	NULL
was	NULL
quantitated	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
,	NULL
right	NULL
panel	NULL
)	NULL
.	NULL

MBP-Btk	NULL
was	NULL
most	NULL
active	NULL
in	NULL
reactions	NULL
containing	NULL
2	NULL
mx	NULL
Mn**	NULL
,	NULL
and	NULL
these	NULL
conditions	NULL
were	NULL
used	NULL
in	NULL
all	NULL
subsequent	NULL
in	NULL
vitro	NULL
reactions	NULL
.	NULL

Localization	NULL
of	NULL
Btk	NULL
Phosphorylation	NULL
Sites	NULL
within	NULL
BAP	NULL
!	NULL

TFILI-I-Similar	NULL
amounts	NULL
of	NULL
purified	NULL
,	NULL
epitope-tagged	NULL
BAP/	NULL
TFII-I	NULL
or	NULL
BAP/TFII-I	NULL
truncation	NULL
mutants	NULL
,	NULL
as	NULL
assessed	NULL
by	NULL
immunoblotting	NULL
with	NULL
an	NULL
anti-Myc	NULL
antibody	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
,	NULL
were	NULL
incubated	NULL
with	NULL
MBP-Btk	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
[	NULL
7-32P	NULL
]	NULL
ATP	NULL
.	NULL

Kinase	NULL
reactions	NULL
were	NULL
performed	NULL
in	NULL
triplicate	NULL
.	NULL

Full-length	NULL
BAP/TFII-I	NULL
was	NULL
incubated	NULL
with	NULL
MBP-Btk	NULL
(	NULL
KA30E	NULL
)	NULL
as	NULL
a	NULL
control	NULL
.	NULL

Products	NULL
were	NULL
fractionated	NULL
by	NULL
gel	NULL
electrophoresis	NULL
,	NULL
transferred	NULL
to	NULL
PVDF	NULL
,	NULL
and	NULL
visualized	NULL
by	NULL
phosphorimaging	NULL
;	NULL
a	NULL
representative	NULL
experiment	NULL
is	NULL
shown	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
radioactivity	NULL
in	NULL
each	NULL
BAP/TFIL-I	NULL
fragment	NULL
was	NULL
assessed	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
.	NULL

These	NULL
experiments	NULL
localized	NULL
the	NULL
major	NULL
sites	NULL
of	NULL
phosphorylation	NULL
by	NULL
Btk	NULL
in	NULL
vitro	NULL
to	NULL
the	NULL
region	NULL
of	NULL
BAP/TFII-I	NULL
extending	NULL
from	NULL
the	NULL
amino	NULL
terminus	NULL
through	NULL
the	NULL
third	NULL
HLH-like	NULL
repeat	NULL
,	NULL
although	NULL
phosphorylation	NULL
to	NULL
a	NULL
lesser	NULL
extent	NULL
in	NULL
other	NULL
regions	NULL
could	NULL
not	NULL
be	NULL
excluded	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
.	NULL

We	NULL
proceeded	NULL
to	NULL
map	NULL
the	NULL
major	NULL
sites	NULL
of	NULL
phosphorylation	NULL
by	NULL
Btk	NULL
in	NULL
vitro	NULL
.	NULL

One-dimensional	NULL
tryptic	NULL
phosphopeptide	NULL
mapping	NULL
by	NULL
40	NULL
%	NULL
alkaline	NULL
gel	NULL
electrophoresis	NULL
(	NULL
40	NULL
)	NULL
confirmed	NULL
that	NULL
while	NULL
Btk	NULL
phosphorylation	NULL
sites	NULL
are	NULL
distributed	NULL
throughout	NULL
BAP/TFII-I	NULL
,	NULL
the	NULL
principal	NULL
sites	NULL
of	NULL
phosphorylation	NULL
in	NULL
vitro	NULL
are	NULL
located	NULL
within	NULL
the	NULL
interval	NULL
extending	NULL
from	NULL
the	NULL
amino	NULL
terminus	NULL
through	NULL
the	NULL
third	NULL
HLH-like	NULL
repeat	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
,	NULL
compare	NULL
lanes	NULL
1	NULL
,	NULL
2	NULL
,	NULL
and	NULL
5	NULL
with	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

Importantly	NULL
,	NULL
most	NULL
phosphopeptides	NULL
present	NULL
in	NULL
full-length	NULL
BAP/TFII-I	NULL
were	NULL
also	NULL
present	NULL
in	NULL
the	NULL
BAP	NULL
N-3R	NULL
fragment	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
,	NULL
compare	NULL
lanes	NULL
2	NULL
and	NULL
5	NULL
)	NULL
.	NULL

Comparison	NULL
of	NULL
the	NULL
phosphopeptide	NULL
patterns	NULL
obtained	NULL
from	NULL
BAP	NULL
N-2R	NULL
and	NULL
BAP	NULL
N-3R	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
revealed	NULL
the	NULL
presence	NULL
of	NULL
at	NULL
least	NULL
one	NULL
Btk	NULL
phosphorylation	NULL
site	NULL
between	NULL
amino	NULL
acid	NULL
residues	NULL
398	NULL
and	NULL
503	NULL
(	NULL
3R	NULL
)	NULL
of	NULL
BAP/TFII-I	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
filled	NULL
arrows	NULL
)	NULL
.	NULL

The	NULL
weak	NULL
phosphorylation	NULL
of	NULL
BAP	NULL
4R-CT	NULL
and	NULL
BAP	NULL
5R-CT	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
and	NULL
the	NULL
presence	NULL
of	NULL
at	NULL
least	NULL
one	NULL
phosphopeptide	NULL
in	NULL
full-length	NULL
BAP/TFII-I	NULL
that	NULL
is	NULL
not	NULL
found	NULL
in	NULL
BAP	NULL
N-3R	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
,	NULL
open	NULL
arrow	NULL
)	NULL
indicate	NULL
that	NULL
one	NULL
or	NULL
more	NULL
minor	NULL
Btk	NULL
phosphorylation	NULL
sites	NULL
probably	NULL
exist	NULL
within	NULL
the	NULL
C-terminal	NULL
portion	NULL
of	NULL
BAP	NULL
.	NULL

Further	NULL
dissection	NULL
of	NULL
the	NULL
amino	NULL
portion	NULL
of	NULL
BAP	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
revealed	NULL
that	NULL
,	NULL
in	NULL
addition	NULL
to	NULL
the	NULL
398-503	NULL
region	NULL
(	NULL
3R	NULL
)	NULL
,	NULL
the	NULL
intervals	NULL
spanning	NULL
residues	NULL
304-398	NULL
(	NULL
2R	NULL
)	NULL
and	NULL
189-303	NULL
(	NULL
NR2	NULL
)	NULL
of	NULL
BAP/TFII-I	NULL
each	NULL
contain	NULL
at	NULL
least	NULL
one	NULL
Btk	NULL
phosphorylation	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
compare	NULL
lanes	NULL
1	NULL
,	NULL
2	NULL
,	NULL
4	NULL
,	NULL
6	NULL
,	NULL
and	NULL
7	NULL
)	NULL
;	NULL
peptides	NULL
corresponding	NULL
to	NULL
these	NULL
three	NULL
intervals	NULL
are	NULL
indicated	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
filled	NULL
arrows	NULL
)	NULL
.	NULL

While	NULL
one	NULL
phosphopeptide	NULL
fragment	NULL
was	NULL
recovered	NULL
from	NULL
a	NULL
reaction	NULL
containing	NULL
BAP	NULL
N-1R	NULL
,	NULL
this	NULL
may	NULL
not	NULL
represent	NULL
a	NULL
specific	NULL
phosphorylation	NULL
site	NULL
,	NULL
since	NULL
a	NULL
comigrating	NULL
species	NULL
was	NULL
present	NULL
in	NULL
all	NULL
samples	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
the	NULL
data	NULL
obtained	NULL
from	NULL
phosphopeptide	NULL
mapping	NULL
of	NULL
truncation	NULL
mutants	NULL
indicated	NULL
that	NULL
the	NULL
principal	NULL
targets	NULL
of	NULL
phosphorylation	NULL
by	NULL
Btk	NULL
lie	NULL
in	NULL
three	NULL
discrete	NULL
intervals	NULL
of	NULL
BAP/TFII-I	NULL
,	NULL
comprising	NULL
the	NULL
second	NULL
nonrepeat	NULL
region	NULL
,	NULL
the	NULL
second	NULL
HLH-like	NULL
region	NULL
,	NULL
and	NULL
the	NULL
third	NULL
HLH-like	NULL
region	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
)	NULL
.	NULL

Fine	NULL
Mapping	NULL
of	NULL
Major	NULL
Btk	NULL
Phosphorylation	NULL
Sites	NULL
in	NULL
BAP	NULL
!	NULL

TFII-I	NULL
by	NULL
Site-directed	NULL
Mutagenesis-Site-directed	NULL
mutagene-	NULL
Btk	NULL
Phosphorylation	NULL
Sites	NULL
in	NULL
BAP/TFILI-I	NULL
A	NULL
B	NULL
Btk	NULL
Bke	NULL
A	NULL
A	NULL
¢	NULL
&	NULL
.2	NULL
.S	NULL
¢	NULL
&	NULL
.8	NULL
,	NULL
o	NULL
&	NULL
yoy	NULL
C	NULL
#	NULL
(	NULL
01636558	NULL
:	NULL
ng	NULL
*	NULL
MBP-Btk	NULL
-	NULL
»	NULL
Q	NULL
'	NULL
.	NULL

‘	NULL
cut	NULL
#	NULL
B	NULL
us	NULL
m	NULL
--	NULL
>	NULL
>	NULL
,	NULL
mm	NULL
mme	NULL
opp	NULL
ons	NULL
aas	NULL
aum	NULL
pf	NULL
On	NULL
Alli	NULL
1	NULL
_	NULL
2	NULL
3	NULL
4	NULL
5	NULL
10	NULL
2	NULL
3	NULL
40	NULL
5006	NULL
a	NULL
myc	NULL
In	NULL
vitro	NULL
kinase	NULL
400	NULL
300	NULL
200	NULL
CPM	NULL
100	NULL
FL	NULL
N-2R	NULL
N-3R	NULL
_	NULL
4R-CT	NULL
_	NULL
SR-CT	NULL
FL	NULL
Btk	NULL
Bke	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

Btk	NULL
preferentially	NULL
phosphorylates	NULL
sites	NULL
within	NULL
the	NULL
ami-no-terminal	NULL
508	NULL
residues	NULL
of	NULL
BAP/TFII-I	NULL
in	NULL
vitro	NULL
.	NULL

A	NULL
,	NULL
quantitation	NULL
of	NULL
full-length	NULL
and	NULL
truncated	NULL
BAP/TFII-I	NULL
proteins	NULL
.	NULL

Full-length	NULL
(	NULL
FL	NULL
;	NULL
lane	NULL
1	NULL
)	NULL
and	NULL
truncated	NULL
(	NULL
N-2R	NULL
,	NULL
N-3R	NULL
,	NULL
4R-CT	NULL
,	NULL
and	NULL
5R-CT	NULL
;	NULL
lanes	NULL
2-5	NULL
)	NULL
BAP/TEFII-I	NULL
proteins	NULL
,	NULL
fused	NULL
to	NULL
polyhistidine	NULL
and	NULL
a	NULL
c-Myc	NULL
epitope	NULL
,	NULL
were	NULL
expressed	NULL
in	NULL
E.	NULL
coli	NULL
,	NULL
purified	NULL
by	NULL
Ni°*-nitrilotriacetic	NULL
acid	NULL
chromatography	NULL
,	NULL
fractionated	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
and	NULL
detected	NULL
by	NULL
immunoblotting	NULL
with	NULL
an	NULL
anti-Myc	NULL
antibody	NULL
.	NULL

B	NULL
,	NULL
phosphorylation	NULL
of	NULL
BAP/TFII-I	NULL
fragments	NULL
by	NULL
Btk	NULL
in	NULL
vitro	NULL
.	NULL

Equimolar	NULL
amounts	NULL
of	NULL
full-length	NULL
(	NULL
Zanes	NULL
1	NULL
and	NULL
6	NULL
)	NULL
or	NULL
truncated	NULL
(	NULL
Zanes	NULL
2-5	NULL
)	NULL
BAP/TFII-I	NULL
proteins	NULL
,	NULL
as	NULL
assessed	NULL
in	NULL
A	NULL
,	NULL
were	NULL
incubated	NULL
with	NULL
5	NULL
ul	NULL
of	NULL
MBP-Btk	NULL
(	NULL
Zanes	NULL
1-5	NULL
)	NULL
or	NULL
MBP-Btk	NULL
(	NULL
K430E	NULL
)	NULL
(	NULL
Zane	NULL
6	NULL
)	NULL
and	NULL
10	NULL
uCi	NULL
[	NULL
y-*	NULL
``	NULL
PJATP	NULL
in	NULL
a	NULL
buffer	NULL
containing	NULL
20	NULL
mM	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
7.2	NULL
)	NULL
,	NULL
2	NULL
mM	NULL
MnCl	NULL
,	NULL
,	NULL
and	NULL
1	NULL
mM	NULL
Na	NULL
,	NULL
Mo0	NULL
,	NULL
.	NULL

After	NULL
30	NULL
min	NULL
at	NULL
37°C	NULL
,	NULL
products	NULL
were	NULL
fractionated	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
transferred	NULL
to	NULL
PVDF	NULL
,	NULL
and	NULL
detected	NULL
by	NULL
PhosphorImager	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
full-length	NULL
,	NULL
N-2R	NULL
,	NULL
and	NULL
N-3R	NULL
BAP/TFII-I	NULL
are	NULL
indicated	NULL
by	NULL
the	NULL
open	NULL
,	NULL
filled	NULL
and	NULL
shaded	NULL
arrowheads	NULL
,	NULL
respectively	NULL
.	NULL

A	NULL
contaminating	NULL
phosphoprotein	NULL
is	NULL
indicated	NULL
by	NULL
an	NULL
asterisk	NULL
.	NULL

C	NULL
,	NULL
radiolabeled	NULL
substrates	NULL
were	NULL
excised	NULL
from	NULL
PVDF	NULL
membranes	NULL
,	NULL
and	NULL
radioactivity	NULL
(	NULL
Cerenkov	NULL
)	NULL
was	NULL
quantitated	NULL
.	NULL

The	NULL
results	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
are	NULL
plotted	NULL
.	NULL

Bik	NULL
,	NULL
reactions	NULL
performed	NULL
with	NULL
MBP-Btk	NULL
;	NULL
Bke	NULL
,	NULL
reactions	NULL
performed	NULL
with	NULL
MBP-Btk	NULL
(	NULL
KA80E	NULL
)	NULL
.	NULL

Full-length	NULL
(	NULL
FL	NULL
)	NULL
and	NULL
truncated	NULL
(	NULL
N-2R	NULL
,	NULL
N-3R	NULL
,	NULL
4R-CT	NULL
,	NULL
and	NULL
5R-CT	NULL
)	NULL
substrates	NULL
are	NULL
indicated	NULL
.	NULL

sis	NULL
was	NULL
used	NULL
to	NULL
identify	NULL
the	NULL
specific	NULL
tyrosine	NULL
residues	NULL
targeted	NULL
for	NULL
phosphorylation	NULL
by	NULL
Btk	NULL
in	NULL
each	NULL
of	NULL
the	NULL
three	NULL
intervals	NULL
identified	NULL
in	NULL
the	NULL
previous	NULL
experiments	NULL
.	NULL

There	NULL
are	NULL
four	NULL
tyrosine	NULL
residues	NULL
,	NULL
Tyr®*	NULL
,	NULL
Tyr®*	NULL
,	NULL
Tyr	NULL
``	NULL
,	NULL
and	NULL
Tyr®	NULL
``	NULL
``	NULL
,	NULL
within	NULL
the	NULL
second	NULL
nonrepeat	NULL
region	NULL
(	NULL
residues	NULL
190-303	NULL
)	NULL
of	NULL
BAP/TFII-I	NULL
.	NULL

Simultaneous	NULL
mutation	NULL
of	NULL
these	NULL
tyrosine	NULL
residues	NULL
to	NULL
phenylalanine	NULL
in	NULL
BAP	NULL
N-2R	NULL
and	NULL
BAP	NULL
N-3R	NULL
(	NULL
BAP	NULL
N-2R	NULL
(	NULL
4F	NULL
)	NULL
and	NULL
BAP	NULL
N-3R	NULL
(	NULL
4F	NULL
)	NULL
)	NULL
specifically	NULL
eliminated	NULL
phosphopeptides	NULL
previously	NULL
mapped	NULL
to	NULL
the	NULL
second	NULL
nonrepeat	NULL
region	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
compare	NULL
lanes	NULL
3	NULL
and	NULL
5	NULL
with	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
at	NULL
least	NULL
one	NULL
of	NULL
these	NULL
four	NULL
tyrosine	NULL
residues	NULL
is	NULL
a	NULL
target	NULL
for	NULL
phosphorylation	NULL
by	NULL
Btk	NULL
in	NULL
vitro	NULL
.	NULL

Tryptic	NULL
phosphopeptides	NULL
derived	NULL
from	NULL
outside	NULL
of	NULL
the	NULL
second	NULL
nonrepeat	NULL
region	NULL
of	NULL
BAP/TFII-I	NULL
were	NULL
unaffected	NULL
by	NULL
these	NULL
point	NULL
mutations	NULL
.	NULL

Phosphorylation	NULL
of	NULL
other	NULL
sites	NULL
within	NULL
BAP/TFII-I	NULL
by	NULL
Btk	NULL
is	NULL
therefore	NULL
independent	NULL
of	NULL
phosphorylation	NULL
in	NULL
the	NULL
190-303	NULL
interval	NULL
.	NULL

To	NULL
determine	NULL
which	NULL
of	NULL
the	NULL
four	NULL
tyrosines	NULL
in	NULL
the	NULL
second	NULL
nonrepeat	NULL
region	NULL
are	NULL
phosphorylated	NULL
by	NULL
Btk	NULL
in	NULL
vitro	NULL
,	NULL
full-length	NULL
,	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
Btk	NULL
Phosphorylation	NULL
Sites	NULL
in	NULL
BAP/TFILI-I	NULL
J	NULL
>	NULL
ue	NULL
!	NULL

MBP-Btk	NULL
MBP-Btk	NULL
&	NULL
&	NULL
A	NULL
A	NULL
®	NULL
``	NULL
a	NULL
£	NULL
&	NULL
.9	NULL
,	NULL
G	NULL
¢	NULL
¢	NULL
&	NULL
&	NULL
&	NULL
&	NULL
x	NULL
&	NULL
C	NULL
£	NULL
o	NULL
o_	NULL
s	NULL
[	NULL
y	NULL
§	NULL
&	NULL
C	NULL
§	NULL
3R	NULL
-	NULL
>	NULL
titis	NULL
Altice	NULL
.	NULL

#	NULL
aand	NULL
<	NULL
-	NULL
SR	NULL
ps	NULL
e	NULL
``	NULL
o	NULL
-	NULL
He	NULL
a	NULL
aes	NULL
ey	NULL
:	NULL
*	NULL
«	NULL
comm	NULL
n	NULL
-	NULL
»	NULL
ates	NULL
.	NULL

-s	NULL
-+	NULL
=	NULL
tes	NULL
28	NULL
h	NULL
«	NULL
ume	NULL
!	NULL

mons	NULL
:	NULL
\	NULL
:	NULL
:	NULL
<	NULL
Aek	NULL
NRZ	NULL
-o-	NULL
)	NULL
ue	NULL
|	NULL
mame	NULL
:	NULL
|	NULL
...	NULL
.	NULL

sane	NULL
|___	NULL
,	NULL
«	NULL
a-wod	NULL
we-	NULL
|	NULL
<	NULL
-3R	NULL
-	NULL
NR2	NULL
mi-	NULL
wn	NULL
:	NULL
Jags	NULL
.	NULL

=	NULL
,	NULL
e	NULL
3R	NULL
-	NULL
»	NULL
«	NULL
tin	NULL
.	NULL

oms	NULL
.	NULL

1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
1	NULL
2	NULL
3	NULL
4	NULL
50	NULL
6	NULL
7	NULL
C	NULL
-	NULL
BAP	NULL
(	NULL
Nmr	NULL
Nrz	NULL
ar	NULL
ar	NULL
ar	NULL
(	NULL
sr	NULL
6Rr	NULL
]	NULL
Btk	NULL
D	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

Phosphorylation	NULL
of	NULL
BAP/TFII-I	NULL
within	NULL
the	NULL
second	NULL
and	NULL
third	NULL
HLH-like	NULL
domains	NULL
and	NULL
the	NULL
second	NULL
nonrepeat	NULL
region	NULL
by	NULL
Btk	NULL
in	NULL
vitro	NULL
.	NULL

A	NULL
,	NULL
one-dimensional	NULL
tryptic	NULL
phosphopeptide	NULL
analysis	NULL
of	NULL
full-length	NULL
and	NULL
truncated	NULL
BAP/TFII-I	NULL
,	NULL
phosphorylated	NULL
by	NULL
Btk	NULL
in	NULL
vitro	NULL
.	NULL

Lanes	NULL
1-4	NULL
,	NULL
truncation	NULL
mutants	NULL
N-2R	NULL
,	NULL
N-3R	NULL
,	NULL
4R-CT	NULL
,	NULL
and	NULL
5R-CT	NULL
,	NULL
respectively	NULL
.	NULL

Lane	NULL
5	NULL
,	NULL
full-length	NULL
BAP/TFII-I	NULL
.	NULL

Phosphopeptides	NULL
derived	NULL
from	NULL
the	NULL
third	NULL
HLH-like	NULL
repeat	NULL
are	NULL
indicated	NULL
by	NULL
closed	NULL
arrows	NULL
.	NULL

A	NULL
minor	NULL
phosphopeptide	NULL
present	NULL
in	NULL
the	NULL
full-length	NULL
protein	NULL
but	NULL
not	NULL
contained	NULL
within	NULL
the	NULL
N-3R	NULL
mutant	NULL
is	NULL
indicated	NULL
by	NULL
the	NULL
open	NULL
arrow	NULL
.	NULL

B	NULL
,	NULL
one-dimensional	NULL
tryptic	NULL
phosphopeptide	NULL
analysis	NULL
of	NULL
wild-type	NULL
and	NULL
mutant	NULL
BAP/	NULL
TFII-I	NULL
,	NULL
phosphorylated	NULL
by	NULL
Btk	NULL
in	NULL
vitro	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
full-length	NULL
,	NULL
wild-type	NULL
BAP/TFII-I	NULL
;	NULL
lare	NULL
2	NULL
,	NULL
BAP/TFII-I	NULL
N-2R	NULL
;	NULL
lane	NULL
3	NULL
,	NULL
BAP/TFII-I	NULL
N-2R	NULL
(	NULL
4F	NULL
)	NULL
,	NULL
which	NULL
carries	NULL
phenylalanine	NULL
substitutions	NULL
at	NULL
Tyr	NULL
``	NULL
,	NULL
Tyr	NULL
``	NULL
*	NULL
``	NULL
,	NULL
Tyr	NULL
``	NULL
,	NULL
and	NULL
Tyr	NULL
``	NULL
;	NULL
lane	NULL
4	NULL
,	NULL
BAP/TFII-L	NULL
N-8R	NULL
;	NULL
lane	NULL
5	NULL
,	NULL
BAP/TFII-L	NULL
N-8R	NULL
(	NULL
4F	NULL
)	NULL
,	NULL
which	NULL
carries	NULL
phenylalanine	NULL
substitutions	NULL
at	NULL
Tyr®*	NULL
``	NULL
,	NULL
Tyr	NULL
``	NULL
,	NULL
Tyr®	NULL
``	NULL
``	NULL
,	NULL
and	NULL
Tyr	NULL
``	NULL
``	NULL
``	NULL
;	NULL
lane	NULL
6	NULL
,	NULL
BAP/TFIl-L	NULL
N-NR2	NULL
;	NULL
lane	NULL
7	NULL
,	NULL
BAP/TFII-I	NULL
N-1R	NULL
.	NULL

Phosphopeptides	NULL
derived	NULL
from	NULL
the	NULL
second	NULL
HLH-like	NULL
domain	NULL
(	NULL
28	NULL
)	NULL
,	NULL
the	NULL
third	NULL
HLH-like	NULL
domain	NULL
(	NULL
3R	NULL
)	NULL
,	NULL
and	NULL
the	NULL
second	NULL
nonrepeat	NULL
region	NULL
(	NULL
NRZ	NULL
)	NULL
are	NULL
indicated	NULL
by	NULL
closed	NULL
arrows	NULL
.	NULL

wild-type	NULL
BAP/TFII-I	NULL
and	NULL
BAP/TFII-I	NULL
mutants	NULL
were	NULL
phosphorylated	NULL
in	NULL
vitro	NULL
by	NULL
MBP-Btk	NULL
,	NULL
and	NULL
tryptic	NULL
phosphopeptides	NULL
were	NULL
resolved	NULL
by	NULL
electrophoresis	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
a	NULL
BAP/	NULL
TFII-I	NULL
mutant	NULL
carrying	NULL
phenylalanine	NULL
replacements	NULL
at	NULL
all	NULL
four	NULL
tyrosines	NULL
in	NULL
the	NULL
second	NULL
nonrepeat	NULL
region	NULL
(	NULL
BAP/TFII-I	NULL
(	NULL
4F	NULL
)	NULL
)	NULL
,	NULL
mutants	NULL
carrying	NULL
phenylalanine	NULL
substitutions	NULL
for	NULL
tyrosines	NULL
248	NULL
(	NULL
Y248F	NULL
)	NULL
,	NULL
277	NULL
(	NULL
Y277F	NULL
)	NULL
,	NULL
and	NULL
248	NULL
and	NULL
277	NULL
(	NULL
Y248F	NULL
,	NULL
Y277F	NULL
)	NULL
were	NULL
tested	NULL
.	NULL

The	NULL
pattern	NULL
of	NULL
tryptic	NULL
phosphopeptides	NULL
obtained	NULL
from	NULL
BAP/TFII-I	NULL
(	NULL
Y277F	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
was	NULL
identical	NULL
to	NULL
that	NULL
of	NULL
wild-type	NULL
BAP/TFII-I	NULL
(	NULL
Fig	NULL
.	NULL

54	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
at	NULL
least	NULL
one	NULL
tryptic	NULL
phosphopeptide	NULL
present	NULL
in	NULL
the	NULL
wild-type	NULL
protein	NULL
was	NULL
eliminated	NULL
by	NULL
the	NULL
Y248F	NULL
mutation	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
,	NULL
lane	NULL
2	NULL
;	NULL
filled	NULL
arrow	NULL
)	NULL
.	NULL

The	NULL
appearance	NULL
of	NULL
a	NULL
novel	NULL
species	NULL
,	NULL
which	NULL
probably	NULL
represents	NULL
a	NULL
partial	NULL
proteolytic	NULL
fragment	NULL
,	NULL
is	NULL
correlated	NULL
with	NULL
the	NULL
Y248F	NULL
mutation	NULL
(	NULL
Zanes	NULL
2	NULL
,	NULL
4	NULL
,	NULL
and	NULL
5	NULL
,	NULL
open	NULL
arrow	NULL
)	NULL
.	NULL

Mutation	NULL
of	NULL
additional	NULL
tyrosines	NULL
had	NULL
no	NULL
further	NULL
effect	NULL
on	NULL
the	NULL
pattern	NULL
of	NULL
tryptic	NULL
phosphopeptides	NULL
,	NULL
since	NULL
the	NULL
profiles	NULL
obtained	NULL
for	NULL
BAP/	NULL
TFII-I	NULL
(	NULL
Y248F	NULL
,	NULL
Y277F	NULL
)	NULL
and	NULL
BAP/TFII-I	NULL
(	NULL
4F	NULL
)	NULL
are	NULL
identical	NULL
to	NULL
that	NULL
of	NULL
the	NULL
Y248F	NULL
mutant	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
,	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
Tyr	NULL
``	NULL
(	NULL
Fig	NULL
.	NULL

5D	NULL
)	NULL
is	NULL
a	NULL
site	NULL
of	NULL
phosphorylation	NULL
by	NULL
Btk	NULL
in	NULL
vitro	NULL
.	NULL

Four	NULL
tyrosine	NULL
residues	NULL
,	NULL
Tyr®*	NULL
``	NULL
,	NULL
Tyr®**	NULL
,	NULL
Tyr®	NULL
``	NULL
``	NULL
,	NULL
and	NULL
Tyr®	NULL
``	NULL
*	NULL
,	NULL
lie	NULL
within	NULL
the	NULL
second	NULL
HLH-like	NULL
repeat	NULL
of	NULL
BAP/TFII-I	NULL
.	NULL

To	NULL
determine	NULL
sites	NULL
of	NULL
phosphorylation	NULL
in	NULL
this	NULL
region	NULL
,	NULL
the	NULL
corresponding	NULL
phenylalanine	NULL
substitutions	NULL
were	NULL
introduced	NULL
into	NULL
BAP/TFII-I	NULL
,	NULL
27811	NULL
and	NULL
their	NULL
effects	NULL
on	NULL
tryptic	NULL
phosphopeptide	NULL
patterns	NULL
were	NULL
analyzed	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
double	NULL
Y346F	NULL
,	NULL
Y357F	NULL
mutant	NULL
was	NULL
analyzed	NULL
because	NULL
these	NULL
residues	NULL
lie	NULL
within	NULL
a	NULL
single	NULL
tryptic	NULL
fragment	NULL
.	NULL

The	NULL
Y357F	NULL
mutation	NULL
was	NULL
sufficient	NULL
to	NULL
eliminate	NULL
the	NULL
two	NULL
predominant	NULL
phosphopeptides	NULL
present	NULL
in	NULL
the	NULL
wild-type	NULL
substrate	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
,	NULL
compare	NULL
lanes	NULL
4	NULL
and	NULL
1	NULL
)	NULL
.	NULL

Mutation	NULL
of	NULL
Tyr®**	NULL
had	NULL
no	NULL
additional	NULL
effect	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
,	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

The	NULL
phosphopeptide	NULL
pattern	NULL
was	NULL
unchanged	NULL
by	NULL
individual	NULL
mutations	NULL
at	NULL
Tyr®*	NULL
``	NULL
,	NULL
Tyr	NULL
``	NULL
,	NULL
or	NULL
Tyr®'*	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
Tyr	NULL
``	NULL
(	NULL
Fig	NULL
.	NULL

5D	NULL
)	NULL
is	NULL
phosphorylated	NULL
by	NULL
Btk	NULL
in	NULL
vitro	NULL
.	NULL

Similar	NULL
mutational	NULL
analysis	NULL
revealed	NULL
that	NULL
residue	NULL
Tyr'©	NULL
``	NULL
,	NULL
which	NULL
lies	NULL
within	NULL
the	NULL
third	NULL
HLH-like	NULL
repeat	NULL
,	NULL
is	NULL
phosphorylated	NULL
in	NULL
vitro	NULL
by	NULL
Btk	NULL
,	NULL
because	NULL
a	NULL
Y462F	NULL
mutation	NULL
,	NULL
in	NULL
the	NULL
context	NULL
of	NULL
full-length	NULL
BAP/TFII-I	NULL
,	NULL
eliminated	NULL
both	NULL
of	NULL
the	NULL
tryptic	NULL
phosphopeptide	NULL
fragments	NULL
specific	NULL
to	NULL
this	NULL
region	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
,	NULL
compare	NULL
lane	NULL
3	NULL
with	NULL
lanes	NULL
6	NULL
and	NULL
7	NULL
;	NULL
relevant	NULL
peptides	NULL
are	NULL
marked	NULL
by	NULL
closed	NULL
arrows	NULL
)	NULL
.	NULL

Mutation	NULL
of	NULL
residues	NULL
Tyr**	NULL
``	NULL
and	NULL
Tyr*	NULL
``	NULL
®	NULL
did	NULL
not	NULL
alter	NULL
the	NULL
tryptic	NULL
phosphopeptide	NULL
pattern	NULL
,	NULL
relative	NULL
to	NULL
that	NULL
of	NULL
the	NULL
wild-type	NULL
protein	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
5	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
phosphopeptide	NULL
pattern	NULL
of	NULL
the	NULL
Y451F	NULL
,	NULL
Y462F	NULL
double	NULL
mutant	NULL
was	NULL
identical	NULL
to	NULL
that	NULL
of	NULL
the	NULL
Y462F	NULL
single	NULL
mutant	NULL
.	NULL

Thus	NULL
Tyr**	NULL
(	NULL
Fig	NULL
.	NULL

5D	NULL
)	NULL
is	NULL
the	NULL
predominant	NULL
site	NULL
of	NULL
in	NULL
vitro	NULL
phosphorylation	NULL
by	NULL
Btk	NULL
within	NULL
the	NULL
third	NULL
HLH-like	NULL
region	NULL
of	NULL
BAP/TFII-L.	NULL
To	NULL
determine	NULL
the	NULL
contribution	NULL
of	NULL
Btk	NULL
phosphorylation	NULL
of	NULL
BAP/TFII-I	NULL
at	NULL
the	NULL
identified	NULL
sites	NULL
relative	NULL
to	NULL
total	NULL
phosphorylation	NULL
by	NULL
Btk	NULL
in	NULL
vitro	NULL
,	NULL
BAP/TFII-I	NULL
full-length	NULL
protein	NULL
bearing	NULL
phenylalanine	NULL
mutations	NULL
at	NULL
residues	NULL
Tyr®**	NULL
,	NULL
Tyr®	NULL
``	NULL
``	NULL
,	NULL
and	NULL
Tyr*4*	NULL
?	NULL

(	NULL
BAP/TFII-I	NULL
(	NULL
3YF	NULL
)	NULL
)	NULL
was	NULL
expressed	NULL
in	NULL
E.	NULL
coli	NULL
and	NULL
purified	NULL
in	NULL
parallel	NULL
with	NULL
the	NULL
wild-type	NULL
BAP/TFII-I	NULL
protein	NULL
(	NULL
Fig	NULL
.	NULL

5D	NULL
)	NULL
.	NULL

BAP/	NULL
TFII-I	NULL
(	NULL
3YF	NULL
)	NULL
was	NULL
phosphorylated	NULL
to	NULL
a	NULL
substantially	NULL
lesser	NULL
extent	NULL
than	NULL
the	NULL
wild-type	NULL
protein	NULL
in	NULL
in	NULL
vifro	NULL
kinase	NULL
reactions	NULL
performed	NULL
in	NULL
duplicate	NULL
with	NULL
MBP-Btk	NULL
;	NULL
control	NULL
reactions	NULL
were	NULL
run	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
kinase-defective	NULL
MBP-Btk	NULL
(	NULL
K4830E	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

56	NULL
)	NULL
.	NULL

Quantitation	NULL
of	NULL
phosphorylated	NULL
products	NULL
(	NULL
Fig	NULL
.	NULL

5F	NULL
)	NULL
indicated	NULL
that	NULL
the	NULL
majority	NULL
of	NULL
Btk-specific	NULL
phosphorylation	NULL
was	NULL
eliminated	NULL
by	NULL
the	NULL
mutation	NULL
of	NULL
Tyr	NULL
``	NULL
,	NULL
Tyr®	NULL
``	NULL
``	NULL
,	NULL
and	NULL
Tyr*	NULL
``	NULL
to	NULL
phenylalanine	NULL
.	NULL

The	NULL
Btk-specific	NULL
phosphorylation	NULL
remaining	NULL
in	NULL
BAP/TFII-I	NULL
(	NULL
3YEF	NULL
)	NULL
is	NULL
consistent	NULL
with	NULL
data	NULL
presented	NULL
in	NULL
Fig	NULL
.	NULL

44	NULL
,	NULL
which	NULL
indicated	NULL
that	NULL
at	NULL
least	NULL
one	NULL
site	NULL
for	NULL
Btk	NULL
phosphorylation	NULL
resides	NULL
outside	NULL
of	NULL
the	NULL
N-3R	NULL
region	NULL
of	NULL
BAP/TFII-I	NULL
.	NULL

Correspondence	NULL
between	NULL
Phosphorylation	NULL
Sites	NULL
in	NULL
Vitro	NULL
and	NULL
in	NULL
Vivo-We	NULL
next	NULL
wished	NULL
to	NULL
determine	NULL
whether	NULL
the	NULL
phosphorylation	NULL
sites	NULL
defined	NULL
in	NULL
vitro	NULL
correspond	NULL
to	NULL
sites	NULL
at	NULL
which	NULL
BAP/TFII-I	NULL
is	NULL
hyperphosphorylated	NULL
in	NULL
vivo	NULL
upon	NULL
cotransfection	NULL
of	NULL
Btk	NULL
.	NULL

Epitope-tagged	NULL
BAP/TFII-I	NULL
or	NULL
the	NULL
BAP	NULL
N-3R	NULL
fragment	NULL
was	NULL
expressed	NULL
in	NULL
293	NULL
cells	NULL
with	NULL
cotransfected	NULL
Btk	NULL
or	NULL
kinase-inactive	NULL
Btk	NULL
(	NULL
K430E	NULL
)	NULL
.	NULL

Protein	NULL
was	NULL
labeled	NULL
metabolically	NULL
with	NULL
°°P	NULL
and	NULL
recovered	NULL
by	NULL
immunoprecipitation	NULL
with	NULL
an	NULL
anti-c-Mye	NULL
antibody	NULL
.	NULL

Immunoprecipitates	NULL
were	NULL
fractionated	NULL
by	NULL
polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
,	NULL
and	NULL
radiolabeled	NULL
BAP/TFII-I	NULL
species	NULL
were	NULL
isolated	NULL
.	NULL

Phosphoamino	NULL
acid	NULL
analysis	NULL
of	NULL
gel-purified	NULL
BAP/	NULL
TFII-I	NULL
revealed	NULL
the	NULL
presence	NULL
of	NULL
radiolabeled	NULL
phosphotyrosine	NULL
upon	NULL
coexpression	NULL
with	NULL
active	NULL
Btk	NULL
but	NULL
not	NULL
with	NULL
Btk	NULL
(	NULL
K430E	NULL
)	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Tryptic	NULL
digestion	NULL
of	NULL
BAP	NULL
N-3R	NULL
,	NULL
labeled	NULL
in	NULL
vivo	NULL
,	NULL
revealed	NULL
that	NULL
a	NULL
subset	NULL
of	NULL
peptides	NULL
were	NULL
preferentially	NULL
phosphorylated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
Btk	NULL
,	NULL
relative	NULL
to	NULL
Btk	NULL
(	NULL
KA430E	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
,	NULL
compare	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
.	NULL

The	NULL
majority	NULL
of	NULL
these	NULL
phosphopeptides	NULL
corresponded	NULL
to	NULL
tryptic	NULL
fragments	NULL
phosphorylated	NULL
by	NULL
Btk	NULL
in	NULL
vitro	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
,	NULL
lane	NULL
1	NULL
;	NULL
relevant	NULL
peptides	NULL
are	NULL
marked	NULL
by	NULL
arrows	NULL
)	NULL
,	NULL
consistent	NULL
with	NULL
the	NULL
interpretation	NULL
that	NULL
they	NULL
contain	NULL
target	NULL
sites	NULL
for	NULL
direct	NULL
phosphorylation	NULL
by	NULL
Btk	NULL
in	NULL
vivo	NULL
.	NULL

The	NULL
major	NULL
sites	NULL
at	NULL
which	NULL
BAP/TFII-I	NULL
is	NULL
hyperphosphorylated	NULL
upon	NULL
cotransfection	NULL
with	NULL
Btk	NULL
were	NULL
determined	NULL
by	NULL
site-directed	NULL
mutagenesis	NULL
(	NULL
Figs	NULL
.	NULL

6	NULL
,	NULL
B	NULL
and	NULL
C	NULL
)	NULL
.	NULL

A	NULL
Btk-enhanced	NULL
,	NULL
in	NULL
vivo	NULL
labeled	NULL
phosphopeptide	NULL
from	NULL
BAP	NULL
N-3R	NULL
was	NULL
absent	NULL
in	NULL
the	NULL
BAP	NULL
N-3R	NULL
(	NULL
4F	NULL
)	NULL
mutant	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
,	NULL
compare	NULL
lanes	NULL
1	NULL
and	NULL
3	NULL
;	NULL
the	NULL
relevant	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
27812	NULL
Btk	NULL
Phosphorylation	NULL
Sites	NULL
in	NULL
BAP/TFILI-I	NULL
&	NULL
%	NULL
o	NULL
.¥	NULL
¢	NULL
&	NULL
#	NULL
A	NULL
«	NULL
.P	NULL
&	NULL
£	NULL
&	NULL
«	NULL
_	NULL
&	NULL
o	NULL
®	NULL
b	NULL
©	NULL
A	NULL
6°	NULL
®	NULL
O	NULL
a	NULL
~	NULL
C	NULL
¢	NULL
&	NULL
sﬁ	NULL
‘	NULL
if	NULL
.	NULL

Ari/10	NULL
K\	NULL
{	NULL
é	NULL
(	NULL
bu	NULL
)	NULL
(	NULL
bu	NULL
(	NULL
3g	NULL
?	NULL

{	NULL
5h	NULL
4:31	NULL
}	NULL
Q6	NULL
“	NULL
lib	NULL
“	NULL
05°	NULL
513363	NULL
“	NULL
it	NULL
;	NULL
‘	NULL
yq	NULL
’	NULL
‘	NULL
xﬁ	NULL
*	NULL
Yo	NULL
-	NULL
~	NULL
»	NULL
eee	NULL
10	NULL
2	NULL
3	NULL
4	NULL
50	NULL
6	NULL
»	NULL
--	NULL
]	NULL
at	NULL
4	NULL
a	NULL
_4	NULL
Nlt	NULL
:	NULL
Alas	NULL
i	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
m	NULL
*	NULL
wT	NULL
ayr	NULL
w	NULL
--	NULL
|I	NULL
--	NULL
3E	NULL
-|-	NULL
s00	NULL
MBP-|	NULL
_	NULL
Btk	NULL
Bke	NULL
Btk	NULL
Bke	NULL
_	NULL
Btk|Bke	NULL
500	NULL
mo	NULL
wa-	NULL
up	NULL
way	NULL
~~	NULL
«	NULL
»	NULL
BAP	NULL
..	NULL
with	NULL
@	NULL
»	NULL
)	NULL
400	NULL
.	NULL

Ss	NULL
MBP'BTK—Q	NULL
,	NULL
..	NULL
feal	NULL
g	NULL
300	NULL
mat	NULL
*	NULL
200	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
100	NULL
0	NULL
WT	NULL
3YF	NULL
Fic	NULL
.	NULL

5	NULL
.	NULL

Phosphorylation	NULL
of	NULL
BAP/TFII-I	NULL
at	NULL
residues	NULL
Tyr®*	NULL
``	NULL
,	NULL
Tyr®	NULL
``	NULL
,	NULL
and	NULL
Tyr**	NULL
>	NULL
by	NULL
Btk	NULL
in	NULL
vitro	NULL
.	NULL

Full-length	NULL
wild-type	NULL
or	NULL
mutant	NULL
BAP/TFIL-I	NULL
was	NULL
purified	NULL
and	NULL
phosphorylated	NULL
in	NULL
vitro	NULL
by	NULL
MBP-Btk	NULL
.	NULL

Products	NULL
were	NULL
analyzed	NULL
by	NULL
one-dimensional	NULL
tryptic	NULL
phosphopeptide	NULL
mapping	NULL
.	NULL

A	NULL
,	NULL
the	NULL
second	NULL
nonrepeat	NULL
region	NULL
of	NULL
BAP/TFII-I	NULL
is	NULL
phosphorylated	NULL
by	NULL
Btk	NULL
at	NULL
Tyr®	NULL
``	NULL
in	NULL
vitro	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
wild-type	NULL
protein	NULL
;	NULL
lane	NULL
2	NULL
;	NULL
BAP/TFII-I	NULL
(	NULL
Y248F	NULL
)	NULL
;	NULL
lane	NULL
3	NULL
,	NULL
BAP/TFII-I	NULL
(	NULL
Y277F	NULL
)	NULL
;	NULL
lane	NULL
4	NULL
,	NULL
BAP/TFII-I	NULL
(	NULL
Y248F	NULL
,	NULL
Y277F	NULL
)	NULL
;	NULL
lane	NULL
5	NULL
,	NULL
BAP/TFII-I	NULL
(	NULL
4F	NULL
)	NULL
.	NULL

A	NULL
phosphopeptide	NULL
eliminated	NULL
by	NULL
the	NULL
mutation	NULL
of	NULL
Y248F	NULL
(	NULL
Zane	NULL
2	NULL
)	NULL
is	NULL
indicated	NULL
(	NULL
closed	NULL
arrow	NULL
)	NULL
,	NULL
as	NULL
is	NULL
the	NULL
altered	NULL
mobility	NULL
of	NULL
a	NULL
likely	NULL
partial	NULL
peptide	NULL
containing	NULL
the	NULL
same	NULL
mutation	NULL
(	NULL
open	NULL
arrow	NULL
)	NULL
.	NULL

B	NULL
,	NULL
the	NULL
second	NULL
HLH-like	NULL
domain	NULL
of	NULL
BAP/TFII-I	NULL
is	NULL
phosphorylated	NULL
by	NULL
Btk	NULL
at	NULL
Tyr®	NULL
``	NULL
``	NULL
in	NULL
vitro	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
wild-type	NULL
protein	NULL
;	NULL
lane	NULL
2	NULL
;	NULL
BAP/TFII-I	NULL
(	NULL
Y382F	NULL
)	NULL
;	NULL
lane	NULL
3	NULL
,	NULL
BAP/TFII-I	NULL
(	NULL
Y846F	NULL
)	NULL
;	NULL
lane	NULL
4	NULL
,	NULL
BAP/TFII-I	NULL
(	NULL
Y357F	NULL
)	NULL
;	NULL
lane	NULL
5	NULL
,	NULL
BAP/TFII-I	NULL
(	NULL
Y346F	NULL
,	NULL
Y857F	NULL
)	NULL
;	NULL
lane	NULL
6	NULL
,	NULL
BAP/TFII-I	NULL
(	NULL
Y378F	NULL
)	NULL
.	NULL

The	NULL
Y357F	NULL
mutation	NULL
eliminated	NULL
two	NULL
prominent	NULL
tryptic	NULL
phosphopeptides	NULL
(	NULL
closed	NULL
arrows	NULL
)	NULL
.	NULL

C	NULL
,	NULL
the	NULL
third	NULL
HLH-like	NULL
domain	NULL
of	NULL
BAP/TFII-I	NULL
is	NULL
phosphorylated	NULL
by	NULL
Btk	NULL
at	NULL
Tyr**	NULL
``	NULL
in	NULL
vitro	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
wild-type	NULL
protein	NULL
;	NULL
lane	NULL
2	NULL
,	NULL
BAP/TFII-I	NULL
(	NULL
Y419F	NULL
)	NULL
;	NULL
lane	NULL
3	NULL
,	NULL
BAP/TFII-I	NULL
(	NULL
Y462F	NULL
)	NULL
;	NULL
lane	NULL
4	NULL
,	NULL
BAP/TFII-I	NULL
(	NULL
Y451F	NULL
,	NULL
Y462F	NULL
)	NULL
;	NULL
lane	NULL
5	NULL
,	NULL
BAP/TFII-I	NULL
(	NULL
Y478F	NULL
)	NULL
;	NULL
lane	NULL
6	NULL
,	NULL
BAP/TFII-I	NULL
N-2R	NULL
;	NULL
lane	NULL
7	NULL
,	NULL
BAP/TFII-L	NULL
N-3R	NULL
.	NULL

Comparison	NULL
of	NULL
lanes	NULL
6	NULL
and	NULL
7	NULL
identifies	NULL
phosphopeptides	NULL
derived	NULL
from	NULL
the	NULL
third	NULL
HLH-like	NULL
domain	NULL
that	NULL
are	NULL
present	NULL
in	NULL
the	NULL
wild-type	NULL
protein	NULL
(	NULL
closed	NULL
arrows	NULL
)	NULL
.	NULL

These	NULL
phosphopeptides	NULL
were	NULL
eliminated	NULL
by	NULL
mutation	NULL
of	NULL
Tyr	NULL
``	NULL
alone	NULL
(	NULL
Zane	NULL
3	NULL
)	NULL
or	NULL
in	NULL
combination	NULL
with	NULL
Tyr*	NULL
``	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

D	NULL
,	NULL
purified	NULL
BAP/TFII-I	NULL
and	NULL
Y248F	NULL
,	NULL
Y357F	NULL
,	NULL
Y462F	NULL
BAP/TFII-I	NULL
(	NULL
3YF	NULL
)	NULL
.	NULL

Full-length	NULL
BAP/TFII-I	NULL
wild-type	NULL
(	NULL
WT	NULL
)	NULL
(	NULL
anes	NULL
1-4	NULL
)	NULL
and	NULL
3YF	NULL
(	NULL
lanes	NULL
5-8	NULL
)	NULL
were	NULL
expressed	NULL
in	NULL
£	NULL
.	NULL

coli	NULL
and	NULL
purified	NULL
in	NULL
parallel	NULL
by	NULL
metal	NULL
ion	NULL
affinity	NULL
chromatography	NULL
.	NULL

Following	NULL
fractionation	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
protein	NULL
was	NULL
detected	NULL
by	NULL
staining	NULL
with	NULL
Coomassie	NULL
Blue	NULL
.	NULL

£	NULL
,	NULL
phosphorylation	NULL
of	NULL
full-length	NULL
BAP/TFII-I	NULL
and	NULL
mutant	NULL
BAP/TFII-I	NULL
(	NULL
Y248F	NULL
,	NULL
Y357F	NULL
,	NULL
Y462F	NULL
)	NULL
proteins	NULL
by	NULL
MBP-Btk	NULL
in	NULL
vitro	NULL
.	NULL

MBP-Btk	NULL
(	NULL
lanes	NULL
1	NULL
,	NULL
2	NULL
,	NULL
5	NULL
,	NULL
6	NULL
,	NULL
and	NULL
9	NULL
)	NULL
or	NULL
MBP-Btk	NULL
(	NULL
K4830E	NULL
)	NULL
(	NULL
anes	NULL
3	NULL
,	NULL
4	NULL
,	NULL
7	NULL
,	NULL
8	NULL
,	NULL
and	NULL
10	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
equivalent	NULL
amounts	NULL
of	NULL
purified	NULL
BAP/TFII-I	NULL
(	NULL
WT	NULL
)	NULL
(	NULL
Zanes	NULL
1-4	NULL
)	NULL
or	NULL
3YF	NULL
(	NULL
lanes	NULL
5-8	NULL
)	NULL
or	NULL
without	NULL
BAP/TFII-I	NULL
(	NULL
Zanes	NULL
9	NULL
and	NULL
10	NULL
)	NULL
in	NULL
a	NULL
buffer	NULL
containing	NULL
20	NULL
mM	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
7.2	NULL
)	NULL
,	NULL
2	NULL
mm	NULL
MnCl	NULL
,	NULL
1	NULL
mM	NULL
Na	NULL
,	NULL
MoO0	NULL
,	NULL
,	NULL
and	NULL
10	NULL
uCi	NULL
of	NULL
[	NULL
y-*P	NULL
]	NULL
ATP	NULL
for	NULL
80	NULL
min	NULL
at	NULL
87	NULL
°C	NULL
.	NULL

Products	NULL
were	NULL
fractionated	NULL
by	NULL
SDS-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
,	NULL
transferred	NULL
to	NULL
PVDF	NULL
,	NULL
and	NULL
detected	NULL
by	NULL
PhosphorImager	NULL
.	NULL

Phosphorylated	NULL
BAP/TFII-I	NULL
(	NULL
BAP	NULL
)	NULL
and	NULL
autophosphorylated	NULL
MBP-Btk	NULL
are	NULL
indicated	NULL
.	NULL

F	NULL
,	NULL
phosphorylation	NULL
of	NULL
BAP/TFII-I	NULL
in	NULL
vitro	NULL
by	NULL
Btk	NULL
is	NULL
reduced	NULL
in	NULL
the	NULL
BAP/TFII-I	NULL
(	NULL
Y248F	NULL
,	NULL
Y857F	NULL
,	NULL
Y462F	NULL
)	NULL
mutant	NULL
.	NULL

Radiolabeled	NULL
substrates	NULL
were	NULL
excised	NULL
from	NULL
the	NULL
PVDF	NULL
membranes	NULL
in	NULL
E	NULL
,	NULL
and	NULL
radioactivity	NULL
(	NULL
Cerenkov	NULL
)	NULL
was	NULL
quantitated	NULL
.	NULL

The	NULL
results	NULL
of	NULL
two	NULL
independent	NULL
experiments	NULL
are	NULL
plotted	NULL
.	NULL

Bik	NULL
,	NULL
reactions	NULL
performed	NULL
with	NULL
MBP-Btk	NULL
;	NULL
Bke	NULL
,	NULL
reactions	NULL
performed	NULL
with	NULL
MBP-Btk	NULL
(	NULL
KA80E	NULL
)	NULL
.	NULL

peptide	NULL
is	NULL
marked	NULL
by	NULL
the	NULL
open	NULL
arrow	NULL
)	NULL
,	NULL
consistent	NULL
with	NULL
identification	NULL
of	NULL
Tyr®	NULL
``	NULL
*	NULL
``	NULL
as	NULL
a	NULL
target	NULL
site	NULL
for	NULL
Btk	NULL
in	NULL
vitro	NULL
.	NULL

A	NULL
pair	NULL
of	NULL
Btk-independent	NULL
radiolabeled	NULL
phosphopeptides	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
,	NULL
closed	NULL
circles	NULL
)	NULL
are	NULL
absent	NULL
in	NULL
the	NULL
BAP	NULL
N-3R	NULL
(	NULL
4F	NULL
)	NULL
mutant	NULL
and	NULL
its	NULL
derivatives	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
,	NULL
lanes	NULL
3-6	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
one	NULL
or	NULL
more	NULL
of	NULL
the	NULL
four	NULL
tyrosines	NULL
in	NULL
the	NULL
second	NULL
nonrepeat	NULL
region	NULL
of	NULL
BAP/TFII-I	NULL
is	NULL
a	NULL
target	NULL
for	NULL
phosphorylation	NULL
by	NULL
an	NULL
endogenous	NULL
tyrosine	NULL
kinase	NULL
other	NULL
than	NULL
Btk	NULL
.	NULL

Additional	NULL
mutation	NULL
of	NULL
Tyr**	NULL
'	NULL
and	NULL
Tyr**	NULL
>	NULL
to	NULL
phenylalanine	NULL
eliminated	NULL
a	NULL
Btk-dependent	NULL
phosphopeptide	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
,	NULL
closed	NULL
arrow	NULL
)	NULL
,	NULL
consistent	NULL
with	NULL
the	NULL
identification	NULL
of	NULL
Tyr*©	NULL
``	NULL
as	NULL
a	NULL
target	NULL
for	NULL
Btk	NULL
phosphorylation	NULL
in	NULL
vitro	NULL
.	NULL

Last	NULL
,	NULL
examination	NULL
of	NULL
the	NULL
in	NULL
vivo	NULL
phosphopeptide	NULL
pattern	NULL
from	NULL
full-length	NULL
BAP/TFII-I	NULL
revealed	NULL
that	NULL
a	NULL
Btk-dependent	NULL
species	NULL
was	NULL
absent	NULL
from	NULL
BAP/TFII-I	NULL
(	NULL
Y357F	NULL
)	NULL
but	NULL
unperturbed	NULL
by	NULL
mutations	NULL
at	NULL
Tyr®**	NULL
,	NULL
Tyr®	NULL
``	NULL
``	NULL
,	NULL
or	NULL
Tyr*®	NULL
?	NULL

(	NULL
Fig	NULL
.	NULL

6C	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
residue	NULL
Tyr®	NULL
``	NULL
``	NULL
of	NULL
BAP/TFII-I	NULL
is	NULL
hyperphosphorylated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
cotransfected	NULL
Btk	NULL
in	NULL
vivo	NULL
.	NULL

If	NULL
residues	NULL
Tyr®	NULL
``	NULL
``	NULL
,	NULL
and	NULL
Tyr*©	NULL
``	NULL
are	NULL
indeed	NULL
major	NULL
sites	NULL
of	NULL
Btk	NULL
phosphorylation	NULL
within	NULL
BAP/TFII-I	NULL
in	NULL
vivo	NULL
,	NULL
then	NULL
BAP/	NULL
TFII-I	NULL
(	NULL
3YF	NULL
)	NULL
,	NULL
in	NULL
which	NULL
these	NULL
residues	NULL
are	NULL
mutated	NULL
,	NULL
should	NULL
exhibit	NULL
reduced	NULL
Btk-dependent	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
transfected	NULL
cells	NULL
.	NULL

BAP/TFII-I	NULL
N-3R	NULL
became	NULL
hyperphosphorylated	NULL
on	NULL
tyrosine	NULL
when	NULL
coexpressed	NULL
with	NULL
Btk	NULL
in	NULL
293	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

6D	NULL
,	NULL
compare	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

This	NULL
is	NULL
in	NULL
contrast	NULL
to	NULL
the	NULL
mutant	NULL
BAP/TFII-I	NULL
N-3R	NULL
(	NULL
3YF	NULL
)	NULL
,	NULL
which	NULL
showed	NULL
no	NULL
increase	NULL
in	NULL
tyrosine	NULL
phosphorylation	NULL
when	NULL
coexpressed	NULL
with	NULL
Btk	NULL
(	NULL
Fig	NULL
.	NULL

6D	NULL
,	NULL
compare	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

Quantitation	NULL
indicated	NULL
that	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
unmutated	NULL
BAP	NULL
N-3R	NULL
increased	NULL
at	NULL
least	NULL
2-fold	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
Btk	NULL
,	NULL
while	NULL
there	NULL
was	NULL
no	NULL
discernible	NULL
Btk-dependent	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
the	NULL
3YF	NULL
mutant	NULL
(	NULL
Fig	NULL
.	NULL

6KE	NULL
)	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
the	NULL
major	NULL
sites	NULL
at	NULL
which	NULL
BAP/TFII-I	NULL
is	NULL
phosphorylated	NULL
in	NULL
mammalian	NULL
cells	NULL
upon	NULL
cotransfection	NULL
with	NULL
Btk	NULL
correspond	NULL
to	NULL
the	NULL
predominant	NULL
targets	NULL
of	NULL
phosphorylation	NULL
by	NULL
Btk	NULL
in	NULL
vitro	NULL
.	NULL

To	NULL
assess	NULL
the	NULL
functional	NULL
significance	NULL
of	NULL
phosphorylation	NULL
at	NULL
residues	NULL
Tyr®**	NULL
,	NULL
Tyr®	NULL
``	NULL
``	NULL
,	NULL
and	NULL
we	NULL
examined	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
wild-type	NULL
and	NULL
phenylalanine-substituted	NULL
BAP/TFII-I	NULL
on	NULL
the	NULL
c-fos	NULL
promoter	NULL
,	NULL
which	NULL
is	NULL
responsive	NULL
to	NULL
BAP/	NULL
TFII-I	NULL
(	NULL
82	NULL
,	NULL
33	NULL
)	NULL
.	NULL

Transfection	NULL
of	NULL
COS-7	NULL
cells	NULL
with	NULL
wild-type	NULL
BAP/TFII-I	NULL
stimulated	NULL
expression	NULL
of	NULL
the	NULL
c-fos	NULL
luciferase	NULL
reporter	NULL
gene	NULL
relative	NULL
to	NULL
the	NULL
vector-transfected	NULL
control	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
.	NULL

Mutation	NULL
of	NULL
Tyr®**	NULL
,	NULL
Tyr®	NULL
``	NULL
``	NULL
,	NULL
or	NULL
Tyr*®	NULL
>	NULL
individually	NULL
to	NULL
phenylalanine	NULL
impaired	NULL
the	NULL
ability	NULL
of	NULL
BAP/TFII-I	NULL
to	NULL
stimulate	NULL
c-fos	NULL
activity	NULL
.	NULL

Interestingly	NULL
,	NULL
cotransfection	NULL
of	NULL
BAP/TFII-I	NULL
(	NULL
Y248F	NULL
)	NULL
suppressed	NULL
expression	NULL
from	NULL
the	NULL
c-fos	NULL
promoter	NULL
,	NULL
relative	NULL
to	NULL
the	NULL
samples	NULL
cotransfected	NULL
with	NULL
vector	NULL
alone	NULL
,	NULL
suggesting	NULL
that	NULL
this	NULL
mutant	NULL
may	NULL
have	NULL
repressive	NULL
activity	NULL
.	NULL

The	NULL
BAP/TFII-I	NULL
(	NULL
3YF	NULL
)	NULL
triple	NULL
mutant	NULL
also	NULL
displayed	NULL
reduced	NULL
activity	NULL
relative	NULL
to	NULL
wild	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
Btk	NULL
Phosphorylation	NULL
Sites	NULL
in	NULL
BAP/TFILI-I	NULL
30	NULL
p	NULL
%	NULL
I	NULL
j	NULL
|	NULL
Arbitrarty	NULL
units	NULL
[	NULL
=	NULL
s	NULL
©	NULL
1	NULL
2	NULL
3	NULL
4	NULL
WIT	NULL
3YF	NULL
Fic	NULL
.	NULL

6	NULL
.	NULL

Btk	NULL
phosphorylates	NULL
BAP	NULL
at	NULL
similar	NULL
positions	NULL
in	NULL
vivo	NULL
and	NULL
in	NULL
vitro	NULL
.	NULL

A	NULL
,	NULL
comparison	NULL
of	NULL
tryptic	NULL
phosphopeptides	NULL
from	NULL
BAP/	NULL
TFII-I	NULL
N-3R	NULL
,	NULL
phosphorylated	NULL
in	NULL
vitro	NULL
by	NULL
Btk	NULL
or	NULL
in	NULL
vivo	NULL
upon	NULL
cotransfection	NULL
with	NULL
Btk	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
tryptic	NULL
phosphopeptides	NULL
from	NULL
BAP/TFII-I	NULL
N-3R	NULL
,	NULL
phosphorylated	NULL
in	NULL
vitro	NULL
by	NULL
MBP-Btk	NULL
.	NULL

Lanes	NULL
2	NULL
and	NULL
3	NULL
,	NULL
tryptic	NULL
phosphopeptides	NULL
from	NULL
BAP/TFII-I	NULL
,	NULL
labeled	NULL
metabolically	NULL
in	NULL
298	NULL
cells	NULL
cotransfected	NULL
with	NULL
Btk	NULL
(	NULL
Zane	NULL
2	NULL
)	NULL
or	NULL
Btk	NULL
(	NULL
KA80E	NULL
)	NULL
(	NULL
Zane	NULL
3	NULL
)	NULL
.	NULL

Tryptic	NULL
phosphopeptides	NULL
from	NULL
metabolically	NULL
labeled	NULL
BAP/TFII-I	NULL
N-3R	NULL
that	NULL
are	NULL
enhanced	NULL
by	NULL
co-expression	NULL
of	NULL
Btk	NULL
(	NULL
Zane	NULL
2	NULL
)	NULL
relative	NULL
to	NULL
co-expression	NULL
with	NULL
Btk	NULL
(	NULL
KA30E	NULL
)	NULL
(	NULL
Zane	NULL
3	NULL
)	NULL
correspond	NULL
to	NULL
phosphopeptides	NULL
derived	NULL
from	NULL
BAP/	NULL
TFII-I	NULL
phosphorylated	NULL
by	NULL
Btk	NULL
in	NULL
vitro	NULL
(	NULL
closed	NULL
arrows	NULL
)	NULL
.	NULL

B	NULL
,	NULL
effects	NULL
of	NULL
point	NULL
mutations	NULL
within	NULL
the	NULL
second	NULL
nonrepeat	NULL
or	NULL
third	NULL
HLH-like	NULL
region	NULL
on	NULL
phosphorylation	NULL
of	NULL
BAP/TFII-IL	NULL
N-3R	NULL
in	NULL
vivo	NULL
.	NULL

Wild-type	NULL
(	NULL
Zanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
or	NULL
mutant	NULL
(	NULL
Zanes	NULL
3-6	NULL
)	NULL
BAP/TFII-I	NULL
N-3R	NULL
was	NULL
co-expressed	NULL
with	NULL
Btk	NULL
(	NULL
lanes	NULL
1	NULL
,	NULL
3	NULL
,	NULL
4	NULL
,	NULL
5	NULL
,	NULL
and	NULL
6	NULL
)	NULL
or	NULL
Btk	NULL
(	NULL
KA430E	NULL
)	NULL
(	NULL
Zane	NULL
2	NULL
)	NULL
,	NULL
labeled	NULL
metabolically	NULL
,	NULL
and	NULL
analyzed	NULL
by	NULL
one-dimensional	NULL
tryptic	NULL
phosphopeptide	NULL
mapping	NULL
.	NULL

Mutations	NULL
in	NULL
the	NULL
second	NULL
nonrepeat	NULL
region	NULL
(	NULL
NRZ	NULL
)	NULL
or	NULL
the	NULL
third	NULL
HLH-like	NULL
domain	NULL
(	NULL
3R	NULL
)	NULL
are	NULL
identified	NULL
at	NULL
the	NULL
top	NULL
.	NULL

4F	NULL
,	NULL
phenylalanine	NULL
substitutions	NULL
at	NULL
Tyr	NULL
``	NULL
,	NULL
Tyr	NULL
``	NULL
,	NULL
Tyr	NULL
``	NULL
,	NULL
and	NULL
Tyr	NULL
``	NULL
``	NULL
``	NULL
.	NULL

wt	NULL
,	NULL
wild-type	NULL
.	NULL

Btk-dependent	NULL
phosphopeptides	NULL
are	NULL
marked	NULL
by	NULL
arrows	NULL
.	NULL

Closed	NULL
circles	NULL
,	NULL
Btk-independent	NULL
phosphopeptides	NULL
eliminated	NULL
by	NULL
the	NULL
4F	NULL
mutation	NULL
;	NULL
open	NULL
arrow	NULL
,	NULL
Btk-dependent	NULL
phosphopeptide	NULL
eliminated	NULL
by	NULL
the	NULL
4F	NULL
mutation	NULL
;	NULL
filled	NULL
arrow	NULL
,	NULL
Btk-dependent	NULL
phosphopeptide	NULL
eliminated	NULL
by	NULL
the	NULL
Y451F	NULL
,	NULL
Y462F	NULL
muta-tion	NULL
.	NULL

C	NULL
,	NULL
tyrosine	NULL
857	NULL
of	NULL
BAP/TFII-I	NULL
is	NULL
a	NULL
target	NULL
for	NULL
Btk-dependent	NULL
phosphorylation	NULL
in	NULL
vivo	NULL
.	NULL

Full-length	NULL
,	NULL
wild-type	NULL
(	NULL
Zanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
or	NULL
mutant	NULL
(	NULL
lanes	NULL
1-4	NULL
and	NULL
7-10	NULL
)	NULL
BAP/TFII-I	NULL
was	NULL
coexpressed	NULL
with	NULL
Btk	NULL
(	NULL
Btk	NULL
,	NULL
lanes	NULL
1-5	NULL
)	NULL
or	NULL
Btk	NULL
(	NULL
KA30E	NULL
)	NULL
(	NULL
Bke	NULL
,	NULL
lanes	NULL
6-10	NULL
)	NULL
in	NULL
298	NULL
cells	NULL
,	NULL
labeled	NULL
metabolically	NULL
with	NULL
°°P	NULL
,	NULL
and	NULL
analyzed	NULL
by	NULL
one-dimensional	NULL
tryptic	NULL
phosphopeptide	NULL
mapping	NULL
.	NULL

Mutants	NULL
(	NULL
Y248F	NULL
,	NULL
Y277F	NULL
,	NULL
Y357F	NULL
,	NULL
and	NULL
Y462F	NULL
)	NULL
are	NULL
identified	NULL
.	NULL

A	NULL
Btk-dependent	NULL
tryptic	NULL
phosphopeptide	NULL
is	NULL
eliminated	NULL
by	NULL
the	NULL
Y857F	NULL
mutation	NULL
(	NULL
arrow	NULL
)	NULL
.	NULL

D	NULL
,	NULL
hyperphosphorylation	NULL
of	NULL
BAP/TFII-I	NULL
N-3R	NULL
on	NULL
tyrosine	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
coexpressed	NULL
Btk	NULL
is	NULL
eliminated	NULL
in	NULL
the	NULL
BAP/	NULL
TFII-I	NULL
(	NULL
Y248F	NULL
,	NULL
Y857F	NULL
,	NULL
Y462F	NULL
)	NULL
N-3R	NULL
mutant	NULL
.	NULL

Myc-tagged	NULL
,	NULL
BAP/TFIL-I	NULL
N-3R	NULL
fragment	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
or	NULL
the	NULL
mutant	NULL
BAP/TFII-I	NULL
(	NULL
Y248F	NULL
,	NULL
Y357F	NULL
,	NULL
Y462F	NULL
)	NULL
N-3R	NULL
fragment	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
were	NULL
coexpressed	NULL
in	NULL
298	NULL
cells	NULL
with	NULL
Btk	NULL
(	NULL
Zanes	NULL
1	NULL
and	NULL
3	NULL
)	NULL
or	NULL
Btk	NULL
(	NULL
KA30E	NULL
)	NULL
(	NULL
Zanes	NULL
2	NULL
and	NULL
4	NULL
)	NULL
.	NULL

BAP/TFII-L	NULL
N-3R	NULL
protein	NULL
was	NULL
immunoprecipitated	NULL
using	NULL
the	NULL
anti-Myc	NULL
antibody	NULL
9E10	NULL
.	NULL

Following	NULL
immunoprecipitation	NULL
,	NULL
gel	NULL
fractionation	NULL
,	NULL
and	NULL
transfer	NULL
to	NULL
membrane	NULL
,	NULL
immunoblotting	NULL
was	NULL
performed	NULL
with	NULL
the	NULL
anti-phosphotyrosine	NULL
antibody	NULL
4G10	NULL
(	NULL
upper	NULL
panel	NULL
)	NULL
or	NULL
the	NULL
anti-Myc	NULL
antibody	NULL
9E10	NULL
(	NULL
lower	NULL
panel	NULL
)	NULL
.	NULL

E	NULL
,	NULL
densitometric	NULL
quantitation	NULL
of	NULL
the	NULL
anti-phosphotyrosine	NULL
immunoblot	NULL
of	NULL
D.	NULL
27813	NULL
A	NULL
0.40	NULL
4	NULL
Relative	NULL
activity	NULL
0	NULL
o	NULL
o	NULL
o	NULL
o	NULL
z	NULL
ho	NULL
to	NULL
o	NULL
o	NULL
o	NULL
[	NULL
=	NULL
]	NULL
C-CLeecw	NULL
~~	NULL
m	NULL
Bik	NULL
C	NULL
Bke	NULL
1.0	NULL
0.0	NULL
&	NULL
€	NULL
&	NULL
g	NULL
&	NULL
&	NULL
Qé	NULL
P	NULL
®	NULL
©	NULL
``	NULL
$	NULL
BAP	NULL
243	NULL
s	NULL
®	NULL
D	NULL
P	NULL
D	NULL
Y	NULL
Y	NULL
Q	NULL
Y	NULL
N	NULL
I	NULL
253	NULL
352	NULL
H	NULL
V	NULL
E	NULL
D	NULL
L	NULL
¥	NULL
V	NULL
E	NULL
G	NULL
L	NULL
P	NULL
362	NULL
457	NULL
#	NULL
P	NULL
N	NULL
D	NULL
L	NULL
Y	NULL
V	NULL
E	NULL
G	NULL
L	NULL
P	NULL
467	NULL
BTK	NULL
218	NULL
K	NULL
v	NULL
v	NULL
A	NULL
L	NULL
¥	NULL
D	NULL
Y	NULL
M	NULL
P	NULL
M	NULL
228	NULL
Fic	NULL
.	NULL

7	NULL
.	NULL

Mutation	NULL
of	NULL
Btk	NULL
phosphorylation	NULL
sites	NULL
impairs	NULL
BAP/TFII-I	NULL
activity	NULL
at	NULL
the	NULL
c-fos	NULL
promoter	NULL
in	NULL
vivo	NULL
.	NULL

A	NULL
,	NULL
involvement	NULL
of	NULL
BAP/TFII-I	NULL
residues	NULL
Tyr	NULL
``	NULL
,	NULL
Tyr	NULL
``	NULL
``	NULL
``	NULL
,	NULL
and	NULL
Tyr	NULL
``	NULL
in	NULL
Btk-independent	NULL
activation	NULL
of	NULL
the	NULL
c-fos	NULL
promoter	NULL
.	NULL

COS-7	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
0.1	NULL
ug	NULL
of	NULL
cfos	NULL
in	NULL
PGL3	NULL
,	NULL
0.1	NULL
ug	NULL
of	NULL
pRL-TK	NULL
,	NULL
and	NULL
0.6	NULL
ug	NULL
of	NULL
vector	NULL
,	NULL
wild-type	NULL
BAP/TFII-I	NULL
,	NULL
or	NULL
mutant	NULL
BAP/	NULL
TFII-I	NULL
,	NULL
as	NULL
indicated	NULL
.	NULL

Following	NULL
serum	NULL
stimulation	NULL
,	NULL
cell	NULL
lysates	NULL
were	NULL
assayed	NULL
for	NULL
c-fos	NULL
and	NULL
TK	NULL
transcriptional	NULL
activity	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
the	NULL
cfos	NULL
promoter	NULL
was	NULL
analyzed	NULL
relative	NULL
to	NULL
that	NULL
of	NULL
TK	NULL
.	NULL

Means	NULL
and	NULL
S.E	NULL
.	NULL

of	NULL
three	NULL
independent	NULL
transfections	NULL
are	NULL
plotted	NULL
.	NULL

B	NULL
,	NULL
evaluation	NULL
of	NULL
BAP/TFII-I	NULL
expression	NULL
in	NULL
transfected	NULL
COS-7	NULL
cells	NULL
.	NULL

Equal	NULL
volumes	NULL
of	NULL
cell	NULL
lysate	NULL
from	NULL
the	NULL
experiment	NULL
in	NULL
A	NULL
were	NULL
fractionated	NULL
by	NULL
SDS-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
and	NULL
immuno-blotted	NULL
with	NULL
the	NULL
anti-Myc	NULL
antibody	NULL
9E10	NULL
.	NULL

C.	NULL
BAP/TFII-I	NULL
residues	NULL
Tyr	NULL
``	NULL
*	NULL
``	NULL
and	NULL
Tyr®	NULL
``	NULL
``	NULL
are	NULL
implicated	NULL
in	NULL
Btk-dependent	NULL
activation	NULL
of	NULL
a	NULL
c-fos	NULL
reporter	NULL
construct	NULL
in	NULL
vivo	NULL
.	NULL

COS-7	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
0.1	NULL
ug	NULL
of	NULL
c-fos	NULL
in	NULL
PGL3	NULL
;	NULL
0.1	NULL
ug	NULL
of	NULL
pRL-TK	NULL
;	NULL
0.3	NULL
ug	NULL
of	NULL
Btk	NULL
(	NULL
Bik	NULL
)	NULL
or	NULL
Btk	NULL
(	NULL
KA480E	NULL
)	NULL
(	NULL
Bke	NULL
)	NULL
,	NULL
and	NULL
0.4	NULL
ug	NULL
of	NULL
wild-type	NULL
BAP/TFII-I	NULL
,	NULL
mutant	NULL
BAP/TFII-I	NULL
,	NULL
or	NULL
vector	NULL
DNA	NULL
.	NULL

Following	NULL
serum	NULL
stimulation	NULL
,	NULL
cells	NULL
lysates	NULL
were	NULL
analyzed	NULL
for	NULL
c-fos	NULL
and	NULL
TK	NULL
promoter	NULL
activities	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
the	NULL
c-fos	NULL
promoter	NULL
was	NULL
analyzed	NULL
relative	NULL
to	NULL
that	NULL
of	NULL
TK	NULL
.	NULL

Means	NULL
and	NULL
S.E	NULL
.	NULL

of	NULL
three	NULL
independent	NULL
transfections	NULL
are	NULL
plotted	NULL
.	NULL

D	NULL
,	NULL
alignment	NULL
of	NULL
amino	NULL
acid	NULL
sequences	NULL
in	NULL
the	NULL
vicinity	NULL
of	NULL
BAP/TFII-I	NULL
tyrosine	NULL
residues	NULL
phosphorylated	NULL
in	NULL
vitro	NULL
by	NULL
MBP-Btk	NULL
and	NULL
the	NULL
corresponding	NULL
amino	NULL
acid	NULL
sequence	NULL
of	NULL
a	NULL
previously	NULL
described	NULL
Btk	NULL
autophosphorylation	NULL
site	NULL
(	NULL
22	NULL
)	NULL
.	NULL

type	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
effects	NULL
of	NULL
the	NULL
combined	NULL
mutations	NULL
were	NULL
not	NULL
additive	NULL
.	NULL

The	NULL
debilitating	NULL
effects	NULL
of	NULL
the	NULL
phosphorylation	NULL
site	NULL
mutations	NULL
were	NULL
specific	NULL
,	NULL
as	NULL
mutation	NULL
of	NULL
residue	NULL
Tyr**	NULL
``	NULL
,	NULL
which	NULL
is	NULL
not	NULL
phosphorylated	NULL
by	NULL
Btk	NULL
in	NULL
vitro	NULL
or	NULL
in	NULL
vivo	NULL
,	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
27814	NULL
BAP/TFII-I	NULL
activity	NULL
in	NULL
this	NULL
assay	NULL
.	NULL

Btk	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
enhance	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
BAP/TFII-I	NULL
at	NULL
the	NULL
c-fos	NULL
promoter	NULL
in	NULL
fibroblastoid	NULL
cell	NULL
lines	NULL
(	NULL
82	NULL
)	NULL
.	NULL

In	NULL
experiments	NULL
presented	NULL
above	NULL
,	NULL
transfection	NULL
was	NULL
performed	NULL
under	NULL
conditions	NULL
that	NULL
maximized	NULL
the	NULL
effect	NULL
of	NULL
BAP/	NULL
TFII-I	NULL
on	NULL
transcription	NULL
from	NULL
the	NULL
c-fos	NULL
promoter	NULL
.	NULL

Under	NULL
these	NULL
conditions	NULL
,	NULL
mutation	NULL
of	NULL
Btk	NULL
phosphorylation	NULL
sites	NULL
in	NULL
BAP/	NULL
TFII-I	NULL
reduced	NULL
the	NULL
stimulatory	NULL
effect	NULL
of	NULL
BAP/TFII-I	NULL
.	NULL

We	NULL
next	NULL
wanted	NULL
to	NULL
determine	NULL
the	NULL
effects	NULL
of	NULL
the	NULL
same	NULL
mutations	NULL
on	NULL
enhancement	NULL
of	NULL
BAP/TFII-I	NULL
activity	NULL
by	NULL
Btk	NULL
.	NULL

These	NULL
experiments	NULL
were	NULL
performed	NULL
using	NULL
transfection	NULL
conditions	NULL
in	NULL
which	NULL
stimulation	NULL
of	NULL
c-fos	NULL
activity	NULL
was	NULL
dependent	NULL
on	NULL
the	NULL
presence	NULL
of	NULL
both	NULL
BAP/TFII-I	NULL
and	NULL
Btk	NULL
(	NULL
see	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
``	NULL
)	NULL
;	NULL
transfection	NULL
of	NULL
BAP/TFII-I	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
active	NULL
Btk	NULL
,	NULL
or	NULL
of	NULL
Btk	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
BAP/TFII-I	NULL
,	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
c-fos	NULL
promoter	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

7C	NULL
)	NULL
.	NULL

Mutation	NULL
of	NULL
Tyr®	NULL
``	NULL
``	NULL
,	NULL
and	NULL
to	NULL
phenylalanine	NULL
,	NULL
singly	NULL
or	NULL
in	NULL
combination	NULL
,	NULL
impaired	NULL
(	NULL
Fig	NULL
.	NULL

7C	NULL
,	NULL
Y462F	NULL
and	NULL
3YF	NULL
)	NULL
or	NULL
eliminated	NULL
(	NULL
Fig	NULL
.	NULL

7C	NULL
,	NULL
Y248F	NULL
and	NULL
Y357F	NULL
)	NULL
stimulation	NULL
of	NULL
c-fos	NULL
promoter	NULL
activity	NULL
by	NULL
Btk	NULL
and	NULL
BAP/TFII-I	NULL
.	NULL

The	NULL
BAP/TFII-I	NULL
(	NULL
Y248F	NULL
)	NULL
mutant	NULL
,	NULL
moreover	NULL
,	NULL
consistently	NULL
suppressed	NULL
basal	NULL
expression	NULL
of	NULL
the	NULL
c-fos	NULL
reporter	NULL
construct	NULL
as	NULL
well	NULL
(	NULL
Fig	NULL
.	NULL

7C	NULL
)	NULL
.	NULL

These	NULL
results	NULL
are	NULL
consistent	NULL
with	NULL
roles	NULL
for	NULL
residues	NULL
Tyr®**	NULL
and	NULL
Tyr®	NULL
``	NULL
``	NULL
,	NULL
and	NULL
perhaps	NULL
also	NULL
for	NULL
Tyr**	NULL
>	NULL
,	NULL
in	NULL
mediating	NULL
synergistic	NULL
effects	NULL
of	NULL
BAP/TFII-I	NULL
and	NULL
Btk	NULL
at	NULL
the	NULL
c-fos	NULL
promoter	NULL
.	NULL

DISCUSSION	NULL
While	NULL
the	NULL
participation	NULL
of	NULL
Btk	NULL
in	NULL
signaling	NULL
pathways	NULL
essential	NULL
to	NULL
B	NULL
cell	NULL
development	NULL
and	NULL
activation	NULL
is	NULL
clear	NULL
,	NULL
relatively	NULL
little	NULL
is	NULL
known	NULL
concerning	NULL
the	NULL
targets	NULL
of	NULL
this	NULL
kinase	NULL
and	NULL
the	NULL
consequences	NULL
of	NULL
their	NULL
phosphorylation	NULL
.	NULL

BAP/TFII-I	NULL
,	NULL
phospho-lipase	NULL
Cy	NULL
,	NULL
protein	NULL
kinase	NULL
CB	NULL
,	NULL
and	NULL
Wiskott-Aldrich	NULL
syndrome	NULL
protein	NULL
have	NULL
all	NULL
been	NULL
identified	NULL
as	NULL
possible	NULL
Btk	NULL
substrates	NULL
in	NULL
vivo	NULL
(	NULL
26	NULL
,	NULL
41-43	NULL
)	NULL
.	NULL

Until	NULL
now	NULL
,	NULL
however	NULL
,	NULL
direct	NULL
phosphorylation	NULL
of	NULL
these	NULL
substrates	NULL
by	NULL
Btk	NULL
has	NULL
not	NULL
been	NULL
documented	NULL
.	NULL

Results	NULL
presented	NULL
in	NULL
this	NULL
communication	NULL
suggest	NULL
strongly	NULL
that	NULL
Btk	NULL
is	NULL
capable	NULL
of	NULL
phosphorylating	NULL
BAP/TFII-I	NULL
directly	NULL
,	NULL
thereby	NULL
providing	NULL
one	NULL
means	NULL
by	NULL
which	NULL
Btk	NULL
activation	NULL
may	NULL
mediate	NULL
cellular	NULL
responses	NULL
to	NULL
antigen	NULL
receptor	NULL
engagement	NULL
.	NULL

Several	NULL
lines	NULL
of	NULL
evidence	NULL
support	NULL
this	NULL
conclusion	NULL
.	NULL

First	NULL
,	NULL
BAP/	NULL
TFII-I	NULL
is	NULL
a	NULL
substrate	NULL
for	NULL
bacterially	NULL
expressed	NULL
,	NULL
purified	NULL
Btk	NULL
in	NULL
vitro	NULL
.	NULL

Second	NULL
,	NULL
there	NULL
exists	NULL
a	NULL
correspondence	NULL
between	NULL
tryptic	NULL
phosphopeptides	NULL
from	NULL
BAP/TFII-I	NULL
phosphorylated	NULL
by	NULL
Btk	NULL
in	NULL
vitro	NULL
and	NULL
Btk-dependent	NULL
tryptic	NULL
phosphopeptides	NULL
from	NULL
BAP/	NULL
TFII-I	NULL
expressed	NULL
in	NULL
mammalian	NULL
cells	NULL
.	NULL

Third	NULL
,	NULL
mutation	NULL
of	NULL
BAP/	NULL
TFII-I	NULL
at	NULL
tyrosine	NULL
residues	NULL
phosphorylated	NULL
by	NULL
Btk	NULL
in	NULL
vitro	NULL
eliminated	NULL
Btk-dependent	NULL
phosphopeptides	NULL
from	NULL
metabolically	NULL
labeled	NULL
BAP/TFII-I	NULL
.	NULL

We	NULL
have	NULL
relied	NULL
on	NULL
deletion	NULL
and	NULL
point	NULL
mutagenesis	NULL
to	NULL
locate	NULL
sites	NULL
of	NULL
protein	NULL
phosphorylation	NULL
.	NULL

In	NULL
pursuing	NULL
this	NULL
approach	NULL
,	NULL
we	NULL
considered	NULL
the	NULL
possibility	NULL
that	NULL
truncation	NULL
might	NULL
permit	NULL
phosphorylation	NULL
at	NULL
sites	NULL
that	NULL
are	NULL
inaccessible	NULL
in	NULL
the	NULL
intact	NULL
protein	NULL
or	NULL
that	NULL
a	NULL
point	NULL
mutation	NULL
might	NULL
indirectly	NULL
impair	NULL
phosphorylation	NULL
at	NULL
a	NULL
different	NULL
residue	NULL
.	NULL

In	NULL
the	NULL
studies	NULL
presented	NULL
here	NULL
,	NULL
however	NULL
,	NULL
the	NULL
predominant	NULL
patterns	NULL
of	NULL
phosphorylation	NULL
within	NULL
individual	NULL
BAP/TFII-I	NULL
fragments	NULL
were	NULL
recapitulated	NULL
in	NULL
the	NULL
full-length	NULL
protein	NULL
,	NULL
arguing	NULL
that	NULL
truncation	NULL
did	NULL
not	NULL
generate	NULL
artifactual	NULL
phosphorylation	NULL
sites	NULL
.	NULL

Moreover	NULL
,	NULL
within	NULL
each	NULL
phosphorylated	NULL
region	NULL
of	NULL
BAP/TFII-I	NULL
,	NULL
as	NULL
defined	NULL
by	NULL
nested	NULL
trunca-tions	NULL
,	NULL
mutation	NULL
of	NULL
a	NULL
single	NULL
tyrosine	NULL
residue	NULL
affected	NULL
phosphorylation	NULL
,	NULL
eliminating	NULL
only	NULL
phosphopeptides	NULL
mapping	NULL
to	NULL
that	NULL
region	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
observations	NULL
are	NULL
consistent	NULL
with	NULL
the	NULL
interpretation	NULL
that	NULL
tyrosine	NULL
residues	NULL
248	NULL
,	NULL
357	NULL
,	NULL
and	NULL
462	NULL
of	NULL
BAP/TFII-I	NULL
represent	NULL
sites	NULL
of	NULL
direct	NULL
phosphorylation	NULL
by	NULL
Btk	NULL
.	NULL

We	NULL
note	NULL
,	NULL
however	NULL
,	NULL
that	NULL
identification	NULL
of	NULL
phosphorylation	NULL
sites	NULL
by	NULL
the	NULL
methods	NULL
employed	NULL
here	NULL
is	NULL
limited	NULL
by	NULL
the	NULL
stoichiometry	NULL
of	NULL
phosphorylation	NULL
and	NULL
,	NULL
in	NULL
the	NULL
case	NULL
of	NULL
metabolic	NULL
labeling	NULL
,	NULL
by	NULL
the	NULL
flux	NULL
of	NULL
phosphate	NULL
through	NULL
tyrosine	NULL
.	NULL

Thus	NULL
,	NULL
we	NULL
can	NULL
not	NULL
exclude	NULL
Btk	NULL
Phosphorylation	NULL
Sites	NULL
in	NULL
BAP/TFILI-I	NULL
the	NULL
existence	NULL
of	NULL
additional	NULL
Btk	NULL
target	NULL
sites	NULL
within	NULL
BAP/TFII-I	NULL
.	NULL

The	NULL
substrate	NULL
specificities	NULL
of	NULL
Btk	NULL
and	NULL
other	NULL
tyrosine	NULL
kinases	NULL
of	NULL
the	NULL
Tec	NULL
family	NULL
are	NULL
as	NULL
yet	NULL
poorly	NULL
defined	NULL
.	NULL

Of	NULL
the	NULL
three	NULL
residues	NULL
of	NULL
BAP/TFII-I	NULL
shown	NULL
here	NULL
to	NULL
be	NULL
phosphorylated	NULL
by	NULL
Btk	NULL
(	NULL
Fig	NULL
.	NULL

7D	NULL
)	NULL
,	NULL
two	NULL
(	NULL
Tyr®	NULL
``	NULL
``	NULL
and	NULL
Tyr*®	NULL
?	NULL
)	NULL

occur	NULL
in	NULL
similar	NULL
sequence	NULL
contexts	NULL
(	NULL
nine	NULL
identities	NULL
among	NULL
the	NULL
11	NULL
residues	NULL
from	NULL
the	NULL
-5-position	NULL
through	NULL
the	NULL
+5-position	NULL
)	NULL
within	NULL
the	NULL
loop	NULL
regions	NULL
of	NULL
consecutive	NULL
HLH-like	NULL
domains	NULL
.	NULL

The	NULL
context	NULL
of	NULL
Tyr®**	NULL
is	NULL
dis-tinct	NULL
,	NULL
differing	NULL
from	NULL
the	NULL
corresponding	NULL
sequence	NULL
surrounding	NULL
Tyr®	NULL
``	NULL
``	NULL
in	NULL
all	NULL
of	NULL
the	NULL
11	NULL
residues	NULL
from	NULL
-5	NULL
through	NULL
+5	NULL
,	NULL
except	NULL
the	NULL
target	NULL
tyrosine	NULL
.	NULL

The	NULL
contexts	NULL
of	NULL
all	NULL
three	NULL
Btk	NULL
phosphorylation	NULL
sites	NULL
in	NULL
BAP/TFII-I	NULL
differ	NULL
substantially	NULL
from	NULL
that	NULL
of	NULL
the	NULL
Btk	NULL
autophosphorylation	NULL
site	NULL
at	NULL
Tyr®	NULL
``	NULL
``	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
any	NULL
features	NULL
of	NULL
primary	NULL
sequence	NULL
that	NULL
might	NULL
confer	NULL
specificity	NULL
for	NULL
Btk	NULL
remain	NULL
obscure	NULL
.	NULL

BAP/TFII-I	NULL
is	NULL
able	NULL
to	NULL
associate	NULL
with	NULL
Btk	NULL
and	NULL
other	NULL
kinases	NULL
in	NULL
vivo	NULL
(	NULL
26	NULL
,	NULL
44	NULL
)	NULL
,	NULL
and	NULL
Btk	NULL
has	NULL
a	NULL
modest	NULL
stimulatory	NULL
effect	NULL
on	NULL
transcriptional	NULL
activation	NULL
by	NULL
BAP/TFII-I	NULL
in	NULL
transfected	NULL
cells	NULL
(	NULL
82	NULL
)	NULL
.	NULL

These	NULL
observations	NULL
as	NULL
well	NULL
as	NULL
an	NULL
apparent	NULL
requirement	NULL
for	NULL
phosphorylation	NULL
of	NULL
BAP/TFII-I	NULL
in	NULL
transcriptional	NULL
assays	NULL
in	NULL
vitro	NULL
(	NULL
81	NULL
)	NULL
have	NULL
suggested	NULL
that	NULL
Btk	NULL
and	NULL
perhaps	NULL
other	NULL
kinases	NULL
may	NULL
regulate	NULL
the	NULL
activity	NULL
of	NULL
BAP/TFII-I	NULL
.	NULL

In	NULL
support	NULL
of	NULL
this	NULL
possibility	NULL
,	NULL
a	NULL
BAP/TFII-I	NULL
mutant	NULL
carrying	NULL
phenylalanine	NULL
substitutions	NULL
at	NULL
both	NULL
Tyr®**	NULL
and	NULL
Tyr®*	NULL
``	NULL
exhibited	NULL
impaired	NULL
transcriptional	NULL
activity	NULL
in	NULL
transfected	NULL
cells	NULL
(	NULL
32	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
Btk	NULL
dependence	NULL
of	NULL
BAP/TFII-I	NULL
activity	NULL
was	NULL
not	NULL
addressed	NULL
in	NULL
that	NULL
study	NULL
,	NULL
one	NULL
interpretation	NULL
is	NULL
suggested	NULL
by	NULL
our	NULL
identification	NULL
of	NULL
Tyr®*	NULL
``	NULL
as	NULL
a	NULL
target	NULL
site	NULL
for	NULL
phosphorylation	NULL
of	NULL
BAP/TFII-I	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
the	NULL
mutations	NULL
at	NULL
Tyr®*	NULL
``	NULL
and	NULL
Tyr®*	NULL
``	NULL
on	NULL
transcription	NULL
,	NULL
however	NULL
,	NULL
would	NULL
also	NULL
be	NULL
consistent	NULL
with	NULL
phosphorylation	NULL
at	NULL
Tyr	NULL
``	NULL
by	NULL
a	NULL
kinase	NULL
other	NULL
than	NULL
Btk	NULL
,	NULL
including	NULL
members	NULL
of	NULL
the	NULL
Tec	NULL
family	NULL
that	NULL
are	NULL
more	NULL
broadly	NULL
expressed	NULL
.	NULL

Consistent	NULL
with	NULL
this	NULL
notion	NULL
,	NULL
we	NULL
have	NULL
observed	NULL
that	NULL
overexpression	NULL
of	NULL
the	NULL
BAP/	NULL
TFII-I	NULL
(	NULL
Y248F	NULL
)	NULL
mutant	NULL
consistently	NULL
impairs	NULL
basal	NULL
expression	NULL
from	NULL
a	NULL
transfected	NULL
c-fos	NULL
reporter	NULL
construct	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
.	NULL

Our	NULL
findings	NULL
suggest	NULL
that	NULL
two	NULL
other	NULL
Btk	NULL
targets	NULL
within	NULL
BAP/TFII-I	NULL
,	NULL
residues	NULL
Tyr®	NULL
``	NULL
``	NULL
and	NULL
Tyr**	NULL
``	NULL
,	NULL
may	NULL
be	NULL
phosphorylated	NULL
by	NULL
more	NULL
broadly	NULL
expressed	NULL
kinases	NULL
as	NULL
well	NULL
,	NULL
because	NULL
phenylalanine	NULL
substitutions	NULL
at	NULL
these	NULL
sites	NULL
also	NULL
impair	NULL
Btk-independent	NULL
transcription	NULL
from	NULL
the	NULL
c-fos	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
.	NULL

Our	NULL
studies	NULL
implicate	NULL
phosphorylation	NULL
of	NULL
BAP/TFII-I	NULL
at	NULL
residues	NULL
Tyr®**	NULL
and	NULL
Tyr	NULL
``	NULL
,	NULL
and	NULL
perhaps	NULL
at	NULL
Tyr**	NULL
>	NULL
,	NULL
in	NULL
Btk-dependent	NULL
stimulation	NULL
of	NULL
transcription	NULL
from	NULL
the	NULL
c-fos	NULL
promoter	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
debilitating	NULL
effects	NULL
of	NULL
these	NULL
mutations	NULL
were	NULL
not	NULL
additive	NULL
.	NULL

This	NULL
suggests	NULL
the	NULL
existence	NULL
of	NULL
one	NULL
or	NULL
more	NULL
functional	NULL
interactions	NULL
among	NULL
these	NULL
three	NULL
sites	NULL
;	NULL
an	NULL
understanding	NULL
of	NULL
these	NULL
interactions	NULL
may	NULL
warrant	NULL
further	NULL
study	NULL
.	NULL

Two	NULL
of	NULL
the	NULL
Btk	NULL
phosphorylation	NULL
sites	NULL
within	NULL
BAP/TFII-I	NULL
occur	NULL
within	NULL
loop	NULL
regions	NULL
of	NULL
helix-loop-helix-like	NULL
domains	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
these	NULL
loop	NULL
domains	NULL
are	NULL
available	NULL
for	NULL
modification	NULL
by	NULL
phosphorylation	NULL
and	NULL
perhaps	NULL
for	NULL
interactions	NULL
with	NULL
other	NULL
proteins	NULL
.	NULL

BAP/TFII-I	NULL
promotes	NULL
the	NULL
formation	NULL
of	NULL
a	NULL
ternary	NULL
complex	NULL
involving	NULL
serum	NULL
response	NULL
factor	NULL
,	NULL
Phox1	NULL
and	NULL
the	NULL
c-fos	NULL
promoter	NULL
(	NULL
28	NULL
)	NULL
.	NULL

On	NULL
this	NULL
basis	NULL
,	NULL
BAP/TFII-I	NULL
has	NULL
been	NULL
proposed	NULL
to	NULL
act	NULL
as	NULL
a	NULL
scaffold	NULL
that	NULL
assists	NULL
in	NULL
the	NULL
assembly	NULL
of	NULL
multicomponent	NULL
transcription	NULL
complexes	NULL
(	NULL
28	NULL
,	NULL
33	NULL
)	NULL
.	NULL

Phosphorylation	NULL
of	NULL
BAP/	NULL
TFII-I	NULL
,	NULL
in	NULL
particular	NULL
within	NULL
the	NULL
loop	NULL
regions	NULL
of	NULL
HLH-like	NULL
domains	NULL
,	NULL
may	NULL
facilitate	NULL
the	NULL
construction	NULL
of	NULL
such	NULL
complexes	NULL
,	NULL
perhaps	NULL
through	NULL
the	NULL
creation	NULL
of	NULL
binding	NULL
sites	NULL
for	NULL
specific	NULL
proteins	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Tsukada	NULL
,	NULL
S.	NULL
,	NULL
Saffran	NULL
,	NULL
D.	NULL
C.	NULL
,	NULL
Rawlings	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Parolini	NULL
,	NULL
O.	NULL
,	NULL
Allen	NULL
,	NULL
R.	NULL
C.	NULL
,	NULL
Klisak	NULL
,	NULL
I.	NULL
,	NULL
Sparkes	NULL
,	NULL
R.	NULL
S.	NULL
,	NULL
Kubagawa	NULL
,	NULL
H.	NULL
,	NULL
Mohandas	NULL
,	NULL
T.	NULL
,	NULL
Quan	NULL
,	NULL
S.	NULL
,	NULL
Belmont	NULL
,	NULL
J.	NULL
,	NULL
Cooper	NULL
,	NULL
M.	NULL
,	NULL
Conley	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Witte	NULL
,	NULL
O	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
Cell	NULL
72	NULL
,	NULL
279-290	NULL
2	NULL
.	NULL

Vetrie	NULL
,	NULL
D.	NULL
,	NULL
Vorechovsky	NULL
,	NULL
I.	NULL
,	NULL
Sideras	NULL
,	NULL
P.	NULL
,	NULL
Holland	NULL
,	NULL
J.	NULL
,	NULL
Davies	NULL
,	NULL
A.	NULL
,	NULL
Flinter	NULL
,	NULL
F.	NULL
,	NULL
Hammarstrom	NULL
,	NULL
L.	NULL
,	NULL
Kinnon	NULL
,	NULL
C.	NULL
,	NULL
Levinsky	NULL
,	NULL
R.	NULL
,	NULL
Bobrow	NULL
,	NULL
M.	NULL
,	NULL
Smith	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Bentley	NULL
,	NULL
D.	NULL
R.	NULL
(	NULL
1993	NULL
)	NULL
Nature	NULL
861	NULL
,	NULL
226-233	NULL
3	NULL
.	NULL

Pearl	NULL
,	NULL
E.	NULL
R.	NULL
,	NULL
Vogler	NULL
,	NULL
L.	NULL
B.	NULL
,	NULL
Okos	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
Crist	NULL
,	NULL
W.	NULL
M.	NULL
,	NULL
Lawton	NULL
,	NULL
A.	NULL
R.	NULL
D.	NULL
,	NULL
and	NULL
Cooper	NULL
,	NULL
M.	NULL
D.	NULL
(	NULL
1978	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

120	NULL
,	NULL
1169-1175	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14.	NULL
.	NULL

Haire	NULL
,	NULL
R.	NULL
N.	NULL
,	NULL
Ohta	NULL
,	NULL
Y.	NULL
,	NULL
Lewis	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Fu	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Kroisel	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Litman	NULL
,	NULL
G.	NULL
W.	NULL
16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

Btk	NULL
Phosphorylation	NULL
Sites	NULL
in	NULL
BAP/TFILI-I	NULL
.	NULL

Rawlings	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Saffran	NULL
,	NULL
D.	NULL
C.	NULL
,	NULL
Tsukada	NULL
,	NULL
S.	NULL
,	NULL
Largaespada	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
Grimaldi	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
Cohen	NULL
,	NULL
L.	NULL
,	NULL
Mohr	NULL
,	NULL
R.	NULL
N.	NULL
,	NULL
Bazan	NULL
,	NULL
J.	NULL
F.	NULL
,	NULL
Howard	NULL
,	NULL
M.	NULL
,	NULL
Copeland	NULL
,	NULL
N.	NULL
G.	NULL
,	NULL
Jenkins	NULL
,	NULL
N.	NULL
A.	NULL
,	NULL
and	NULL
Witte	NULL
,	NULL
O	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Science	NULL
261	NULL
,	NULL
358-361	NULL
.	NULL

Thomas	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Sideras	NULL
,	NULL
P.	NULL
,	NULL
Smith	NULL
,	NULL
C.	NULL
I.	NULL
,	NULL
Vorechovsky	NULL
,	NULL
I.	NULL
,	NULL
Chapman	NULL
,	NULL
V.	NULL
,	NULL
and	NULL
Paul	NULL
,	NULL
W.	NULL
E.	NULL
(	NULL
1993	NULL
)	NULL
Science	NULL
261	NULL
,	NULL
355-358	NULL
.	NULL

Scher	NULL
,	NULL
L	NULL
(	NULL
1982	NULL
)	NULL
Adv	NULL
.	NULL

Immunol	NULL
.	NULL

88	NULL
,	NULL
1-71	NULL
.	NULL

Hardy	NULL
,	NULL
R.	NULL
R.	NULL
,	NULL
Hayakawa	NULL
,	NULL
K.	NULL
,	NULL
Parks	NULL
,	NULL
D.	NULL
R.	NULL
,	NULL
and	NULL
Herzenberg	NULL
,	NULL
L.	NULL
A	NULL
.	NULL

(	NULL
1983	NULL
)	NULL
Nature	NULL
306	NULL
,	NULL
270-272	NULL
.	NULL

Hayakawa	NULL
,	NULL
K.	NULL
,	NULL
Hardy	NULL
,	NULL
R.	NULL
R.	NULL
,	NULL
and	NULL
Herzenberg	NULL
,	NULL
L.	NULL
A	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

16	NULL
,	NULL
450-456	NULL
.	NULL

Perlmutter	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
Nahm	NULL
,	NULL
M.	NULL
,	NULL
Stein	NULL
,	NULL
K.	NULL
E.	NULL
,	NULL
Slack	NULL
,	NULL
J.	NULL
,	NULL
Zitron	NULL
,	NULL
I.	NULL
,	NULL
Paul	NULL
,	NULL
W.	NULL
E.	NULL
,	NULL
and	NULL
Davie	NULL
,	NULL
J.	NULL
M.	NULL
(	NULL
1979	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

149	NULL
,	NULL
993-998	NULL
Khan	NULL
,	NULL
W.	NULL
N.	NULL
,	NULL
Nilsson	NULL
,	NULL
A.	NULL
,	NULL
Mizoguchi	NULL
,	NULL
E.	NULL
,	NULL
Castigli	NULL
,	NULL
E.	NULL
,	NULL
Forsell	NULL
,	NULL
J.	NULL
,	NULL
Bhan	NULL
,	NULL
A.	NULL
K.	NULL
,	NULL
Geha	NULL
,	NULL
R.	NULL
,	NULL
Sideras	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Alt	NULL
,	NULL
F.	NULL
W.	NULL
(	NULL
1997	NULL
)	NULL
Int	NULL
.	NULL

Immunol	NULL
.	NULL

9	NULL
,	NULL
395-405	NULL
Siliciano	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Morrow	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
and	NULL
Desiderio	NULL
,	NULL
S.	NULL
V.	NULL
(	NULL
1992	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

89	NULL
,	NULL
11194-11198	NULL
Mano	NULL
,	NULL
H.	NULL
,	NULL
Mano	NULL
,	NULL
K.	NULL
,	NULL
Tang	NULL
,	NULL
B.	NULL
,	NULL
Koehler	NULL
,	NULL
M.	NULL
,	NULL
Yi	NULL
,	NULL
T.	NULL
,	NULL
Gilbert	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Jenkins	NULL
,	NULL
N.	NULL
A.	NULL
,	NULL
Copeland	NULL
,	NULL
N.	NULL
G.	NULL
,	NULL
and	NULL
Thle	NULL
,	NULL
J.	NULL
N.	NULL
(	NULL
19983	NULL
)	NULL
Oncogene	NULL
8	NULL
,	NULL
417-424	NULL
Tamagnone	NULL
,	NULL
L.	NULL
,	NULL
Lahtinen	NULL
,	NULL
L.	NULL
,	NULL
Mustonen	NULL
,	NULL
T.	NULL
,	NULL
Virtaneva	NULL
,	NULL
K.	NULL
,	NULL
Francis	NULL
,	NULL
F.	NULL
,	NULL
Muscatelli	NULL
,	NULL
F.	NULL
,	NULL
Alitalo	NULL
,	NULL
R.	NULL
,	NULL
Smith	NULL
,	NULL
C.	NULL
I.	NULL
,	NULL
Larsson	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Alitalo	NULL
,	NULL
K.	NULL
(	NULL
1994	NULL
)	NULL
Oncogene	NULL
9	NULL
,	NULL
3683-3688	NULL
Vihinen	NULL
,	NULL
M.	NULL
,	NULL
Nilsson	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Smith	NULL
,	NULL
C.	NULL
I	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
FEBS	NULL
Lett	NULL
.	NULL

350	NULL
,	NULL
263-265	NULL
(	NULL
1994	NULL
)	NULL
Hum	NULL
.	NULL

Mol	NULL
.	NULL

Genet	NULL
.	NULL

8	NULL
,	NULL
897-901	NULL
Hu	NULL
,	NULL
Q.	NULL
,	NULL
Davidson	NULL
,	NULL
D.	NULL
,	NULL
Schwartzberg	NULL
,	NULL
P.	NULL
L.	NULL
,	NULL
Macchiarini	NULL
,	NULL
F.	NULL
,	NULL
Lenardo	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
Bluestone	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
and	NULL
Matis	NULL
,	NULL
L.	NULL
A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
1928-1934	NULL
Koike	NULL
,	NULL
M.	NULL
,	NULL
Kikuchi	NULL
,	NULL
Y.	NULL
,	NULL
Tominaga	NULL
,	NULL
A.	NULL
,	NULL
Takaki	NULL
,	NULL
S.	NULL
,	NULL
Akagi	NULL
,	NULL
K.	NULL
,	NULL
Miyazaki	NULL
,	NULL
J.	NULL
,	NULL
Yamamura	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Takatsu	NULL
,	NULL
K.	NULL
(	NULL
1995	NULL
)	NULL
Int	NULL
.	NULL

Immunol	NULL
.	NULL

7	NULL
,	NULL
21-80	NULL
Matsuda	NULL
,	NULL
T.	NULL
,	NULL
Takahashi-Tezuka	NULL
,	NULL
M.	NULL
,	NULL
Fukada	NULL
,	NULL
T.	NULL
,	NULL
Okuyama	NULL
,	NULL
Y.	NULL
,	NULL
Fujitani	NULL
,	NULL
Y.	NULL
,	NULL
Tsukada	NULL
,	NULL
S.	NULL
,	NULL
Mano	NULL
,	NULL
H.	NULL
,	NULL
Hirai	NULL
,	NULL
H.	NULL
,	NULL
Witte	NULL
,	NULL
O.	NULL
N.	NULL
,	NULL
and	NULL
Hirano	NULL
,	NULL
T.	NULL
(	NULL
1995	NULL
)	NULL
Blood	NULL
85	NULL
,	NULL
627-633	NULL
Santos-Argumedo	NULL
,	NULL
L.	NULL
,	NULL
Lund	NULL
,	NULL
F.	NULL
E.	NULL
,	NULL
Heath	NULL
,	NULL
A.	NULL
W.	NULL
,	NULL
Solvason	NULL
,	NULL
N.	NULL
,	NULL
Wu	NULL
,	NULL
W.	NULL
W.	NULL
,	NULL
Grimaldi	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
Parkhouse	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
and	NULL
Howard	NULL
,	NULL
M.	NULL
(	NULL
1995	NULL
)	NULL
Int	NULL
.	NULL

Immunol	NULL
.	NULL

7	NULL
,	NULL
163-170	NULL
Kawakami	NULL
,	NULL
Y.	NULL
,	NULL
Yao	NULL
,	NULL
L.	NULL
,	NULL
Miura	NULL
,	NULL
T.	NULL
,	NULL
Tsukada	NULL
,	NULL
S.	NULL
,	NULL
Witte	NULL
,	NULL
O.	NULL
N.	NULL
,	NULL
and	NULL
Kawakami	NULL
,	NULL
T.	NULL
(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
5108-5113	NULL
Rawlings	NULL
,	NULL
D.	NULL
J	NULL
.	NULL

(	NULL
1999	NULL
)	NULL
Clin	NULL
.	NULL

Immunol	NULL
.	NULL

91	NULL
,	NULL
248-2583	NULL
Rawlings	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Scharenberg	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Park	NULL
,	NULL
H.	NULL
,	NULL
Wahl	NULL
,	NULL
M.	NULL
I.	NULL
,	NULL
Lin	NULL
,	NULL
S.	NULL
,	NULL
Kato	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
Fluckiger	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
Witte	NULL
,	NULL
O.	NULL
N.	NULL
,	NULL
and	NULL
Kinet	NULL
,	NULL
J.	NULL
P.	NULL
(	NULL
1996	NULL
)	NULL
Science	NULL
271	NULL
,	NULL
822-825	NULL
28	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

27815	NULL
Bence	NULL
,	NULL
K.	NULL
,	NULL
Ma	NULL
,	NULL
W.	NULL
,	NULL
Kozasa	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Huang	NULL
,	NULL
X.	NULL
Y	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
Nature	NULL
889	NULL
,	NULL
296-299	NULL
Langhans-Rajasekaran	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
Wan	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Huang	NULL
,	NULL
X.	NULL
Y	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

92	NULL
,	NULL
8601-8605	NULL
Scharenberg	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
El-Hillal	NULL
,	NULL
O.	NULL
,	NULL
Fruman	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
Beitz	NULL
,	NULL
L.	NULL
O.	NULL
,	NULL
Li	NULL
,	NULL
Z.	NULL
,	NULL
Lin	NULL
,	NULL
S.	NULL
,	NULL
Gout	NULL
,	NULL
L.	NULL
,	NULL
Cantley	NULL
,	NULL
L.	NULL
C.	NULL
,	NULL
Rawlings	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
and	NULL
Kinet	NULL
,	NULL
J.	NULL
P.	NULL
(	NULL
1998	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

17	NULL
,	NULL
1961-1972	NULL
Yang	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
Desiderio	NULL
,	NULL
S.	NULL
(	NULL
1997	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

94	NULL
,	NULL
604-609	NULL
Roy	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
Du	NULL
,	NULL
H.	NULL
,	NULL
Gregor	NULL
,	NULL
P.	NULL
D.	NULL
,	NULL
Novina	NULL
,	NULL
C.	NULL
D.	NULL
,	NULL
Martinez	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Roeder	NULL
,	NULL
R.	NULL
G.	NULL
(	NULL
1997	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

16	NULL
,	NULL
7091-7104	NULL
Grueneberg	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
Henry	NULL
,	NULL
R.	NULL
W.	NULL
,	NULL
Brauer	NULL
,	NULL
A.	NULL
,	NULL
Novina	NULL
,	NULL
C.	NULL
D.	NULL
,	NULL
Cheriyath	NULL
,	NULL
V.	NULL
,	NULL
Roy	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
and	NULL
Gilman	NULL
,	NULL
M.	NULL
(	NULL
1997	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

11	NULL
,	NULL
2482-2493	NULL
Ferre-D'Amare	NULL
,	NULL
A.	NULL
R.	NULL
,	NULL
Prendergast	NULL
,	NULL
G.	NULL
C.	NULL
,	NULL
Ziff	NULL
,	NULL
E.	NULL
B.	NULL
,	NULL
and	NULL
Burley	NULL
,	NULL
S.	NULL
K.	NULL
(	NULL
1998	NULL
)	NULL
Nature	NULL
868	NULL
,	NULL
38-45	NULL
Cheriyath	NULL
,	NULL
V.	NULL
,	NULL
and	NULL
Roy	NULL
,	NULL
A.	NULL
L.	NULL
(	NULL
2000	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

275	NULL
,	NULL
26300-26308	NULL
Novina	NULL
,	NULL
C.	NULL
D.	NULL
,	NULL
Cheriyath	NULL
,	NULL
V.	NULL
,	NULL
and	NULL
Roy	NULL
,	NULL
A.	NULL
L.	NULL
(	NULL
1998	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

278	NULL
,	NULL
33448-33448	NULL
Novina	NULL
,	NULL
C.	NULL
D.	NULL
,	NULL
Kumar	NULL
,	NULL
S.	NULL
,	NULL
Bajpai	NULL
,	NULL
U.	NULL
,	NULL
Cheriyath	NULL
,	NULL
V.	NULL
,	NULL
Zhang	NULL
,	NULL
K.	NULL
,	NULL
Pillai	NULL
,	NULL
S.	NULL
,	NULL
Wortis	NULL
,	NULL
H.	NULL
H.	NULL
,	NULL
and	NULL
Roy	NULL
,	NULL
A.	NULL
L.	NULL
(	NULL
1999	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

19	NULL
,	NULL
5014-5024	NULL
Kim	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
Cheriyath	NULL
,	NULL
V.	NULL
,	NULL
Roy	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
and	NULL
Cochran	NULL
,	NULL
B.	NULL
H.	NULL
(	NULL
1998	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18	NULL
,	NULL
3310-3320	NULL
Kozak	NULL
,	NULL
M.	NULL
(	NULL
1989	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

9	NULL
,	NULL
5073-5080	NULL
Jones	NULL
,	NULL
D.	NULL
H.	NULL
,	NULL
and	NULL
Winistorfer	NULL
,	NULL
S.	NULL
C.	NULL
(	NULL
1992	NULL
)	NULL
BioTechniques	NULL
12	NULL
,	NULL
528-530	NULL
,	NULL
532	NULL
,	NULL
534-535	NULL
Gorman	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
Gies	NULL
,	NULL
D.	NULL
R.	NULL
,	NULL
and	NULL
McCray	NULL
,	NULL
G.	NULL
(	NULL
1990	NULL
)	NULL
DNA	NULL
Protein	NULL
Eng	NULL
.	NULL

Tech	NULL
.	NULL

2	NULL
,	NULL
3-10	NULL
Yang	NULL
,	NULL
W.	NULL
,	NULL
Malek	NULL
,	NULL
S.	NULL
N.	NULL
,	NULL
and	NULL
Desiderio	NULL
,	NULL
S.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
20832-20840	NULL
Paborsky	NULL
,	NULL
L.	NULL
R.	NULL
,	NULL
Fendly	NULL
,	NULL
B.	NULL
M.	NULL
,	NULL
Fisher	NULL
,	NULL
K.	NULL
L.	NULL
,	NULL
Lawn	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
Marks	NULL
,	NULL
B.	NULL
J.	NULL
,	NULL
McCray	NULL
,	NULL
G.	NULL
,	NULL
Tate	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
Vehar	NULL
,	NULL
G.	NULL
A.	NULL
,	NULL
and	NULL
Gorman	NULL
,	NULL
C.	NULL
M.	NULL
(	NULL
1990	NULL
)	NULL
Protein	NULL
Eng	NULL
.	NULL

8	NULL
,	NULL
547-553	NULL
Hunter	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Sefton	NULL
,	NULL
B.	NULL
M.	NULL
(	NULL
1991	NULL
)	NULL
Methods	NULL
Enzymol	NULL
.	NULL

210	NULL
,	NULL
110-153	NULL
West	NULL
,	NULL
M.	NULL
H.	NULL
P.	NULL
,	NULL
Wu	NULL
,	NULL
R.	NULL
S.	NULL
,	NULL
and	NULL
Bonner	NULL
,	NULL
W.	NULL
M.	NULL
(	NULL
1984	NULL
)	NULL
Electrophoresis	NULL
5	NULL
,	NULL
183-138	NULL
Takata	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Kurosaki	NULL
,	NULL
T.	NULL
(	NULL
1996	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

184	NULL
,	NULL
31-40	NULL
Yao	NULL
,	NULL
L.	NULL
,	NULL
Kawakami	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Kawakami	NULL
,	NULL
T.	NULL
(	NULL
1994	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

91	NULL
,	NULL
9175-9179	NULL
Baba	NULL
,	NULL
Y.	NULL
,	NULL
Nonoyama	NULL
,	NULL
S.	NULL
,	NULL
Matsushita	NULL
,	NULL
M.	NULL
,	NULL
Yamadori	NULL
,	NULL
T.	NULL
,	NULL
Hashimoto	NULL
,	NULL
S.	NULL
,	NULL
Imai	NULL
,	NULL
K.	NULL
,	NULL
Arai	NULL
,	NULL
S.	NULL
,	NULL
Kunikata	NULL
,	NULL
T.	NULL
,	NULL
Kurimoto	NULL
,	NULL
M.	NULL
,	NULL
Kurosaki	NULL
,	NULL
T.	NULL
,	NULL
Ochs	NULL
,	NULL
H.	NULL
D.	NULL
,	NULL
Yata	NULL
,	NULL
J.	NULL
,	NULL
Kishimoto	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Tsukada	NULL
,	NULL
S.	NULL
(	NULL
1999	NULL
)	NULL
Blood	NULL
98	NULL
,	NULL
2003-2012	NULL
Kim	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
and	NULL
Cochran	NULL
,	NULL
B.	NULL
H.	NULL
(	NULL
2000	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

20	NULL
,	NULL
1140-1148	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
Identification	NULL
of	NULL
Phosphorylation	NULL
Sites	NULL
for	NULL
Bruton	NULL
's	NULL
Tyrosine	NULL
Kinase	NULL
within	NULL
the	NULL
Transcriptional	NULL
Regulator	NULL
BAP/TFII-I	NULL
Ann	NULL
Marie	NULL
Egloff	NULL
and	NULL
Stephen	NULL
Desiderio	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

2001	NULL
,	NULL
276:27806-27815.	NULL
doi	NULL
:	NULL
10.1074/jbc.M103692200	NULL
originally	NULL
published	NULL
online	NULL
May	NULL
23	NULL
,	NULL
2001	NULL
Access	NULL
the	NULL
most	NULL
updated	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
doi	NULL
:	NULL
10.1074/jbe.M103692200	NULL
Alerts	NULL
:	NULL
«	NULL
When	NULL
this	NULL
article	NULL
is	NULL
cited	NULL
«	NULL
When	NULL
a	NULL
correction	NULL
for	NULL
this	NULL
article	NULL
is	NULL
posted	NULL
Click	NULL
here	NULL
to	NULL
choose	NULL
from	NULL
all	NULL
of	NULL
JBC	NULL
's	NULL
e-mail	NULL
alerts	NULL
This	NULL
article	NULL
cites	NULL
44	NULL
references	NULL
,	NULL
24	NULL
of	NULL
which	NULL
can	NULL
be	NULL
accessed	NULL
free	NULL
at	NULL
http	NULL
:	NULL
//www	NULL
.	NULL

full.html	NULL
#	NULL
ref-list-1	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL

